A new, cutting- edge technology that allows for complete medical information confidentiality was implemented at Rambam last week. The BIG DATA software enables physicians and researchers to conduct a wide range of searches quickly, all while maintaining patients' medical record confidentiality.
This innovative technology was developed by the Israeli company- MDCLONE and transforms real medical records into "synthetic" information. It scans through all the real medical records and "invents"/ "clones" patients. This means that all the information is identical to the information in the real database; however, each case contains no real information about the patient’s' identity.
Today, with the use of this new technology, there is no concern regarding the information researched, as it is comprised of "synthetic patients". Dr. Irit Hochberg, an Endocrinologist at Rambam, is the first to use this cutting-edge technology, after conducting a research study that checked BIG DATA’s accuracy. Dr. Hochberg compared parameters found in real life research with data collected through the BIG DATA technology. The results she received were identical.
Prof. Rafi Beyar, Rambam's Director and CEO said, "This technology puts us at the forefront of science and research, so that every physician who receives approval will be able to conduct research, while maintaining complete patient confidentiality. This will allow for quicker and more available research, cut research costs, and most importantly ensure complete patient anonymity."
Photo provided by Rambam Health Care Campus
Joint venture between Ultra Health, Panaxia brings smokeless cannabis medicine to United States
(Albuquerque, New Mexico) – Ultra Health®, New Mexico’s No. 1 cannabis company with a nationwide presence, and Panaxia Pharmaceuticals Industries Ltd, an Israeli pharmaceutical company specializing in pharmaceutical cannabis R&D and manufacturing, launched their first pharmaceutical cannabis production facility in the United States, located in Bernalillo, New Mexico. The facility will manufacture smokeless, accurately dosed cannabis medicine in a variety of delivery methods.
Panaxia is providing smokeless proprietary cannabinoid dosage and treatment protocols, which are not readily available in the United States, in order to manufacture state-of-the-art products to treat a number of illnesses. The production facility is implementing Panaxia's technology, including advanced Good Manufacturing Practice (GMP) production protocols as well as validated analytical system and proprietary production technology.
The smokeless products include sublingual and oral tablets, rectal and vaginal suppositories, cannabis oil, pastilles, transdermal pain relief patches and topical creams for the treatment of pain, burns and psoriasis. They are beneficial to current chronic conditions requiring ongoing dosing such as PTSD, chronic pain, cancer, neuropathy pain, epilepsy, anorexia and HIV/AIDS.
"At Ultra Health, our mission is to provide superior-quality and affordable medical grade cannabis to New Mexico patient's,” Rodriguez said. “Ultra Health is driven by compassionate innovation and supported by science and technology. It is important that we develop new products in anticipation of meeting the rapidly growing patient and provider demands.”
"We are extremely excited to open our first production facility in the United States,” said Dr. Dadi Segal, CEO of Panaxia. “It is history in the making for an Israeli company to bring the tidings to the citizens of New Mexico. Panaxia is part of an organization that has been active in the Israeli and global pharmaceutical industry for more than 40 years. Since we established Panaxia in 2010, we constantly strive to bring the strictest protocols and most advanced technology available in the pharma industry to the production of our cannabis based products. At Panaxia, we believe that pharmaceutical cannabis products should be developed and manufactured under the highest standards and quality assurance levels like any other pharmaceutical product. We are happy to move forward into bringing smokeless, exact and reproducible dosing capabilities for medical cannabis products to the United States market."
He continued: "We believe in the coming months of 2017 both companies will be launching an additional production".
About Ultra Health
Ultra Health is a turnkey solutions provider for the specialty healthcare cannabis industry, with operations and facilities in Arizona, New Mexico, and Nevada. From retail dispensaries to commercial-scale cannabis production, Ultra Health offers the unmatched technical expertise, proprietary business tools and deep industry knowledge to fulfill the specific requirements of any project related to the cannabis industry. Ultra Health partners with a broad spectrum of businesses and Tribal Nations to design formulate and manage cannabis-related economic development opportunities that are profitable, scalable and mutually beneficial.
About Panaxia pharmaceutical industries Ltd
Panaxia pharmaceutical Industries is a manufacturer of pharmaceutical dosage forms based on Cannabis. The company is part of a larger group of companies, which manufacture pharmaceuticals for more than 40 years. Altogether, the group produces more than 300 different conventional medication products, with a wide range of indications from sore throat lozenges to dermal fillers. The group sells in more than 25 countries and is very R&D oriented. Panaxia pharmaceutical Industries has been developing and manufacturing pharmaceutical products based on cannabis since 2010.
APERIO systems was recognized as the most innovative cyber security startup; The five finalists included Cybellum, Sepio Systems, Cymulate & Intezer The announcement was made during a special panel at Cybertech 2017, held in Israel for the fourth time at Pavilion 2 in the Israel Trade Fairs & Convention Center
Buky Carmeli, Head of the Israel National Cyber Security Authority, BG (res) Dr. Daniel Gold, Head of Defense R&D Directorate, IMOD/IDF & Head of Israel National Civilian R&D committee and other cyber security executives were among the prominent speakers at the conference
Tel Aviv, Israel - APERIO Systems was selected as the most innovative startup in cyber security at “The Cybertech Startup Competition powered by YL Ventures", that took place during Cybertech 2017. Yoav Lightersdorf founder of YL Ventures, awarded the winning prize to company founders Yevgeni Nogin and Michael Shalyt. Winning over dozens of other applicants, APERIO Systems secures critical control systems with a last line of defense against both internal and external cyber threats and malicious actors. APERIO Systems enables unprecedented resilience and operational integrity for critical infrastructure such as power plants, water and waste control, manufacturing, oil and gas, energy, transportation, pharma, and food and beverage. The company uses statistical physics and state-of-the-art machine learning techniques to detect operational data forgery attempts and reconstruct the true state of industrial control systems in real time. More information at www.aperio-systems.com
Finalists in the competition included Intezer, who developed a “Shazam” like technology for software, able to identify the name and manufacturer of any unknown file or code, be it secure software or malware. Cymulate- a platform for extended simulation of cyber-attacks, enabling multiple controlled cyber-attacks in the main attack channels simultaneously at any given time, & Cybellum who developed a technology that stops zero-days attacks in the initial and critical stage of the breach.
The startup competition distinguished panel of judges are leading executives from information protection companies, cybersecurity industries and technological corporations as well as partners of American VC funds. The judges included David Cross, Cloud Security Engineering Director, Google Security and Privacy organization, USA, Glenn Chisholm, CTO, Cylance, Jacques Benoski, Partner, USVP,Jay Leek,CISO, The Blackstone Group & Doug Russell, Managing Director & SVP of Strategy & Corporate Development, MassMutual Ventures (Link to the complete Judges list) .
APERIO Systems won two tickets to the prestigious RSA convention, the world's leading cyber conference, being held this coming February in San Francisco. This will be an incredible opportunity for an Israeli start up to attend the largest and most influential Cyber security conference in the world.
Conference highlights – Feb. 1st:
Speaking at the conference’s opening plenary on Feb 1st, BG (res) Dr. Daniel Gold, Head of Defense R&D Directorate, IMOD/IDF & Head of Israel National Civilian R&D committee, stated that: "Holistic approach and collaboration are essential to our ability to address cyber security issues". In his speech, Gold said that "Cyber-attacks will become more powerful & frequent in the near future, and that the same trends are predicted for Ransom ware, SCADA cyber-attacks and DDOS attacks. Cyber-attacks at large are expected to become increasingly malicious and hazardous, creating greater damage and lasting longer".
Gold reviewed the responsibilities of the Defense R&D Directorate, Israel Defense Authorities’ largest R&D organization, which include: Military R&D, production and manufacture, spaceships and satellites, UMV’s, intelligence, aerial defense systems, electro optics, electronic warfare cyber, smart weapons and munitions, sensors, SIGINT etc.
Gold announced that the Directorate he’s heading is working on a program to be submitted to the Government, which will position Israel as a world leader in the cyber arena. The project, lead in collaboration with Academia, focuses on current developments in the field: "The most important issues in Cyber defense are a pro-active approach for cyber-attacks, environmental awareness - knowing who’s behind the attacks and responding accordingly- and damage control. A Holistic view of the field and complete cooperation on all sides, including government officials, can advance the development of systems and techniques for Cyber defense.”
Buky Carmeli, Head of the Israel National Cyber Security Authority, spoke at Cybertech about the role of the NCSA: “Our aim is to ensure that every person in Israel will be able to use the computer and the cyber space safely and securely. The NCSA was founded a year ago with only a few workers. Today it employees 170 people in Tel Aviv and Beersheba, engaged in the broad field of cyber protection in the civil sector. In September last year NCSA established the National CERT already operating successfully these days."
Carmeli added: "A national scale cyber-attack is a national scale emergency just like a weather emergency situation or a terror attack. The results of an attack can be severe and require building roadblocks & calling-up a large number of people for reserve duty.” The NCSA is formulating regulations, instructions and orders on how to handle such situations and is also involved in the preparation of the Cyber Law.
Other interesting assessments were made by Jeffrey Berkowitz and Gerson Panitch, partners at Finnegan who warned Israeli companies that lack sufficient patent protection: “Your competitors are applying for patents in an effort to block you”. The Finnegan representatives explained that “The cyber market for the next four years is estimated at a trillion dollars. That’s a lot of money. In 2015 there were about -35 000 patents in Cyber. This is a huge amount. But, while American companies register thousands of patents a year, Israeli companies only register dozens. It's a huge difference. It shows that Israel is far behind in the patent world. This means that Israeli companies are in trouble because anyone can block their ability to sell on the global market. There’s a huge market for Cyber, but if you are not protected by a patent, you won’t have any protection from a lawsuit with competitors".
Cybertech 2017 Conference, was held in Israel for the fourth year at Pavilion 2 of the Israel Trade Fairs & Convention Center on January 30th - February 1st. It is considered the second largest conference and exhibition of cyber technologies in the world. Cybertech, bringing together leading investors, entrepreneurs and cyber companies, is consisted of a conference with prominent international speakers in the field of cyber security, as well as an exhibition hosting over 250 companies and 100 startups, presenting innovative problem-solving strategies and solutions to challenges relevant for a wide range of sectors.
Photo Credit: Gilad Kavalerchik
Zuk Avraham, Founder and Chairman of 'Zimperium' at Cybertech 2017: "We will allocate 1.5 Million dollars to open a new program for researchers, scientists and communication companies that will enrich the knowledge gathered on mobile attacks"
Zuk Avraham made this announcement today at the second largest cyber conference in the world at the Israel Trade Fairs & Convention Center, Pavilion 2,
Participants in Cybertech, closing today, included heads of state, senior global cyber industry decision-makers and officials from the Cyber industry.
Yitzhak Zuk Avraham opened his speech by describing the main current challenge he identifies: Everyone is talking about IoT security, but we need to put things into perspective. The real threat today is right inside our pockets- a 24/7 active microphone and camera, a continuously transmitting and always available device, without adequate protection- the real danger is in our cellphones. Why aren’t there enough companies providing mobile protection? This is a complex market with high entry barriers. Providing protection solutions is a complicated task." Zuk Avraham is the Founder and Chairman of 'Zimperium', a San Francisco based company that has raised millions of dollars, with the majority of its investors from Japan".
Avraham also declared that 'Zimperium' will open a new program designated for researches, scientists and communication companies designed to enrich and expend the knowledge gathered regarding mobile attacks. The company has appropriated 1.5 Million dollars to establish the data base that will in turn help enhance the company's computer learning capabilities: "we will acquire programs that have proven themselves efficient to learn more about different local and global attacks that occurred that will improve the abilities of our platforms. We will have an open code that we'll share with the community so that people will be able to learn how to handle malfunctions and develop the knowledge in the field".
Cybertech 2017 Conference, held for the fourth year in Israel at Pavilion 2 of the Israel Trade Fairs & Convention Center on January 30th - February 1st is the second largest conference and exhibition of cyber technologies in the world. Cybertech, bringing together leading investors, entrepreneurs and cyber companies, consists of a conference with prominent international speakers in the field of cyber security, as well as an exhibition hosting over 250 companies and 100 startups presenting innovative problem-solving strategies and solutions to challenges relevant for a wide range of sectors.
Photo Credit: Gilad Kavalerchik
"We have excellent relations with Mexico" stated Prime Minister Benjamin Netanyahu this morning at the second largest cyber conference in the world, taking place today and tomorrow at the Israel Trade Fairs & Convention Center, Pavilion 2, alongside heads of state, senior global cyber industry decision-makers and officials from the Cyber industry.
Panels, events and special compounds dedicated to Cyber also operating throughout the exhibition, feature collaborations between global law enforcement authorities; International panels discussing challenges and missions; Hackers arena; Start-up competitions and more.
Prof. Rivka Carmi, President of Ben Gurion University of the Negev, addressed Beersheba’s status as Israel's new cyber capital and the university’s leading role in its development: On behalf of BGU I am honored and proud to welcome you to the cyber tech conference that we are cohosting with Israel defense since it's inception 4 years ago. We have created a robust echo system of cyber technologies’ research and development in Beer Sheva, an international model of collaboration between academia, industry and business supported by the government and the municipality.
With close to 50 multinational companies, and about 1800 employees, many of them BGU graduates and graduate students, we have started a new Silicon Valley or, more appropriately, Wadi, which tackles cyber security challenges in diverse areas looking for advanced, evolving and ever changing solutions to the ever growing world of data and digitalization that we are all facing and experiencing. This collaboration is an engine of growth and development but also one of originality and innovation that are key factors in moving ahead rapidly in imagining the future.”
Dr. Eviatar Matania, Director General, the Israel National Cyber Directorate said that the years that have passed attest to the abundance of cyber threats worldwide. Israel has been one of the first countries to prepare for the cybersecurity challenges through three primary processes. The first process – providing education and information on all cyber-related issues to the business world and the industry. The second process – the establishment of the National Cyber Authority, another move where, once again, Israel has been a world pioneer. The third process – developing cyber technology R&D processes throughout the country, including the industry, academia and educational institutions. In all of these fields, Israel is an established world leader in education, information and the development of cybersecurity technologies.”
The Director General of the Israel Electric Corporation, Yiftah Ron-Tal, called at the CyberTech 2017 Conference for the establishment of a global "Cyber Event Reporting Center" (CERC) that would concentrate all of the information, knowledge and data regarding cybersecurity for the entire world. The Director General of IEC also reported that in the past year, the number of cyberattacks staged against the Israel Electric Corporation decreased, but the attacks became more sophisticated. In the past the number of cyberattacks had reached 5.5 million per month. Ron-Tal is convinced that the world is currently involved in a continuous, on-going cyber war so the most important concept these days is cybersecurity “
Rick Snyder, Governor of the State of Michigan stated that: “in Michigan, we also have a national service cyber unit, much like the IDF. We established The Michigan Cyber Civilian Corps, gathering talented individuals who can respond if anything occurs, which I am very excited about because I believe it is the forefront of the future”.
Addressing the opening plenum of the CyberTech 2017 Conference, Gil Shwed, founder and CEO, Check Point Software Technologies Ltd. presented statistics indicating that more than 90% of users fail to acquire cybersecurity systems and new protective technologies, mainly owing to the mistaken assumption that "we will not be harmed." Shwed suggested that "The correct approach is to develop and build a single, standard cybersecurity system that would handle the various types of threats against the cloud, against mobile devices and against data centers and computer systems. The key word is prevention – preventing cyberattacks, and in order to develop systems for preventing cyberattacks, intelligence should be collected regarding the various attackers. The architecture should be developed and various cybersecurity technologies should be integrated into a single system that would be offered to the clients and provide them with effective protection against attacks aimed at the cloud, mobile devices, data centers and computer systems. Today the industry is aware of the dangers and threats, and we should develop standard cybersecurity systems and convince people to use them so as to cope with the potential damage to cybersecurity through preventive measures."
Photos Gilad Kavalerchik
A new approach to stabilizing protein structures could be key to an efficient vaccine
Despite decades of malaria research, the disease still afflicts hundreds of millions and kills around half a million people each year – most of them children in tropical regions. Part of the problem is that the malaria parasite is a shape-shifter, making it hard to target. But another part of the problem is that even the parasite’s proteins that could be used as vaccines are unstable at tropical temperatures and require complicated, expensive cellular systems to produce them in large quantities. Unfortunately, the vaccines are most needed in areas where refrigeration is lacking and funds to buy vaccines are scarce. A new approach developed at the Weizmann Institute of Science, recently reported in Proceedings of the National Academy of Science (PNAS), could, in the future, lead to an inexpensive malaria vaccine that can be stored at room temperature.
The RH5 protein is one of the malaria parasite’s proteins that have been tested for use as a vaccine. This protein is used by the parasite to anchor itself to the red blood cells it infects. Using the protein as a vaccine alerts the immune system to the threat without causing disease, thus enabling it to mount a rapid response when the disease strikes, and to disrupt the parasite’s cycle of infection. Research student Adi Goldenzweig and Dr. Sarel Fleishman of the Institute’s Biomolecular Sciences Department decided to use the computer-based protein design tools they have been developing in Fleishman’s lab to improve the usefulness of this protein.
Based on software they have been creating for stabilizing protein structures, Goldenzweig developed a new program for “programming” proteins used in vaccines against infectious diseases. Such proteins, because they are under constant attack by the immune system, tend to mutate from generation to generation. So the program she developed uses all the known information on different configurations of the protein sequence in different versions of the parasite. “The parasite deceives the immune system by mutating its surface proteins. Paradoxically, the better the parasite is at evading the immune system, the more clues it leaves for us to use in designing a successful artificial protein,” she says.
The researchers sent the programmed artificial protein to a group in Oxford that specializes in developing a malaria vaccine. This group, led by Prof. Matthew Higgins and Simon Draper, soon had good news: The results showed that, in contrast with the natural ones, the programmed protein can be produced in simple, inexpensive cell cultures, and in large quantities. This could significantly lower production costs. In addition, it is stable at temperatures of up to 50o C, so it won’t need refrigeration. Best of all, in animal trials, the proteins provoked a protective immune response. “The method Adi developed is really general,” says Fleishman. “It has succeeded where others have failed, and because it is so easy to use, it might be applied to emerging infectious diseases like Zika or Ebola, when quick action can stop an epidemic from developing.”
Fleishman and his group are currently using their method to test a different strategy for treating malaria, based on targeting the RH5 protein itself and blocking its ability to mediate the contact between the parasite and human red blood cells.
Dr. Sarel Fleishman’s research is supported by the Rothschild Caesarea Foundation; Sam Switzer, Canada; and the European Research Council. Dr. Fleishman is the incumbent of the Martha S. Sagon Career Development Chair.
A Rusty Green Early Ocean?
Though they may seem rock solid, the ancient sedimentary rocks called iron formations – the world’s chief economic source of iron ore – were once dissolved in seawater. How did that iron go from a dissolved state to banded iron formations? Dr. Itay Halevy and his group in the Weizmann Institute of Science’s Earth and Planetary Sciences Department suggest that billions of years ago, the “rust” that formed in the seawater and sank to the ocean bed was green – an iron-based mineral that is rare on Earth today but might once have been relatively common.
We know there was dissolved iron in the early oceans, and this is a strong indication that Earth’s free oxygen (O2) concentrations were exceedingly low. Otherwise, the iron would have reacted with oxygen to form iron oxides, which are the rusty red deposits familiar to anyone who’s left a bike out in the rain. Today, says Halevy, iron is delivered from the land to the oceans as small insoluble oxide particles in rivers. But this mode of sedimentation only came about as free oxygen accumulated in Earth’s atmosphere, about 2.5 billion years ago. With almost no oxygen, the oceans were iron-rich, but that did not mean that iron remained dissolved in seawater indefinitely: It ultimately formed insoluble compounds with other elements and settled to the seabed to give rise to banded iron formations.
The idea that one of those insoluble compounds could be a rusty green mineral, says Halevy, occurred to him during his doctoral research, when he was trying to recreate the conditions on early Mars, including its rusty-red iron sediments. “I got some green stuff I didn’t recognize at first, which quickly turned orange when I exposed it to air. With a little more careful experimentation, I found that this was a mineral called green rust, which is extremely rare on Earth today, owing to its affinity for oxygen.” Today green rust quickly transforms into the familiar red rust, but with not much free oxygen around, Halevy reasoned, it could have been an important way for dissolved iron to form solid compounds and settle to the seafloor.
Support for these ideas comes from Sulawesi, Indonesia, where green rust forms today in iron-rich, oxygen-poor Lake Matano, thought to be similar to the seawater that existed during extended periods of Earth’s early history. To test his ideas in detail and explore their significance, Halevy set up experiments in which he and his team recreated, as closely as possible, the conditions of the ancient, oxygen-free, Precambrian ocean. They found that green rust not only forms under these conditions, but that when left to age, it transforms into the minerals found in Precambrian iron formations – a combination of iron-bearing oxides, carbonates and silicates.
Could green rust have been a main vehicle for settling iron out of seawater? Halevy and his team developed models to depict the iron cycle in Earth’s early oceans, including the possibility of green rust formation and competition with other mineral shuttles of iron to the seafloor. Their findings suggest that green rust was probably a major player in the iron cycle. The iron in the green rust later transformed into the minerals we can now observe in the geologic record. “Of course, it would have been one of several means of iron deposition, just as a number of different processes are involved in chemical sedimentation in the oceans today,” says Halevy. “But as far as we can tell, green rust should have delivered a substantial proportion of iron to the very early ocean sediments.”
Dr. Itay Halevy’s research is supported by the Helen Kimmel Center for Planetary Science; the Deloro Institute for Advanced Research in Space and Optics; and the Wolfson Family Charitable Trust. Dr. Halevy is the incumbent of the Anna and Maurice Boukstein Career Development Chair in Perpetuity.
Uncovering the Secrets of White Cell Power
White blood cells push their way through barriers to get to infection sites
One of the mysteries of the living body is the movement of cells – not just in the blood, but through cellular and other barriers. New research in the Weizmann Institute of Science has shed light on the subject, especially on the movement of immune cells that race to the sites of infection and inflammation. The study revealed that these cells – white blood cells – actively open large gaps in the internal lining of the blood vessels, so they can exit through the vessel walls and rapidly get to areas of infection.
Prof. Ronen Alon and his group in the Weizmann Institute’s Immunology Department discovered how various white blood cells push their way through the lining of the blood vessels when they reach their particular “exit ramps.” Using their nuclei to exert force, they insert themselves between – as well as into – the cells in the vessel walls called endothelial cells. Dismantling structural filaments within the cytoskeletons – the internal skeletons – of the endothelial cells creates the large holes – several microns in diameter.
Alon explains that the nucleus is the largest, most rigid structure in the cell. When driven by motors specifically engaged for this function, is tough enough to push through the barrier imposed by the blood vessel walls.
The scientists tracked the cytoskeletons of endothelial cells as they were crossed by immune cells in real time, the behavior of the nuclei of various white blood cells during active squeezing and the fate of the various types of actin fibers that make up the endothelial cell skeletons. The researchers used a number of methods, including fluorescence and electron microscopy, in collaboration with Dr. Eugenia Klein of the Microscopy Unit; a unique system in Alon’s lab for simulating blood vessels in a test tube; and in vivo imaging with Prof. Sussan Nourshargh of Queen Mary University of London. The results of this research, conducted in Alon’s lab by research students Sagi Barzilai and Francesco Roncato and postdoctoral fellow Dr. Sandeep Kumar Yadav, were recently reported in Cell Reports.
Common wisdom in this field had held that the endothelial cells must help immune cells squeeze through by contracting themselves like small muscles, but the present study found no evidence for such contraction-based help. Alon says: “Our study shows that the endothelial cells, which were thought to be dynamic assistants in this process of crossing of blood vessel walls, are really more responders to the ‘physical work’ invested by the white blood cell motors and nuclei in generating gaps and crossing through blood vessels.”
Significance for cancer research
In addition to increasing the basic understanding of how the various arms of the immune system reach their sites of differentiation and activity, these findings may aid in cancer research. “We believe that small subsets of metastatic tumor cells have the ability to adopt the mechanisms used by immune cells to exit the blood vessels into the lungs, the bone marrow, the brain and other organs. If this is true, we might be able to identify these subsets and target them before these cells leave their original tumor sites and invade distant organs,” says Alon.
Prof. Ronen Alon’s research is supported by the Herbert L. Janowsky Lung Cancer Research Fund; Mr. and Mrs. William Glied, Canada; and Carol A. Milett, Aventura, FL. Prof. Alon is the incumbent of the Linda Jacobs Professorial Chair in Immune and Stem Cell Research.
The Weizmann Institute of Science is one of the world’s leading multidisciplinary research institutions. Comprising five faculties, 17 departments, a graduate school and 50 multidisciplinary centers, hundreds of scientists, laboratory technicians and research students work on the Institute's lushly landscaped campus, embarking daily on fascinating journeys into the unknown, seeking to improve our understanding of nature and our place within it.
Facebook Weizmann Institute of Science
Photo : by “thinkstock”. provided by Weizmann Department of Media Relations
Forbes Announces First Round of Speakers for 2017 Forbes Under 30 Summit EMEA
Speakers for Forbes’ Under 30 Summit EMEA include Sean Rad, Cofounder and Chairman, Tinder; Yossi Vardi, Internet Entrepreneur; Teddy Sagi, Founder of PlayTech, Market Tech and SafeCharge; Steven Izen, Founder & CEO, Lokai; and Farah Abdi, Somali Refugee, Author, Blogger and Human Rights Activist
750 Young Entrepreneurial Game Changers and Legendary Mentors Are Expected to Gather in
Jerusalem and Tel Aviv, April 2-6, 2017
TEL AVIV (January 26, 2017) – Forbes announced today the first round of speakers and participants for the second Under 30 Summit EMEA (Europe, Middle East and Africa), which will take place in Tel Aviv and Jerusalem, April 2-6, under the theme “Innovation, Exploration, and Inspiration.” For the summit, an invitation-only event, Forbes is expected to bring together over 750 of some of the world’s most influential young entrepreneurs -- 250 from the U.S., 250 from Europe and 250 from Israel, as culled from Forbes’ 30 Under 30 lists. The speakers announced today include:
For more information on the summit, please visit:
Building on last year’s successful entrepreneur-driven summit and cultural immersion, Forbes is expanding its celebration of innovation and startups. For five days, innovators, inventors, pioneers, mentors and investors will focus on breakthrough ideas that tackle the most intractable problems facing our society and the planet.
Forbes will feature -- as part of the summit’s agenda, panels, interviews, performances, product demos and keynote addresses, showcasing the most cutting-edge innovators and disruptors, and will provide mentorship from successful business leaders. The conversation will focus on using innovation to reimagine humanity. At the event, participants will hear from visionaries -- entrepreneurs, artists, activists and inventors -- shaping the future in powerful ways.
“As these innovators explore the intersection of Big Data, smart design, AI, robotics, virtual and augmented reality and other accelerating tech trends, participants in our summit will realize an evident truth: We have the tools and technologies to create a better world, if we can muster the comity and the will,” said Randall Lane, Editor of Forbes magazine and creator of Forbes’ Under 30 franchise.
The summit will offer rich cultural-immersion activities and a unique global-networking environment. Forbes 30 Under 30 Summit attendees will also have the opportunity to mentor and inspire the next generation of young superstar entrepreneurs in the local communities of Israel.
The Presenting Sponsors for the summit are Lokai and Market Tech.
Forbes’ Under 30 franchise is a global multichannel platform that comprises 30 Under 30 lists featuring young global game changers and published in print and online all over the world; live summits in the U.S., Asia and Israel; an Under 30 channel on Forbes.com; and a Forbes Under 30 app. To access Forbes magazine’s 2017 30 Under 30 U.S. list, please visit www.forbes.com/30under30.
About Forbes Media:
Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes and Forbes Asia as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide with its business message each month through its magazines and 38 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services and technology license agreements.
Lokai is a socially responsible lifestyle brand that represents the importance of finding balance along life’s journey. Steven Izen founded the company in 2013, on the heels of a deeply emotional and transformative experience. Realizing that life is a cycle of highs and lows, he grew to appreciate the importance of remaining both humble and hopeful. The company infuses its trademark bracelets with elements sourced from the highest and lowest points on Earth -- water from Mt. Everest and mud from the Dead Sea. The Lokai lifestyle is devoted to finding balance, sharing success during life’s peaks and gaining perspective during lows. Lokai supports this message by donating 10% of net profits to various charitable organizations. Since launching, Lokai is sold in over 160 countries.
About Market Tech:
Market Tech is an LSE-listed property company that owns, manages and is developing a unique 16 acre estate (valued at £1 billion as of September 30, 2016) of office, retail, leisure and living spaces centred around the iconic Camden Markets, and supported by three e-commerce businesses, referred to as Market Tech Digital. These are Stucco Media, an e-commerce marketing platform, Glispa; a Berlin-based mobile marketing business and Fiver; a B2C online fashion retailer. www.market-tech.com
Israeli Prime Minister Benjamin Netanyahu will be the keynote speaker at the second-largest exhibition of cyber technologies worldwide, with attendees including state leaders from around the world, global cyber security executives and investors. Mr. Chuck Robbins, CEO, Cisco, will be among the world-renowned speakers participating.
A variety of cyber-dedicated professional presentations, events and panels with experts from around the world regarding diverse topics such as international collaboration between national law enforcement authorities and the field's present challenges will be held at the conference, in addition to a hacker zone, startup competition and more.
January 30th -February 1st 2017, Israel Trade Fairs & Convention Center, Pavilion 2
The Cybertech 2017 Conference, held for the fourth year in Israel at Pavilion 2 of the Israel Trade Fairs & Convention Center on January 30th - February 1st is the second largest conference and exhibition of cyber technologies in the world. Cybertech, bringing together leading investors, entrepreneurs and cyber companies, will consist of a conference with prominent international speakers in the field of cyber security, as well as an exhibition hosting over 250 companies and 100 startups that will present innovative problem-solving strategies and solutions to challenges relevant for a wide range of sectors.
Hundreds of foreign delegations, representatives of multinational corporations and foreign investors will travel to Israel to gain exposure to the latest innovations in cyber technologies, and take part in the conference and mega exhibition. Israeli Prime Minister Benjamin Netanyahu, who launched the Israel National Cyber authority devoted entirely to cyberwarfare, will open the Cybertech Conference as the keynote speaker.
Other opening plenary speakers alongside Prime Minister Benjamin Netanyahu will include Gov. Rick Snyder, Governor of the State of Michigan as well as Israeli and international cyber industry experts & executives from leading companies such as Cisco, HP, IBM, Checkpoint and Matrix.
The CyberTech Conference will host other prominent speakers, including Mr. Chuck Robbins, CEO, Cisco, Dr. Yossi Vardi, Conference Chairman, Chief Superintendent Meir Hayun, Head of National Cybercrime Unit, Israel Police, Dr. Eviatar Matania, Head of the National Cyber Bureau in the Prime Minister office of Israel, Mr. Yair Frank, Government CIO, Head of ICT Authority, Prime Minister Office of Israel, Mr. Avi Hasson, Chief Scientist, Ministry of Economy & Industry,Mr. Luigi Rebuffi, CEO & founder, EOS; Secretary General, ECSO, DPM., Peter Pellegrini, Deputy Prime Minister, Slovakia, Dr. Dorit Dor, VP of Products, Check Point Software Technologies, Mr. Gerard Brady, Managing Director, CISO, Morgan Stanley, USA, and many others.
The event will provide a unique platform for discussion about the latest cyber-related technological developments through panel discussions such as challenges and solutions for the cyber industry, international collaboration between law enforcement authorities around the world, cognitive computing issues, and the future of cyber security for the fintech industry. Furthermore, Cybertech will also host a variety of other events and complexes dedicated to current issues and breakthroughs, such as an Israeli startup pavilion with 100 different presentations by cyber companies, a hacker zone which will include an IoT hacking challenge and unique cyber-themed escape rooms, a Start Up competition and more.
In addition to the unique opportunity to discover the latest innovations in the local and global cyber community, Cybertech presents problem-solving strategies and solutions to challenges for a wide range of sectors including finance, defense, transportation, utilities, R&D, energy, manufacturing, service sectors, health, media, government, and more.
The event will allow businesses, startups, investors, government officials, military personnel, ambassadors and exhibition visitors to focus on networking, strengthening existing alliances, and forming new ones.
Photos Gilad Kavaranchik
An important milestone in the establishment of GTIIT - Guangdong Technion Israel Institute of Technology - was recorded with the official approval by the Ministry of Education of the People’s Republic of China. The Ministry confirmed that cooperation with Technion is consistent with the strategic goal of the Chinese Government: the establishment of world-class research universities; as well as with the regional strategy of innovation-based development.
The Chinese National Program for Medium- and Long-Term Educational Reform and Development is intended, inter alia, to promote the establishment of superior foreign educational resources and to establish several model Chinese-foreign universities in China, based on cooperation with other countries.
Approval for GTIIT was given exactly one year after the cornerstone laying ceremony for the new campus: a ceremony which was attended by about 5,000 guests, including the late ninth President of the State of Israel, Shimon Peres z”l. At that event, Peres said that “the establishment of a Technion campus in China is one more proof that Israeli innovation is breaking down geographic borders.”
The establishment of Guangdong Technion - the first Israeli university in China - is a dramatic and unprecedented event in Israel-China relations. Israel’s Ambassador to China Matan Vilnai said: “The opening of the Technion branch in China is the most important project in Israel-China relations during my term in office. This project, which focuses on education, is an important asset to China and Israel and hence its great importance. We have worked hard to obtain approval and I am pleased that it has been granted.”
“This is a courageous and important partnership which represents a historic step in Israel-China relations,” said Technion President Prof. Peretz Lavie. “This partnership, which combines the spirit of Israeli innovation with the power of China, will benefit all parties - the Technion and the University of Shantou, Israel and China - and will give a significant boost to the Chinese education system. The outcomes of this historic project will affect the whole of humanity.”
“I’m glad we did it,” said the Mayor of Shantou, Liu Xiaotao. “I would like to thank Technion President Prof. Peretz Lavie and professors from the Technion for their efforts and dedication. On behalf of the 5.5 million residents of Shantou, I would like to thank you for this important project.”
Guangdong Technion, situated near the Shantou University campus, will be a high quality, innovative and research-oriented university. In the future, an innovation center will be built near it, and will serve as a foothold for Israeli companies to crack key markets in the U.S. and China. This project is made possible thanks to the cooperation between China’s Shantou University, Guangdong Provincial Government, Shantou Municipal Government and the Technion. The project leader on behalf of the Technion is Prof. Paul Feigin, Assistant to the President for Strategic Projects.
According to the letter of approval from the Government of China, “GTIIT is a beneficial attempt to build a high standard and exemplary Sino-foreign co-running university. Guangdong Government shall offer guidance and take advantages of subjects and research provided by both sides, integrate educational resources, innovate methods of cultivating talents, classifying subjects and courses, and managing schools. It will promote Sino-Israeli educational cooperation and exchange, and contribute to our educational reform. GTIIT shall progressively carry out the master and doctoral programs by learning from Technion’s advanced experience in the way of independent admission according to the Sino-Foreign Cooperative Education Provision and its concrete measures. Masters and PhD degree certificates will be issued by Technion. “GTIIT shall strive for economic growth and social development based on the areas where Technion excels and in accordance with the environmental challenges faced by China.
The new university is headed by GTIIT Chancellor Mr. Li Jiange and Vice Chancellor Research Professor Aaron Ciechanover from the Technion. “The Government’s approval of the establishment of GTIIT has brought us much joy and confidence,” said Chancellor Mr. Li Jiange. “As an ancient Chinese saying goes, ‘A journey of a thousand miles begins with a single step.’ Now we have achieved the first step of success, we still have a long way to go. To build GTIIT into a world-class university, we need to recruit the elite faculties, and we are willing to pay them with the most attractive salaries.”
“The granting of approval by the Government of China is a moment of great hope for all of us,” said Prof. Ciechanover, winner of the Nobel Prize in Chemistry for 2004. “This is an initiative that will combine the diligence and determination typical of China with the extensive experience of the Technion in training scientists and engineers, and in turning scientific discoveries into developments that are beneficial to mankind.”
According to the letter of approval from the Government of China, GTIIT will have 2,960 students in the initial stage (from 2017 to 2026), including 300 postgraduates, and 5,000 in the long term, including 1,000 postgraduates. Guangdong Technion’s first undergraduate programs are Chemical Engineering, Biotechnology and Food Engineering, and Materials Engineering. Its graduate programs are Chemical Engineering, Materials Engineering, Food Engineering, Environmental Engineering, Mathematics, Physics, Chemistry and Biology. Its doctoral programs will also be in these disciplines .
The cooperation between the Technion and Guangdong Province has already led to several other agreements, including a memorandum of understanding for scientific cooperation between the State of Israel and Guangdong Province, economic cooperation agreements and a twin city agreement between the cities of Haifa and Shantou. The first academic school year at Guangdong Technion is scheduled to begin in October 2017, with 300 students will first complete a preparatory period starting in August.
Photo Left to right: Shantou University Provost Prof. Gu Peihua, GTIIT Chancellor Mr. Li Jiange, Shantou Mayor Liu Xiaotao, Technion President Prof. Peretz Lavie, Assistant to the President for Strategic Projects Prof. Paul Feigin, and Shantou University Vice President Prof. Lin Danming
Credit: Government of the Guangdong Province
The program will support joint projects in the nanotechnology sector in Israel, cooperating with similar teams in Germany. The overall budget for the Israeli and German entities stands at €30 million for three years.
For the past three decades American and Israeli scientists have been engaged in a fruitful collaborative effort and have jointly conducted dozens of challenging research and development programs, aimed at improving the performance of US and Israel's military helicopters and to integrate advanced capabilities in future platforms.
An official ceremony was held at Israel's Ministry of Defense (IMOD) on November 3, 2016, on the occasion of 30 years of fruitful collaboration in the domains of rotorcraft technologies and human factors engineering. The ceremony was headed by US Ambassador to Israel, HE Dan Shapiro, and IMOD Head of DDR&D, Brig. Gen. (res) Dr. Daniel Gold and attended by Director of US ARMDEC, Mr. James B. Lackey, IMOD Head of R&D Technology Base, Dr. Moshe Goldberg, officials and guests.
The rotorcrafts technologies effort is jointly headed by the US Army Aviation & Missile Research Development and Engineering Center (ARMDEC) and the IMOD Directorate of Defense Research & Development (DDR&D). Participating parties include the research and development teams at the IAF, the Technion, Tel Aviv University, Ben-Gurion University and Haifa University.
The United States and Israel have been collaborating on rotorcraft technologies since the 1980's, with over one hundred scientists and engineers from both sides developing breakthrough technologies in the areas of aeronautical mechanics, aerodynamics and human factors engineering (HFE) for helicopters.
The operation of helicopters is especially challenging due to the technical complexity and operational demands of low-level night flights. Accordingly, advanced HFE solutions are required to enable efficient and safe operation. The research efforts in this domain resulted in improved pilot displays and obstacle avoidance solutions. Additional efforts addressed the challenge of two aircraft jointly lifting heavy loads, beyond the capacity of a single helicopter. Some of the research products have been implemented in US rotorcraft, come of which are also operated by the IAF. Other will be integrated in future platforms or upgrades.
HE Ambassador Shapiro: “This rotorcraft cooperation has long been considered among the best US-Israel research agreements. It is unique in that it brings together the technical leaders from our two countries to conduct joint research on problems of common interest to our countries. At the same time the personal connections have enriched understanding of each other’s cultures and history and strengthened the ties between the two countries.”
Dr. Danny Gold: "The defense ties and close collaboration of the US and Israel are deep and long lasting. The Rotorcraft Project Agreement (RPA) collaboration is very special, as it embodies the deep research cooperation between the Parties. In my view, the RPA collaboration sets the gold standard for US-Israeli Defense R&D."
Photo credit: Dana Shraga, Ministry of Defense
The Society of Electrical and Electronics Engineers in Israel (SEEEI) will hold its annual 17th international convention on November 9 – 11, 2016, in Eilat. This year convention, "Electricity 2016", is titled "Smart World a new era of energy".
This is the 17th annual meeting of SEEEIl, and is considered to be one of the largest and most influential in the fields of electricity and energy in Israel, with the participation of senior decision-makers from the governmental agencies and the business sector in Israel; entrepreneurs, experts and opinion leaders from Israel and abroad.
Among the major figures who will participate in the convention: Government Ministers; Shaul Meridor, Director General of the Ministry of national infrastructures, energy and water resources; Ofer Bloch, CEO IEC; Buki Carmeli, head of the national Cyber Defense Authority; Jeffery Ketz, Chief Executive of energy technologies at IBM USA; Prof. Shmuel Oren, University of California, Berkeley; Dr. Alessandro Clerici, Italy, a senior at WEC (the Italian National Committee of World Energy Council); Dr. Frederick Bauchot, IBM, CTO for Gisc Energy; Dr. Cathy Yao Chen, Research department manager at ABB Research Institute in Sweden; Elisha Yanay, Chairman of the Association of electronics & software industries, former Senior Vice President at Motorola worldwide; Omer Keilaf, CEO and Ce-founder of start-up company Innoviz, which generates a revolution in autonomous vehicles; And many other dignitaries.
In 2015 more than 1300 local and overseas visitors attended Electricity 2015. This year we expect similar number of attendees. The main topics that will be discussed include: cyber safety, transport, renewable energy, energy efficiency, smart grid, energy management in buildings, developing smart grids, smart cities and campuses IOT, light engineering; training engineers and the registration regulations for electrical engineers, trends and innovations, power production, etc.
SEEEI's chairman, Emil Kaufmann, forecasts that "in 20 years, most public transportation in the country will be electrified, electricity production will be distributed and a substantial portion will consist of small power stations operated by gas and renewable energies".
Courtesy: SEEEI. From left to right: Lieutenant Colonel Luca Dottarelli; Mr. Emil Koifman – chairman of SEEEI; Prof. Izzy Borovich – the forum chair and Mr. Elisha Yanay – chair of the Industrials Association of Electronics and Software Industries.
The Israeli start up NUVIAD today announced availability of outstanding innovative advertising service which allows business owners to create self mobile campaigns
TEL AVIV, September 20, 2016; The Israeli start upNUVIAD today announced availability of NUVIAD Express™ – an innovative advertising service which allows business owners and mobile marketers to create mobile campaigns focused on location, people knowledge and deep big-data analytics.
For the first time, advertisers and business owners can just enter the address of their business or the addresses of their competitors and NUVIAD Express™ will provide detailed audience analysis including gender, age group, most used apps in the area, and more. This data can then be used to create mobile campaigns targeting the exact audience for the business using advanced click-to-call technology.
"For the first time, we can provide a viable alternative to standard pay-per-click services. NUVIAD Express™ not only provides a better targeting option for business owners, but also offers it at lower costs per customer than the services businesses already use," said Rafi Ton, CEO of NUVIAD.
"Running hundreds of campaigns for our customers, we've managed to refine the technology to fit the needs of local and regional businesses – driving customers to their business using click-to-call technologies. We have also simplified the process of creating the campaign and ads, by focusing on native ad formats. All you need is a title for your ad, a promo line and your logo. Your promotion will appear on thousands of apps targeting potential customers in the proximity of your business. Best of all, you don't even need a website as you can use NUVIAD's click-to-call option and receive calls directly to your business," added Rafi.
NUVIAD Technologies is one of the leading mobile advertising providers focusing on mobile advertising and native ad formats, and utilizing advanced machine learning algorithms to deliver highly targeted mobile advertising campaigns while continuously improving their results.
Photo provided by Nuviad Technologies
Only health in ICC JERUSALEM
"Health starts on the plate", "the current crisis in food industry", "the health system budget", "the horror of hospital infections"
These are just some of the topics that were main discussion on the annual Israel Medical Convention hosted here in "Binyanei Ha'Uma" and organized already a decade by Hadassah Medical Center and "Kol Ha'Ir" newspaper together with International Convention Center in Jerusalem.
Israeli President Reuven Rivlin told to the participants about him being a Vegetarian, and for years now mind to eat healthy.
Minister of Health Rabbi Yaakov Litzman proudly announced that today everybody knows two words in English: "Junk Food", also promised to go till the end in his struggle against industrialized food.
IMA chairman Dr. Leonid Eidelman expressed his deep concern regarding easiness of access to citizen's medical records by business entities and in the future these might be hostile elements.
Prof. Itamar Raz, Chairman of the National Council for Diabetes and Chairman of "From Today" - Israeli Forum for a healthy lifestyle, compared sugar to smoking and emphasized sugar tremendous damage. Just as smoking, sugar is a major factor in morbidity and very addictive due to a strong boost by the industry.
Among speakers and guests at the conference in International Convention Center were: Jerusalem Mayor - Nir Barkat, Director General of the Ministry of Health - Moshe Bar Siman Tov,Director General of the Ministry of Social Affairs- Eliezer Yablon, Director General of the Hadassah medical Center -Professor. Zeev Rotstein, physicians, healthcare system officials, representatives of pharmaceutical companies and many others.
Photo Michal Fattal
150 Holistic Therapists Volunteer Treat Cancer Patients in Hospital's Oncology Department and in Yuri Shtern Holistic Care Center
Yuri Shtern Holistic Care Center, in memory of Yuri Shtern, was established at the initiative of Lena Stern (widow of the late MK Yuri Stern), to honor the memory of MK Yuari Shtern. The foundation operates the Yuri Shtern Holistic Center for Cancer Patients.
The Center provides integrated holistic treatment for individuals dealing with cancer, as well as their families. Every day, 150 qualified therapists come to the oncology department at the Shaare Zedek hospital to provide hospitalized patients alternative medical treatments to help them cope with their disease.
The Center provides alternative medical treatments for a broad population of individuals coping with cancer. Treatments are provided free of charge to hospitalized patients (outpatient or inpatient) and for a minimum fee to family members, at the clinic in Beit Yuri Stern in Jerusalem. These treatments significantly improve the quality of life of patients struggling with cancer, as well as their families, and help ease the side effects associated with chemotherapy, and radiation.
MK Yuri Stern died of cancer nine years ago. Lena Stern, an expert in alternative medicine, provided him with holistic treatments during the last year of his life. He received an enormous benefit from these treatments, including relief of pain, improved quality of life and overall help in coping with the disease.
After the death of Yuri, the Yuri Stern Foundation was established by Lena Stern and family to raise awareness regarding the benefits of holistic treatments in alleviating the suffering of cancer patients. Today the organization has an agreement with Shaare Zedek hospital, in which 150 certified holistic caregivers offer free treatments at the Center to cancer patients. At the Yuri Stern Center in Jerusalem, patients and their families receive therapy at a nominal price.
Lena Stern - Chairman of Yuri Shtern Holistic Care Center: "We believe that our holistic treatments benefit both mind and body, ease the psychological stress of battling cancer, and therefore increase the chances of recovery.Our team consists of therapists, who are all volunteers, specializing in palliative oncology complimentary medicine. We train, qualify and prepare them to face the challenges inherent in working with cancer patients and their families. In addition, they are provided with ongoing professional counseling and training workshops. our therapist volunteers inspiring dedication, provide more than 8,000 treatments a year for cancer patients and their family members."
"The Center advocates the concept of treating the mind and body in combination and not just the illness itself- she said."
The Yuri Shtern Fund and Holistic Care Center is supported by donations and grants.
On November 1, the Center will hold a special fundraising evening in conjunction with the Batsheva Ensemble at the Jerusalem Theater with their special show called "Dkhdans" by Ohad Naharin. The event will be dedicated to continuing the activity of the Center to treat cancer patients. Jerusalem Mayor Nir Barkat will honor the event with his presence.
Contact information for any possible cooperation:
Tel: 052-3244769 or 03-6419030
Photo provided by Aviva Shwatz
Credit Photo Yehudit Arpaz
The Yuri Shtern Holistic Care Center is registered as a nonprofit organization - all donations received are recognized for tax purposes in accordance with Section 46 of the Income Tax Law.
Holistic Center website: https://www.facebook.com/HolistiCenter
We would appreciate you for any cooperation and assistance that can help us continue the running of this important project.
Mobile Ideas for Tomorrow - Competition Summit Event
Monday, 5th of September, in the Council for a Beautiful Israel in the Yarkon Park, Tel-Aviv, a Competition Summit Event marked the end of the competition held between German and Israeli students In recognition of the 50th anniversary of the establishment of diplomatic relations between the two countries.
In 2015, Germany and Israel celebrated 50 years of diplomatic relations between the two countries. To commemorate this land mark, In the middle of 2014, KKL Germany decided to create a unique activity this year - a competition among students at elementary schools in Israel and Germany.
Coming at first place from Germany is –"Projekt Mobile Ideen für Morgen“, Second place – "Beam me up – or not…“and third place – "Fuel Cell Energy".
The winners in Israel for the sustainable mobility are as follow:
· 2nd Place: Shalhevet Betnua , Shalhevet Shoam School
· 3rd Place: The Road, Ahad HaAm High School
An offer to construct a bridge for pedestrians in the region of hotels in Petah Tikva, in aim to prevent accidents.
During the ceremony, KKL-JNF Executive Director of Resources, Development and Public Relations, Avi Dickstein, spoke about the relationship between transportation and environmental protection stating, "KKL-JNF seeks to educate the youth about sustainability."
Photo Caption: "Mobile Ideas for Tomorrow"
Breakthrough research at Tel Aviv University unravels the metastatic mechanism of melanoma
Tel Aviv University researchers, together with the German Cancer Research Center (DKFZ) in Heidelberg, have discovered the mechanism by which melanoma spreads to other organs in the body, and have found ways to prevent the metastasis.
In a landmark discovery, researchers at Tel Aviv University have unraveled the metastatic mechanism of melanoma, the most aggressive of all skin cancers. The scientists discovered that before spreading to other organs, the tumor sends out tiny vesicles containing molecules of microRNA. These induce morphological changes in the dermis – in preparation for receiving and transporting the cancer cells. The researchers also found chemical substances that can stop the process, and are therefore promising drug candidates.
First Israeli Green Renovation Project Inaugurated
The aim of this renovation, which forms part of the Ministry of Housing’s Urban Renewal project, was to upgrade an old building and make it the first structure to be refurbished to meetgreen building standards, and those of the Retrofit method in particular. At the end of June the building was inaugurated at a formal ceremony with the participation of KKL-JNF World Chairman Danny Atar, MK Yael Cohen Paran, Ministry of Housing and Construction Director General Eshel Armoni and Sderot Mayor Alon Davidi.
Smart Prayer Room
Students at the Technion have developed a system that informs the user whether the Faculty prayer room is occupied or vacant and whether the worshipers are men or women. It does this with the aid of sensors alone, and without using a camera, which could violate the worshippers’ privacy
could violate the worshippers’ privacy
Mosallah (مصلى) is the name of an original system for monitoring the presence of worshippers in the Muslim prayer room at the Technion Faculty of Computer Science. The unique app can identify the current stage of the prayer and, according to this information, the system can estimate when the prayer will end. The innovative system was developed by three students at the Technion Faculty of Computer Science - female students Anwar Dabur and Lina Mudalej and male student Bakr Odeh - as their final project in the course on systems programming in an Arduino environment, held in conjunction with Microsoft R&D.
Dabur relates, “It all started two years ago, when the Faculty provided its Muslim students with a mosallah (dedicated prayer room). It was of course a very important step for us Muslims who want to pray during the day, but we soon found that there was a little problem: a person who wants to pray in the room has no way of knowing whether it’s vacant or occupied.”
Unlike prayers with many participants, where men and women gather in the same hall, prayer in small prayer rooms is not mixed. “Therefore it is important for us to know not only if the room is occupied but also who is inside - men or women. We realized that this was a very complex challenge, but we are students at the Technion - there’s no way we would fail to solve all those problems.”
During the past year, the project year, the three visited many prayer rooms in order to analyze the characteristics that could be monitored during prayers in the mosallah, and developed the system, constantly improving it based on experiments. From the outset, it was clear to them that cameras would not be used, because they violate the worshiper’s privacy. Therefore they developed a smart prayer rug equipped with pressure sensors. The rug provides the system with information enabling it to determine whether the worshippers in the room are men or women. “Women and men pray differently,” Dabur explains. “When men pray, one of the worshippers stands in front and the others behind, while women pray in a single row. The order in which they kneel is also different. Therefore, based on the information obtained from the pressure sensors, we can determine the gender of the worshipers without entering the room.”
The system developed by the three students includes pressure and distance sensors, an Arduino controller and servo motor; software that analyzes the data; and a dedicated app that sends the user prayer reminders on his mobile phone and tells him when the prayer room is vacant or partly vacant. The system can also be used without a smartphone, thanks to an interactive interface based on an LCD touch screen installed outside the prayer room, enabling the user to obtain relevant data and inform the system that he is waiting outside.
“Using the system saves the user a lot of time. Everyone knows that time is a rare commodity when you’re a student at the Technion,” concludes Lina. “This way, instead of standing in line to enter the prayer room, I study at the library and when I see on my phone that the room is vacant, I go there to pray. In the future, we intend to turn the app into a tool for learning prayers and the special movements that go with them.”
The course on systems programming in an Arduino environment is held in conjunction with Microsoft R&D, and enables students to use technology and state-of-the-art software during their studies, including smartphones and tablets for running apps during the development phase. In the course, which is designed to challenge the students with independent product-building projects, the students design smart systems that combine hardware and software using Arduino-based controllers connected to Azure, Microsoft’s cloud.
Photo The student Lina Mudalej / Technion
The Right to Ring Representatives of Mazor Robotics Ltd, which was born in Prof. Moshe Shoham’s lab and the Technion incubator, attend the Closing Bell Ceremony at NASDAQ
Representatives of Mazor Robotics, founded at the Technion in 2001, attended the Closing Bell Ceremony at NASDAQ on Wednesday July 13. The representatives from Mazor, including CEO Ori Hadomi, COO & VP R&D Eli Zehavi and Prof. Moshe Shoham of the Technion, were greeted by NASDAQ officials and representatives of ATS - the American Technion Society.
Attending the Closing Bell Ceremony is a show of respect by NASDAQ, generally granted to its listed companies on the occasion of a milestone in their history. Mazor, traded on NASDAQ as MZOR since August 2013, was invited to ring the bell the day after the unveiling of its new robot, the Mazor X. The privilege of ringing the bell was given to Company CEO Ori Hadomi.
Mazor’s technology was born in the medical robotics lab at the Technion Faculty of Mechanical Engineering. The head of the lab, Prof. Moshe Shoham, led the idea to commercial realization at the Technion incubator, together with student Michael Burman and Eli Zehavi, former director of engineering at Elscint (Israel) Elscint and currently COO & VP R&D at Mazor. The company was founded in 2001 at the Technion incubator and moved to the Caesarea industrial zone two years later.
Mazor Robotics develops robotic systems for back and brain surgery. Mazor’s systems, including the Renaissance robot, are used for treating back problems such as spine deformity, herniated discs and spine instability, and brain disorders such as Parkinson’s disease, which require accurate electrode insertion for deep brain stimulation (DBS). These systems, currently operating in over 120 hospitals, have been used in some 17,000 operations with more than 100,000 implants, and have never caused permanent nerve damage in any patient. The advantages of the system, according to Prof. Shoham, are its high precision, minimal invasiveness and the reduced dose of radiation for the patient and operating room staff. He said: “The launch of the Mazor X system, and the signing of an agreement with medical device giant Medtronics, is leading the company into a new era in terms of technology and in terms of the ability to realize our motto: Healing through Innovation.”
Photo credit: © Nasdaq 2016
A Selfie from Space
Participants in the International Space University’s 29th Space Studies Program (SSP), currently being held at Technion – Israel Institute of Technology, posed for a group photo from space yesterday (July 20th). The photo (attached), taken from a height of 520 kilometers, shows the 104 program participants lying on the main lawn of Technion campus in Haifa, with their bodies forming the letters ISU - the abbreviation of International Space University.
The photo was taken by the EROS-B satellite. The EROS observation satellites, built by Israel Aerospace Industries (IAI) and operated by the Israeli company ImageSat International (ISI), are equipped with a space camera manufactured by El-Op. ISI previously purchased two such satellites and ordered a third satellite last year, far more advanced than the existing models. EROS satellite photos are sold to both civilian and defense customers worldwide.
The highly acclaimed Space Studies Program (SSP) has been conducted annually by the International Space University since 1988. Each summer, it is held in a different host institutionin locations spanning the globe. This is the first time it is being held in the Middle East - at Technion in Haifa, Israel. As part of the current session, SSP16, the Technion is hosting lectures and panels that are open to the public, free of charge. All the open events are held in English and require advance registration.
Satellite photo credit: courtesy of ISI (ImageSat International) - taken by the EROS-B satellite built by Israel Aerospace Industries
Ninth President of Israel and Nobel Peace Prize Laureate Shimon Peres is looking out for MENA youth and launching the Israeli Innovation Center
Peres is utilizing innovation as a tool to bring people from around the Middle East together to build peace
President of the State of Israel Reuven (Ruvi) Rivlin: “The Innovation Center inaugurated this morning shall create a link between the past and the future. With one eye, it looks back to the accomplishments we have achieved, with its other eye, it looks ahead to the future, planning its next step.” "The nature of innovation is that it cannot stay put - innovation, too, should be innovated"
Prime Minister of the State of Israel Benjamin Netanyahu: “Innovation and Peace complement one another” “We will continue to be on the cutting edge”
This morning, 21.7, the Ninth President of Israel Shimon Peres launched the establishment of the Israeli Innovation Center together with President Reuven "Ruvi" Rivlin, Prime Minister Benjamin Netanyahu, Tel Aviv Mayor Ron Huldai, and leading figures from the Israeli innovation and high-tech industry.
The Israeli Innovation Center, located at the Peres Peace House in Jaffa, will be an educational hub and visitors' center, drawing guests from around the world to learn about Israel's historic achievements, absorb the core values of innovation, optimism and the pursuit of peace, and be inspired and empowered to positively impact their communities and the world.
Ninth President Peres, who heads the Peres Center for Peace and is leading the establishment of the Israeli Innovation Center said: "The Innovation Center that will be established here will showcase our national pride and will advance peace between people. It will highlight inventions already created as well as those yet to be developed in fields such as science, technology, medicine and healthcare, agriculture, and industry. This Center will, of course, showcase achievements of the past, but its primary focus will be on the path to the future .We will prove that innovation has no limits and no barriers. Innovation enables dialogue between nations and between people. It will enable all young people – Jews, Muslims and Christians –to engage in science and technology equally. Here we will emphasize that we can promote peace from childhood, and we will spark the imagination of every boy and girl and enrich their dreams."
Peres shared his perspective based on his personal experiences since the establishment of the State of Israel and its technological development and said: "All my life I have worked to ensure that Israel's future is based on science and technology as well as on an unwavering moral commitment. They called me a dreamer. But today, when I look at Israel, we all can see clearly that the greater the dream, the more spectacular the results. I am proud of our young people. They have created a new reality. They are gifted with independence, creativity, and Israeli chutzpah. They overcame the obstacles along the way and answered every challenge that appeared. Who would have believed that the entire world would one day use Israeli navigation software in their daily lives? Who would have believed that this stubborn and infertile land would produce an abundance of fresh fruits and vegetables, and that Israel would become self sufficient in water? Who would have believed that millions of people would utilize an Israeli developed stent implanted in damaged heart arteries allowing sick patients to breathe? Who would have predicted that we could give paralyzed individuals the ability to walk through robotic legs that were created in Israel? Our innovative spirit has been recognized the world over, and of course, my heart swells with pride when I see how many nations turn to the tiny State of Israel to learn from our bold innovations, to learn how to turn the impossible into the possible."
President of the State of Israel Reuven (Ruvi) Rivlin said: "In Israel in 2016 it is impossible to talk about innovation without mentioning a man who is also a legend, a young man whose trademark is innovation, Shimon Peres, the Ninth President of the State of Israel. Young people want to devour the world. They have big dreams, visions of "Tikkun Olam". As the years pass, they succumb to reality and give up on their lofty dreams. But you, Shimon, are the opposite. You led the way in atomic research in Israel. Since then, your vision has become bolder, more innovative. Every dream that came true was, for you, just one more step toward the next destination. Shimon, in Israel today you are a leader of innovation, and it is impossible not to be envious. At almost 93 you are leading, creating and challenging yourself every year."
Rivlin added: "The Innovation Center inaugurated this morning shall create a link between the past and the future. With one eye, it looks back to the accomplishments we have achieved, with its other eye, it looks ahead to the future, planning its next step. With its one hand it promotes science and technology, with the other, its vision for a model society. This is a winning combination that I am confident will accelerate and motivate continued creativity, innovation and empowerment."
Prime Minister of the State of Israel Benjamin Netanyahu said:
“We will continue to build upon our immense advantages, first and foremost our heritage, which always sought knowledge. We will ensure that our state will be vibrant, progressive, developed, inquisitive, operating in fields that no one has ever before considered, all while we help many people around the world, and we will remain on the cutting edge. Shimon, you have seen the way to get there.”
Peres has always been a dreamer, an optimist. From building the Israeli air force to developing the nuclear reactor, from the Oslo Accords to peace with Jordan and Egypt, he has been at the forefront of Israeli innovation, always in the pursuit of peace. The Israeli Innovation Center is yet another milestone along Peres' lifelong journey. With the goal of opening similar Innovation Centers in countries across the MENA region, Peres is dreaming big, but as he often says, "Our only mistake was not dreaming big enough".
A nation with more startups per capita, where "impossible" is not in the vocabulary, and where organizations like the Peres Center for Peace are ever searching for new avenues to promote peace, Israel has much to share with its neighbors in the region. And this Innovation Center will be the first step on the long path to building a startup region, an innovation region, a region of peace.
The Innovation Center itself will be made up of four floors that tell the story of Israel and its transformation into the Innovation Nation:
This full sensory journey begins at the entrance, where visitors will experience a large, kinetic art exhibit of interactive screens, and will be exposed to Israeli innovations that changed the face of the world. A unique digital library, the only one of its kind in the world, will provide visitors with the opportunity to ask questions and receive answers about Israeli innovations.
The story of Israel as a startup nation will be shared with visitors through exhibits based on cutting edge technology and information sharing, touch tables and an interactive game, illuminating historically significant events such as the Israeli Military Industry, the development of new agricultural methods, launching the first satellite into space, and more.
Visitors will learn about Israeli innovations that are used around world in fields such as medicine, water, food, agriculture, communication, and more, with a focus on inventions such as cherry tomatoes, Rewalk, Waze, ICQ, drip irrigation, USB flash drives, coronary stents, and more. Visitors will learn about Israeli inventors, the processes that led to their ideas becoming life-changing inventions, all with the goal of developing and enriching the next generation of inventors.
As Israel has been and continues to be a leader in innovation, the Innovation Center will devote a section to contemporary innovation and future technology, showcasing leading Israeli companies. This exhibition will allow every child or tourist to try thinking outside the box and finding creative solutions to the challenges of the future and the problems that lay in store around the world.
Finally, there will be a space for entrepreneurs and developers to meet, take courses, engage in hackathons, and become introduced to leading Israeli innovations that will serve as a tool for training the next generation of Israeli startup leaders. This will be offered in a variety of languages for individuals around the world through a digital platform. With educational components providing every child – Christian, Jewish, and Muslim alike – with the opportunity to learn about technology, persistence, and determination, the Center will fan the spark of creativity and bring each child into the global revolution of innovation, science, and technology. It will offer accelerators, tech hubs and workshops, courses on entrepreneurship, leadership, and the fundamentals for being a part of the tech world, and will teach young people how to reach for their dreams and never give up.
By using technology to build peace and shared-living, for the first time, there will be a safe space for thousands of Jews and Arabs, Israelis and Palestinians to innovate—together.
This Center is a deep source of pride for Peres, as he views the sharing of science with Israel's neighbors, the promotion of peace through innovation, as the most imperative initiative today.
At the age of 93, Peres is still looking to the future, and is just now launching the startup of a lifetime, an initiative that will reshape the way peacebuilding is viewed and conducted in the Middle East, a new phase on his lifelong quest for peace – peacebuilding through innovation.
Good News for Northern Israel: New Oncology Center Opens
The opening of this modern and spacious center marks another milestone in Rambam’s ambitious West Campus development plan, bringing state-of-the-art and secure healthcare in environmentally sustainable facilities to benefit the citizens of Northern Israel.
When Haifa businessman Joseph Fishman (z”l) was treated for cancer at Rambam, he was both impressed by the caliber and dedication of the medical team, and dismayed by the conditions of the over-crowded and aging facilities. Mr. Fishman’s legacy, supported by his family and carried out by Rambam’s leadership, was to establish a new and modern center to benefit the hospital’s cancer patients and the medical staff responsible for their care.
On June 30th, the new Joseph Fishman Oncology Center at Rambam Health Care Campus officially opened its doors, ready to provide excellent, secure and dignified care for thousands of cancer patients from throughout Northern Israel. The Department of Outpatient Chemotherapy and the chemo-pharmacy were the first to move in. Other departments and units will move into the new facility over the coming months. Professor Rafi Beyar, Director of Rambam Health Care Campus, addressed Israel’s Minister of Health, Rabbi Yaakov Leizman, and the audience at the inauguration ceremony, emphasizing that, “cancer continues to be the most devastating illness we are contending with.” The nine-floor, 10,000 square meter structure will eventually house inpatient departments, ambulatory and treatment clinics, cutting-edge radiation treatment technologies, and a complementary medicine clinic. The facilities are designed to maximize comfort and privacy, and enable patients to be accompanied by a family member or friend at all stages of treatment. According to Professor Ron Apelboim, Director of the Division of Oncology, “this is the beginning of a new era for thousands of patients.”
As part of Rambam’s commitment to a healthy environment, the new center was built according to Israel’s most stringent “green building” standards. Already at the planning stage, factors such as the use of environmentally sustainable and energy saving materials were designed into the project. Four linear accelerators will be permanently installed in the Sammy Ofer Fortified Underground Emergency Hospital—assuring access to radiation therapy under the most challenging of circumstances.
After an investment of some $30 Million to build and open the Fishman Oncology Center, Rambam is still seeking funds for additional equipment acquisition, staffing, and related expenses.
Photo description: Outside view of the Joseph Fishman Oncology Center at Rambam.
Photo credit: Micky Koren.
Medicine, the international language
Medical leaders from around the globe convened at RAMBAM Health Care Campus for its 13th Annual International Trauma Course
Twenty-six leading healthcare professionals representing 20 countries around the world recently came to Haifa to participate in RAMBAM Health Care Campus' ' prestigious Trauma Medicine Course. The purpose of the course is to share RAMBAM’s expertise in treating military and civilian trauma victims, and give participants the tools to develop systems capable of dealing with multiple-casualty events in their home countries.
Now in its 13th year, the course is offered in cooperation with MASHAV, Israel’s Agency for International Development Cooperation.
Participants in this year’s trauma course included high-level medical personnel from the Far East, Latin America, the US, and Europe. Among them were the Director of the Office for Emergency Medical Systems in Thailand, a senior medical officer from the UN serving in the Golan Heights, the president of the Vietnamese Nurses and Operating Room Nurses Associations, the Acting Director of the National Emergency Medical Services Center in Nepal, a head nurse from a military hospital in the Philippines, and the Director of the Resuscitation Team at the only pediatric hospital in Kenya, among others.
One of the many activities offered by RAMBAM’s Center for Trauma and Emergency Medicine Studies, the two-week international trauma course includes lectures, workshops, training activities, simulations, and tours of RAMBAM and other sites around the country.
According to Gila Hymes, Director of the Teaching Center for Trauma, Emergency, and Mass Casualty Situations, “We have taken our vast experience treating victims of war, terror and accidents, and are sharing it to benefit medical systems around the world. Medicine is an international language that we are using here at RAMBAM to help save lives around the world.”
Course participants and organizers at the RAMBAM Health Care Campus.
Photo: Pioter Fliter, RHCC
NYC TECH LEADERS HONOR FIRST-EVER GRADUATES OF JACOBS TECHNION-CORNELL INSTITUTE
Israel’s Technion Becomes First Accredited International University to Grant Degrees in the U.S.
NYC Executive Director Julie Samuels, Israeli Consul General Ido Aharoni and others gathered last night to celebrate the inaugural graduating class of the Joan & Irwin Jacobs Technion-Cornell Institute. The pre-graduation event at WeWork Bryant Park honored the globally diverse graduates receiving the MS in Information Systems with a concentration in Connective Media, a one-of-a-kind master’s program combining disciplines of technology, media, sociology and business.
The May 29 graduation ceremony at the Cornell University Ithaca, NY campus will include the Jacobs Institute — a partnership of the Technion-Israel Institute of Technology and Cornell University — and will mark the first time an international university has ever granted an accredited degree for studies on U.S. soil. Graduates will receive two degrees, one from the Technion and one from Cornell. The Institute’s 12 Connective Media graduates, from six different countries, are now launching innovative startups and securing jobs at industry-leading companies across the world.
“These graduating entrepreneurs are armed with the knowledge and experience in areas that are vital to the City’s economic health, and the betterment of society as a whole,” said Professor Adam Shwartz, director of the Jacobs Institute. “We look forward with anticipation to the great things they will accomplish and their impact on the economy, as well as the startups they will launch in New York City and beyond.”
“Congratulations to all of the graduating Jacobs Technion-Cornell Institute students,” said Technion President Peretz Lavie. “This remarkable group, and all it will accomplish, is a clear example of what can happen when innovation, excellence and a commitment to the improving the lives of people around the world come together.”
The Jacobs Institute was established in 2013 with a $133 million gift from Dr. Irwin Mark Jacobs, founding chairman and CEO emeritus of Qualcomm, and his wife, Joan Klein Jacobs. It has quickly become a catalyst for global entrepreneurship and a driver of New York’s emerging tech ecosystem and local economy. The Jacobs Institute combines professors, research and resources from the Technion, a leading global research university, that was a vital factor in Israel’s emergence as the “Startup Nation,” and Cornell, a longtime leader in engineering and computer science, with a strong presence in New York City. The Jacobs Institute’s dual-degree program — accredited through Technion in Israel and Cornell in the U.S. — provides graduates with an international advantage and greater recognition in an increasingly global workforce.
The Connective Media graduate program was created by Jacobs Institute Professor Mor Naaman, whose Social Technologies Lab studies social technologies such as YouTube, Facebook and others, and creates new technologies to help people connect. Built as a strong technical degree, the Connective Media program is unique in expanding beyond tech and combines a wide array of human, business and social disciplines. The program challenges students to engage directly with industry leaders on new projects that can impact the world in significant ways, including creating startup concepts and companies. Connective Media students have worked directly with professionals at AOL, Microsoft, LinkedIn and more than a dozen other companies.
“These graduates have strong technical skills, but also skills and knowledge from the social sciences, business and design. Such set of skills is required to innovate and excel in the Connective Media landscape,” said Mor Naaman, Jacobs Institute professor and founder of the Connective Media program. “Their tech expertise, aimed towards the human and social aspects of media technologies, will be an asset to both established companies and startups, especially within communications and media spaces. These graduates are the next generation of this city’s CTOs, product chiefs, and tech leaders.”
The Jacobs Institute’s 12 inaugural graduates represent the global face of today’s tech industry and hail from the U.S., Canada, China, New Zealand, India, Indonesia, and Spain. Several graduates are already planning to begin careers at Facebook, Google, WeWork, Verizon and Bloomberg. Some will launch startup companies aimed at helping quadriplegics, transforming interactive education and changing other fields, and some will continue research partnerships with the Clinton Foundation and other major institutions.
“At the Jacobs Technion-Cornell Institute you have the opportunity to shape your education and to shape the courses,” said Shawn Bramson, one the inaugural Jacobs Institute graduates. “There’s an amazing entrepreneurial spirit here, reminiscent of the one I was immersed in while I was at the Technion, and an empowerment to apply what we’ve learned to make real social impact in the world.”
Photo Caption: Graduates with Professor Adam Shwartz, director of the Jacobs Technion-Cornell Institute (right) and Professor Mor Naaman, founder of the Connective Media program (left).
Photo : American Technion Society
Laura and Isaac Perlmutter Cancer Center at NYU Langone and Technion-Israel Institute of Technology Officially Launch Global Cancer Research Initiative
Melanoma, Mesothelioma Are the Focus of First Joint Studies
Drug-carrying “nanoghosts” that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology under a groundbreaking research initiative supported by noted philanthropists and NYU Langone Trustees Laura and Isaac Perlmutter.
NYU Langone and its Perlmutter Cancer Center – which the Perlmutters named in 2014 with a separate gift of more than $50 million – and the Technion established the new partnership last year to advance global collaboration in cancer research and therapeutics. The joint program is positioned to attract additional, world-class support from institutions and individuals dedicated to eradicating cancer through focused and efficient research.
The first $3 million of the Perlmutters’ $9 million donation to the two institutions is earmarked to finance six joint research projects. Co-investigators on each project will receive a two-year, $500,000 grant—$250,000 for each site. The remaining $6 million is designated to establish a state-of-the-art research facility on the Technion campus in Israel to support these and other research projects, primarily in the emerging field of cancer metabolomics, the systematic study of the unique chemical fingerprints that cellular processes leave behind. These processes are both affected by, and can influence, a variety of human diseases, including cancer.
Examining a Novel Approach to Treat Metastatic Melanoma
In the first joint collaboration, NYU Langone and Technion researchers will test the ability of a nanotechnology based on stem cell “nanoghosts” to deliver to the brain a promising treatment for metastatic melanoma, skin cancer that has spread or metastasized, and is often incurable.
In earlier studies, researchers at the Technion took a stem cell, removed its contents, and then shaped a piece of the cell’s outer membrane into a vehicle to deliver treatments into the brain. The idea was to borrow the stem cell’s outer membrane ability to home in on cancer cells. As a fragment of the former stem cell’s membrane, the nanoghost encompasses particular mechanisms that slow it enough to traverse the barrier that filters blood flowing into the brain, and which keeps most drugs from entering.
The nanoghost’s cargo is a microRNA (miR), a stretch of genetic material that fine-tunes genetic messages by blocking the conversion of genes into proteins. First applied by NYU researchers to metastatic melanoma, miR-124a, in particular, blocks the expression of cancer-promoting genes. The joint team’s experiments will seek to determine the feasibility of encapsulating miR-124a in the nanoghost, and study how the vehicle reaches its target in mouse models of the disease.
“Our studies should provide important information on nanoghosts’ general value as drug and gene carriers to the brain, and create potential for new treatment approaches against brain tumors and metastases,” said Professor Marcelle Machluf, PhD, head of the Laboratory for Cancer Drug Delivery & Cell Based Technologies at the Technion, and inventor of the nanoghost with her colleagues there. “The difficulty of delivering agents to the brain represents a major impediment to improving outcomes in patients suffering from brain tumors. Our state-of-the-art nanovehicle promises safer, simpler and more clinically relevant treatments than existing vehicles, which are comprised of polymers or synthetic vesicles which largely lack the ability to enter the brain and to target evolving and changing pathologies.”
“It is much harder to secure funding for this type of high risk, high reward research,” said Eva Hernando-Monge, PhD, associate professor in the Department of Pathology at NYU Langone, a member of the Perlmutter Cancer Center, and leader of the NYU team that first identified miR-124 as a suppressor of the growth of brain metastases. “The Perlmutters’ generous gift gives us the ability to be bold.”
Like the stem cells they are based on, nanoghosts are invisible to the immune system, which means they could potentially be made from donated stem cells, expanded to large numbers in the lab, and not just from the patient’s own supply. In the future, this could enable the stockpiling of nanoghost treatments used off the shelf without fear of immune reactions to treatments based on “foreign” cells.
New Approach to Mesothelioma
The second joint project will investigate whether an enzyme called heparanase can be used to diagnose and treat mesothelioma, a rare cancer that develops in the mesothelium, the protective lining of the lungs and other internal organs of the body. Malignant pleural mesothelioma (MPM), the most common form of the disease, often occurs after exposure to asbestos and is resistant to most therapies.
Heparanase was first identified as a treatment target in 2004 by a team led by Israel Vlodavsky, PhD, one of the project’s co-investigators and professor at the Rappaport Faculty of Medicine. Past studies found that patients with high levels of this enzyme in their tumors have lower survival rates after surgery, and that related tumors in mice respond to treatment with heparanase-inhibiting compounds.
The enzyme breaks up molecular chains of heparan sulfate, a building block of the scaffolds that give organs shape and support. Cancer cells use the enzyme to break down tissue barriers around a growing tumor, providing new pathways for the cancer to spread and for the building of blood vessels that supply tumors. In addition, breaking up extracellular matrices releases pro-growth proteins stored there to further drive disease. Furthermore, the joint team has developed the novel theory that heparanase secreted by tumor cells primes local microenvironments in a “vicious” cycle where inflammation and tumor growth drive each other.
The co-investigators at NYU Langone -- led by Harvey I. Pass, MD, the Stephen E. Banner Professor of Thoracic Surgery and vice chair for research, Department of Cardiothoracic Surgery, at NYU Langone, also a member of its Perlmutter Cancer Center -- will use tissue samples from its Thoracic Oncology Archives to validate Dr. Vlodavsky’s findings in hopes of eventually evaluating the treatment potential of heparanase-inhibiting compounds in mesothelioma clinical trials. Dr. Pass has been collecting tissue samples from his surgical patients since 1989, when he was head of thoracic oncology at the National Cancer Institute (NCI). The collection now houses frozen specimens from more than 350 mesothelioma patients.
“This project, supported through the generosity of the Perlmutters, enables us to collaborate with one of the world’s leading experts on the role of heparanase in cancer, and is crucial in developing new strategies,” Dr. Pass says. "We hope that these experiments can be translated into applications for ongoing funding from the NCI, and enable Phase I trials with new therapeutics that influence heparanase pathways.”
“Our collaboration represents the first attempt to focus on heparanase as a major risk factor in mesothelioma and a valid target for the development of heparanase-inhibiting drugs,” Dr. Vlodavsky says. “In fact, applying a potent inhibitor of the heparanase enzyme we have already demonstrated a most prominent inhibition of tumor progression in mouse models of human mesothelioma, resulting in a pronounced extension of mouse survival. This joint effort provides an opportunity to make important strides in both our fundamental understanding of mesothelioma and in translating this knowledge into therapeutics.”
About The Technion-Israel Institute of Technology
The Technion-Israel Institute of Technology is a major source of the innovation and brainpower that drives the Israeli economy, and a key to Israel’s renowned as the world’s “Start-Up Nation.” Its three Nobel Prize winners exemplify academic excellence. Technion people, ideas and inventions make immeasurable contributions to the world including life-saving medicine, sustainable energy, computer science, water conservation and nanotechnology. The Joan and Irwin Jacobs Technion-Cornell Institute is a vital component of Cornell Tech, and a model for graduate applied science education that is expected to transform New York City’s economy.
About NYU Langone Medical Center
NYU Langone Medical Center, a world-class, patient-centered, integrated academic medical center, is one of the nation’s premier centers for excellence in clinical care, biomedical research, and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals—Tisch Hospital, its flagship acute care facility; Rusk Rehabilitation; the Hospital for Joint Diseases, the Medical Center’s dedicated inpatient orthopaedic hospital; and Hassenfeld Children’s Hospital, a comprehensive pediatric hospital supporting a full array of children’s health services across the Medical Center—plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The Medical Center’s tri-fold mission to serve, teach, and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education, and research. For more information, go to www.NYULMC.org, and interact with us on Facebook, Twitter, and YouTube.
Under 30 EMEA: After Blowing Through $700 Million, Failed Better Place CEO Shai Agassi says that “If Not Willing To Fail, You Wont Succeed”
Tel Aviv, Israel--April 4, 2016– At the Forbes Under 30 Summit EMEA today, Israeli serial entrepreneur Shai Agassi, who raised (and subsequently lost) $700 million to accelerate the switchover to electric cars, outlined what he thinks will be the biggest disruption of the 21st century.
“At the end of the day the startups who are most successful are the ones who identify the waves way ahead of time….those who peddle after the wave has come don’t reach shore,” he said.
Led my moderator Maneet Ahuja, CNBC Hedge Fund Specialist & Producer on “Squawk Box,” panelists included some of the world’s top disruptors including Nikita Fahrenholz, Co-Founder & CEO ofBook A Tiger and Co-Founder ofDelivery Hero, in addition to Lisa Falzone, Co-Founder & CEO,Revel Systems. Panelists came together to discuss their secrets to success, how to deal with failure, as well as whether we are facing a new tech bubble.
“Be willing to fail,” explained Agassi. “If you are not willing to fail you will not succeed. Sometimes, the difference between failure and success is so minuscule you won’t even notice it.”
“You know you will make mistakes, stated Falzone, “but it’s about how fast you can recover from those mistakes. Speed is very important.”
When asked about the fear of failure, Fahrenholz stated, “You have to get comfortable with it. I’ve failed and failed- its part of what makes you human. I never thought about the negative consequences of an experiment as much as the possible outcome.”
Falzone noted, “Failure is one of those concepts you have to overcome when you start your company. I had to study it and overcome it to get the courage to start my company. I realized, I would rather be in the arena and fail then to be one of those cold timid souls and never be in the arena at all.”
At the conclusion of the panel, Ahuja asked serial entrepreneur Agassi as to whether another tech bubble was imminent. “This isn’t a bubble,” he explained, “its a tectonic plate shift and those who stay put will basically disappear.”
The Forbes Under 30 Summit EMEA brings together 600 greatest young entrepreneurs and game-changers from across the world, including 200 from the U.S., 200 from Europe and 200 from the Middle East and Africa, selected from the various Forbes 30 Under 30 lists.
# # #
About the Forbes Under 30 Summit
The Forbes Under 30 Summit franchise, one of the company’s most popular franchises, is an extension of Forbes magazine’s annual 30 Under 30 list. Attendees of the summit are culled from Forbes’ 30 Under 30 lists in the U.S., Europe and Israel. The Forbes Under 30 Summit EMEA will bring together 600 of the greatest young entrepreneurs and game-changers from America, Europe, the Middle East and Africa, for five days and nights of fostering world-changing ideas and collaborations. Under the theme “Co-Investment, Co-Creation and Co-Existence,” innovators, inventors, mentors and investors will focus on entrepreneurship and long-term, market-driven solutions to global problems, proving that growth is possible even in challenging times.
For more details on the Under 30 Summit, please visithttp://www.forbesconferences.c
On Twitter, follow #Under30Summit
About Forbes Media
Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia and Forbes Europe magazines as well as Forbes.com. The Forbes brand today reaches more than 80 million people worldwide with its business message each month through its magazines and 37 licensed local editions around the globe, websites, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services and technology license agreements.
A Record Number of 28 Israeli Companies Participating in DEFEXPO 2016
The Israeli pavilion at the DEFEXPO exhibition in India is the largest ever. Head of SIBAT: "Israel and India are working together to enhance cooperation in various technological fields"
Defense Ministry officials inaugurated the Israeli national pavilion at Defexpo in Goa, India, one of the most important defense exhibitions in the world. The opening ceremony of the Israeli pavilion was attended by the Director General of the Ministry of Defense, Maj. Gen. (res.) Dan Harel, Head of SIBAT, Brig. Gen. (res.) Michel Ben-Baruch, and CEO's of major defense industries.
This year, 28 Israeli defense industries and start-up companies will present a wide range of advanced technologies, most of which have been tested successfully on the battlefield. Among other things, Israeli companies will present sophisticated sensors, borders and sensitive facility protection systems, robotic systems, electro-optic systems for artillery and infantry, airborne satellite communications, fire control solutions, tactical medical equipment for the battlefield, and more.
Head of SIBAT, Brig. Gen. (res.) Michel Ben-Baruch said, "Israel and India are working together to enhance cooperation in various technological fields. India is a country with great capabilities. The large Israeli presence in the exhibition reflects our desire to strengthen the ties with Indian companies, and to increase the domestic production of advanced military technologies. A large part of the Israeli companies participating in the exhibition have been working closely with Indian companies, and we are confident that the collaboration will yield massive projects for Indian security forces."
Ben-Baruch added, "In the field of security, Israel and India face similar threats. The technological cooperation between the two countries will help us in the face of these threats, and will contribute to the economy of both countries."
The Israeli industries to exhibit in the national pavilion at DEFEXPO are Aeromaoz, Al Cielo, Astronautics, Beth-El industries, Camero, CI systems, Controp, Elbit Systems, Enercon, Persys Medical, IWI, Magal, Meprolight, MORE, Manomotion, Nimda, Noga-Einat, Opgal, Ophir Optronics, Orbit, PCB, Plasan, Rafael, Optica lab, SCD and Urdan.
Meanwhile, a large Israeli delegation of SIBAT will inaugurate the National Pavilion at FIDAE exhibition in Chile this week. This biennial event is the largest and most important aerospace exhibition in Latin America. Eleven leading Israeli defense industries in the Israeli pavilion will present a series of advanced technological solutions, most of which have had operational experience on the battlefield.
The Ministry of Defense stated that in recent years, the security market in Central and South America is one of the largest emerging markets in the world, both in the military field and in Border Protection and Homeland Security (HLS). More and more countries in Latin America are seeking cooperation with Western countries and leading defense industries. Changes in the geopolitical region also present many opportunities for the defense industry. Israeli defense companies specialize in the development of advanced technologies with proven operational experience, which can be adapted to the unique needs of each country. Therefore, these industries are considered particularly attractive to this market.
The Israeli industries to exhibit at the Israeli Pavilion at FIDAE are Elbit Systems, Rafael, IAI, IMI, IWI, Meprolight, Camero, VISION MAP, Controp, FAB and Beth-El industries.
1st International Digital Diplomacy Conference in Israel
For the first time in Israel - a Digital Diplomacy Conference hosted by the Ministry of Foreign Affairs and the Partner Institute for Internet Studies at the Tel-Aviv University brings together scholars and practitioners from around the world to investigate and advance the practice of diplomacy in the digital age and formulate a research agenda
The 1st International Digital Diplomacy Conference - the first of its kind in Israel - will examine the influence of the social networks and technologies on the activity of ministries of foreign affairs throughout the world. The conference will take place on 29-31 March 2016 at the Tel-Aviv University, with participants from 25 countries, including the US, UK, France, South Korea and Germany, as well as researchers from universities in the US, Europe and Israel in the fields of Diplomacy, Communications and the interaction among them.
The Israeli Ministry of Foreign Affairs has been highly active in the digital arena over the past few years, operating hundreds of accounts in various media and in about 50 languages, including Hebrew, English, Spanish, French, Arabic, Persian, Indonesian, Finnish and numerous others.
The conference will discuss the issue of "Technology at the Service of Diplomacy" and address questions, such as the use of social networks by ministries of foreign affairs to advance political goals; engagement in dialogue with on-line audiences; consular services to citizens in emergency situations; and country branding. In addition, the possibility of establishing an international digital network of ministries of foreign affairs will be explored for the first time.
These issues are being researched at the Department of Communications and the Partner Institute for Internet Studies at the Tel-Aviv University. The conference brings together diplomats who are active in the field and academic researchers, in a step intended to boost the development of digital diplomacy, and to create an exchange of views through which Israeli insights will be shared and each participant will be able to learn from the experience of other countries and from the insights of researchers in the field.
March 30 - 31, 2016, Israel
This two day international conference aims to bring together scholars and practitioners from around the world in order to investigate and advance the practice of diplomacy in the digital age as well as formulating a research agenda that will contribute to the study of Digital Diplomacy.
The conference shall be co-hosted by The Israeli Ministry of Foreign Affairs and the Partner Institute for Internet Studies at the University of Tel Aviv, and will include round-table discussions, expert panels and case - studies in which foreign ministries will be invited to share the insight they have gained. Recent years have seen Ministries of Foreign Affairs (MFA's), embassies and diplomats engage in social networking sites and according to the Twiplomacy website, there are now 228 MFA's and Foreign ministers active on twitter in addition to some 400 heads of state and governments. The conference will bring to the fore the many challenges facing the world of Digital Diplomacy ranging from the need to train diplomats in the art of social media engagement to identifying the means with which to evaluate its impact.
The conference will focus on the rise of a 'whole of government' approach to diplomacy as well as attempting to understand the relationship between the concepts of digital diplomacy, public diplomacy & nation branding.
Over 5000 participants and exhibitors from around the world are expected to attend CleanTech 2016 , the 20th annual international event for Clean Technologies: environmental quality, infrastructures and green building, renewable energy and water technologies. The event will take place at the Ramada Hotel, Jerusalem and will be a central meeting point for the CleanTech industry in Europe, Asia and Africa. The World CleanTech Awards will be delivered to outstanding candidates at the official ceremony.
The geographical location of CleanTech 2016 - in the middle of the three continents - Europe, Asia and Africa - makes it an international magnet for companies to expose their products and services to international customers and traders and for buyers to create new commercial contacts.
Though Israel is a small country with limited natural resources, it stands out as one of the most competitive economies. The country's market economy can be characterized as advanced technology based and globally oriented. In recent years Israel has been focusing on CleanTech and there are now more than 600 companies in Israel that can be defined as specializing in the CleanTech field.
CleanTech Exhibition has gained the status of a high quality international business platform, where companies, researchers and professionals display their newest developments, novel technologies and outstanding quality services in the fields of environmental protection and green solutions, infrastructure, renewable energy, waste treatment, water technologies for treatment, desalination, harvesting, purification, filtration and more. The exhibition includes professional conferences, seminars and symposiums.
Global investment in renewable energy sets new records every year, according to a reports released by the Renewable Energy Policy Network for the 21st Century (REN21). Technologies such as wind, solar, biomass, geothermal, and small hydro now provide hundreds of gigawatts of electricity generating capacity. Subsequently renewable energy markets have been growing robustly. According to the forecasts the market capacity may at least double itself within a relatively short period of time. The steep rise in air pollution and oil prices has spurred the development of energy alternatives that will reduce dependency on expensive, environment-polluting oils. Israel must keep abreast with the developed countries and increase its use of renewable energies. The Exhibition promotes the technologies in this crucial area.
In recent years there has been a growing awareness of "green construction," that is, building that provides a higher quality of life and healthier environment by cutting back on the overall bad effects on the environment from the process of construction and building use. The exhibition will emphasize the environment as a central factor in the planning and implementation of green construction projects.
Waste and Recycling
Organization Name: Mashov Group Ltd.
Address: Ramada Hotel, Jerusalem
Start Date: 03 Apr 2016 End Date: 05 Apr 2016
Phone Number: +972-8-6273838
Fax Number: +972-8-6230950
ISRAEL'S CONTRIBUTION TO THE CITIZENS OF PAPUA NEW GUINEA
The World's First Water Purification Vehicle, GALMOBILE™
Caesarea, Israel (March 2, 2016) – G.A.L. Water Technologies Ltd., creators of the GALMOBILE™, announced on Monday that the State of Israel is donating a unit of their Water Purification Vehicle to the citizens of Papua New Guinea, who are suffering from the country’s worst drought this century. This achievement underscores G.A.L. Water Technologies’ commitment to "Cleaning Water and Saving Lives."
Papua New Guinea
What started out as a simple solution with the intent of saving lives, is signified as one of the leading solutions for supplying clean and safe drinking water in the event of an emergency or natural disaster. Israel's Ministry of Foreign Affairs purchased the desalination vehicle from G.A.L. Water Technologies to be donated to the Independent State of Papua New Guinea. On February 29th at 12:00, an event was held at the Ministry of Foreign Affairs in Jerusalem, with the cooperation of Deputy Foreign Minister, Mrs. Tzipi Hotovely, and Mr. Raphael Morav, Director of the Pacific Department of the Ministry of Foreign Affairs. As part of the program, Mr. Rami Aflalo presented the GALMOBILE's capabilities and how the system will aid the residents of Papua New Guinea in overcoming their water shortage.
Ministry of Foreign Affairs:
G.A.L. Water Technologies Ltd.:
Haim Haviv, Partnerships Officer in the World Bank in Washington, D.C.
Adi Shauly, Executive Manager of the Water Industry, Manufacturers Association of Israel (MAI)
Gadi Aviram, Owner of Kawasaki Israel
Rotem Asa, Sales Manager of Polaris Israel
Dr. Efraim Laor, Professor of Disaster Management
The Israeli Ministry of Economy
Photo : Deputy Foreign Minister Mrs. Tzipi Hotovely in the GALMOBILE with G.A.L.'s CEO, Mr. Rami Aflalo
Israeli scientific discoveries that affected the world
New exhibit at Ben-Gurion Airport will feature approximately 60 discoveries and developments selected for the innovative and pioneering qualities, and their direct and indirect influence on the lives of millions of people around the world.
The Ministry of Science, Technology and Space will, on Monday, 7 March 2016, at Ben-Gurion International (BGI) Airport, in the presence of Science, Technology and Space Minister Ofir Akunis and Transportation and Road Safety, and Intelligence Minister Yisrael Katz, launch a year-long wall exhibit of approximately 60 Israeli developments and discoveries that have affected the world. Nobel laureates, featured researchers and university presidents and vice-presidents for research will also attend.
Photo ReWalk - an exoskeleton invented by Dr. Amit Gopher that allows people with paralyzed legs to walk again
PM Netanyahu addresses the CyberTech Conference
We live in a world of great technological change offering unprecedented possibilities. Yet at the same time, we are facing a savage medievalism that seeks to take our world back to a dark age of humanity.
Following are Prime Minister Benjamin Netanyahu's remarks, today (Tuesday, 26 January 2016), to the CyberTech Conference https://www.cybertechisrael.com/ in Tel Aviv:
"Shalom, I'm pleased to welcome all of you, the Ambassador of the United States to Israel and everyone else.
I'm happy that you're here. There is a great opportunity and a great challenge. This is created by the convergence of universal productivity and vast computing power. That's changing our world. It's creating things that we could not have imagined only a few years ago, both in the availability of information and the power of innovation and the increase of human productivity in everything. This is the blessing. It affects every individual. It affects every nation. It affects the world.
But it has a curse. The curse is not only the reason that you're here and the subject of our meeting. The curse has, for example, the curse of vastness also includes the curse of shallowness – shallowness in public discourse, instant referendums that are very hard to govern with – but this is a fact. This is like the curses of the automobile at the dawn of the industrial age, the addition of machines that change our life and it comes with a cost. But the benefits outweigh the costs and the future beats the past.
But the greatest curse that we face is not that. The greatest curse that we face is that in the internet of everything, everything can be penetrated. Everything can be sabotaged. Everything can be subverted. And when I say everything, I mean everything. It's our personal privacy. It's the robustness of our infrastructure. It's our national economies and our national defense. Everything from our personal accounts and information, our bank accounts, our power grids, our communications centers, our planes, our cars – that'll change too in a big way – even the way we do elections. Everything can be penetrated.
This is a fact. And therefore we cannot grow with the future, with the internet economy, with the possibility of exponential growth in some cases – we cannot grow if we do not have cybersecurity. Cybersecurity is essential. It's essential for our defense as individuals and as nations, but it also creates, because of its vitality, because of its importance, because of its centrality, it creates vast economic opportunity.
This is essentially what we decided to do here in Israel a few years ago. I think in one of the first conferences that we held here, I said that we intend to be one of the five leading cyber powers in the world. I think we've achieved that, but I don't think we should be number five or number four, and I don't think we are. Now, when I say that, I'm talking about the question of cybersecurity in both realms, the realm of national security and the realm of industry. How do we provide for our defenses and yet how do we…? How do we provide cybersecurity solutions for Israel? That's in the national defense. And second, how do we provide solutions for the rest of the world?
First of all, there's a conflict between the two. It's built in because one of the things that we each want to cherish is the secrets of our own defense. And yet I recognize that in this field, unless we cooperate, there cannot be growth and I am a champion of growth. And I believe in this cooperation. So with great deliberation, after much thought, we've decided to embark on a course that deals first with our cybersecurity in this country, and second with our cooperation by taking calculated risks of cooperation with governments and with companies.
And you can see by that fact that we are here in a conference with 8,000 participants that obviously we're able and willing to take some risks and I am very happy to see that other countries recognize this as well. We have here the Foreign Minister, my colleague – I'm the Foreign Minister – the Foreign Minister of Estonia. I'm very happy to see you here. Here's another country that has similar calculations and decisions, and I think this is indicative of the fact that we're open to cooperation with countries and with companies.
Now how do we look at the problem, first on the country-level? We've thought about it long and hard, and one thing I can tell you is that no matter how much other governments think about it, and you may be part of that calculation, you're never going to get it right. And if you try to solve all the problems, you'll solve none of the problems. So we've decided to organize our national cyber effort in – what we say in the army is to move it in a direction and get everything organized as we move forward. In the military, if you have a force in the field – you've got a lot of tanks or armored personnel carriers or jeeps, they're scattered in the field, and you say, 'Well, how am I going to push this thing forward?' And if you think about it and think about it and think about it and think about every individual piece and how they interconnect, you're not going to move.
So what we do often in the military is we say we are moving in that direction and everybody fall in place as we move forward, and in a way it's easier to organize things as you move forward rather than try and solve everything in advance by cogitating, by doing endless seminars. We just decided to move forward.
And we've decided to move forward in the following way: On the national level, first in the military we created a cyber-force. This is like the Air Force or like the Navy or like the ground forces. This is an arm of the military. I won't enlarge on that.
The second is to create a national cybersecurity authority, and we've just appointed its head and I'm sure he's going to take this forward very rapidly. Now, this means that we are coordinating all our civilian cybersecurity efforts in one address. This is something that we do because if we don't, we're just not going to move in the direction that we need to try to give greater cybersecurity to our companies, to our vital infrastructure, to our civilians, our citizens. And we're doing this.
We're looking at this structure, this new authority, in three dimensions. The first dimension is, if I have to liken it to a disease even though fighting diseases, I would say the first thing is to immunize organizations and individuals. And that means approaching businesses, giving them guidelines, best practices, standards, across the country. Every single business. Here's what we expect you to do in cybersecurity. And that's for immunization. The second thing is actually treating attacks, outbreaks, and this means: Here's what we do, here are the things that we are going to do and we will be prepared to do in the case of actually attacks. The third goes beyond that and asks what if we have mega-attacks and this requires the pooling of all our efforts, not only our civilian efforts, but also the involvement of our security establishment and all the knowhow.
So we divide it into immunization, treatment and mega-events that require – how shall I say this? They require treating the attack and treating the attacker. This is what we are involved in on a national level. This decision is something that we are sharing with other governments. But let me say that this a very, very difficult process because it requires change, and like all change it challenges vested interests – not corrupt interests, but vested practices. Because you have to say to this security organization or to that controlling agency or to this arm or that arm of the government or of our security forces, "Fall in place. Get your jeeps, get your APCs, get your tanks following in this direction." And this is the guy who's leading and that takes… Everyone retains their activity to some extent, but there is a hierarchical structure and one responsible address.
Now as I say this, this could change. This could change because we're just moving and we'll see how we adopt our practices as we go along. But we do not want to divide the realm of civilian cyber defense among many addresses. We can have great chaos. Yet at the same time, we want to make sure that we have enough resilience and robustness in the system so that when we are attacked, everything falls at the same time. There's a lot of tension between competing interests, and I can't, obviously discuss everything publicly, but you have to take a decision and you have to move. So we've done that on the national defense. We're doing it and again, we are open to share our conclusions with other governments.
I want to say on this something else. I think that there is a critical need for like-minded governments to have serious discussion about cooperation in the broader international realm. I would not seek to have a universal, universal codes because it's not going to work. It'll work for cyber peacekeeping more or less as the UN works for international peacekeeping. It doesn't, it just doesn't. It works when you have what I call two consenting adults. It works when you have countries that decide basically to have peace between them and you want somebody to monitor that peace. Then it works. But in cases of overt conflict or covert conflict, it doesn't work. And therefore what we need here is a meeting – literally a meeting of the leaders of like-minded nations, with our top experts – to discuss what it is that we could do among countries that want to maintain the free and safe operation of our societies and how do we pool some of our resources tog ether to that effect. Maybe from that we'll begin to establish international standards or at least multinational standards that will increase cybersecurity. This is, I think, something that is yet to be done, but I've been speaking about this with a number of world leaders, and I hope it will be done soon.
Now, as far as the opportunities that accrue to us because of the cybersecurity revolution: I think it's evident that a lot of the cybersecurity technology originated in Israel over the past 25 years, not all of it, but obviously a good part of it. The second thing that's obvious is that the world recognizes that. Your presence here, I think, is testimony to that. We've had a spectacular growth of investments, startup companies. We've got about 20% of the private global investment in cybersecurity here. We've got a great growth in mergers and acquisition. I think it's about 1.3 billion dollars this year, or rather in 2015. In any case, both numbers are almost doubling what we had in previous years. It's our challenge to sustain this growth. That requires maintaining a business environment, a pro-business environment on the one hand, the supply of very smart people on the other hand – the supply of people who study mathematics at a high level – and I believe also the invitation to other countries, other companies, to come here, other countries to send interns here. I have all possible envy against the Silicon Valleys that I know from personal experience, the one around Cambridge, Massachusetts, and the one around Palo Alto. Why shouldn't there be a third one here?
I don't mean just our own capacities. I mean the capacities of other nations. Why can't we send young mathematicians from Asia or from Europe or from around the world and have young Jews and non-Jews who specialize in mathematics come here for a few years and be part of this growth and afterwards they can go to their respective countries and companies. I believe that we can do this, and we should do this. I want Israel to be not merely a cybersecurity power in its own right, but a generator of these capacities for worldwide usage, and I believe we can do this.
Now obviously we have to engage the private sector continuously. We do that not only with the cybersecurity authority, which is not merely coming from high up and telling companies what to do. It also engages them and tries to learn from them, glean from them a lot of information that is then merged with the expertise of our defense establishment. But I think that there is also an opportunity here to develop a special environment which produces the growth of cybersecurity companies to the benefit of the Israeli economy and for the benefit of worldwide cybersecurity.
To that end, we have tried to create in Beer Sheba a special environment. Now, look, I have every admiration for Tel Aviv and Herzliya and what has developed here, but we want to replicate it also in Beer Sheba and we've, I've made a decision to move our NSA to Ben-Gurion University. It's literally, its headquarters is on the campus. All the Beer Sheba people are now applauding, yes. We are taking our national cyber headquarters into that campus and we opened a cyber park. We call it CyberSpark, right there, and it's all within a hundred meters. All within a hundred meters.
And so what we have is the interaction, the physical interaction, of people who are in our defense establishment, in our highest national security arms, with people in the university and with people in industry from Israel and abroad – all there, one place, a hundred meters. They meet, they talk, they interact. Is there a risk involved? Sure. We take that risk. Is there a process that emerges? Yes, it does. It creates tremendous robustness.
So I was there showing off to some visitors from abroad and I saw some of these startup companies. And there's a young man there, must be 25, and I look at him and I said, 'You look familiar'. And he says, 'Prime Minister, I was giving you intelligence briefings a few years ago.' I said, 'Yeah, you look familiar.' And I said, 'So what are you doing here now?' And he looks at me and he says, 'Now? Now I'm rich.'
Well, you can be rich too. You could come there and you can partake of this opportunity, and that's what I encourage you to do. Look, if you insist on being in Tel Aviv, it's okay, but I think you should insist on being in Israel. I think the opportunities that present themselves in Israel are unique. There are advantages to being small. Not many, but some. One of the advantages, for example, is it's easier to police your borders. They tend to be smaller. That today is a big issue for many countries.
But the second advantage is that all these people, people who are serving in our top-notch military units who have become entrepreneurs or knowledge-workers right after they leave, and the academics who are excelling in these disciplines in our universities and cross-disciplines, and the entrepreneurs themselves who are here from Israel and abroad – it's a very small place. And still, and I know this will come as a shock to you for all of you are using these gadgets, okay? Still this interaction is the one that is the most powerful. It is still the other ingredient that really makes the cake. It really gives it robustness. It gives it the growth. It gives it the innovation. It gives that special thing. And in Israel you have all these elements in a very small place constantly, constantly allowing for cross-fertilization.
My late father who was a great historian said that, used to say that conversation fertilizes thought, and I don't just mean gadgets. That's important and the passage of information through digital means, that's clearly vital. I mean the exchange, the human exchange in close proximity has that extra push, that extra punch. It just does. Thank God for that.
And what we have here in a very small space is people from disparate disciplines coming together to resolve, to bring cybersecurity solutions to the world. I think you should be part of it. Those of you who are already here, do more – for yourselves. Those of you who haven't come, come here and do more – for yourselves. Because I think this is a vast business opportunity.
Now, we have obviously the challenge of what I call the calculated risk. And we have had some discussion in the past few weeks about cyber-export controls. I want to tell you my approach, and I want to put all of you at ease. I think this is important for the growth of this industry. If we do not define the problem, then everything will be a problem. Now, in Israel, traditionally we had a fairly closed economy that we opened over the years. I had something to do with that as Prime Minister, as Finance Minister, but the rules in Israel were… in general, they tended to say that everything is forbidden unless something is permitted, okay? That was the way we ran our economy and we had to change that. Otherwise we wouldn't have had the growth of the combination of free market and technology that has produced the story, the economic story of Israel today, which turned it into a global technological power. We changed it and we said in many areas everything is permitted u nless specifically forbidden.
In cyber today that is where we're going. We're going to say everything is permitted unless specifically forbidden, and that will enable us to grow our cyber industry without getting into conflicts in the future. It's something that we're doing in an open discussion with our cyber companies. We have a dialogue between government and business, but my goal, and that's what I want to assure you, my goal is to continue growing the cyber industry nationally and internationally for us at the same rate that we've done in the past, so my goal is to enable that growth, that productivity, while maintaining a very narrow band of interests, of national security, that I think any country would have to treat, probably is treating. But I want to define it. I want you to know the ground rules. I don't want you to fall on your face as you're beginning to develop something and then discover that you're going to be in, go over the cliff. I want to define the narrow elements of national security and I want to give you the greatest freedoms possible to develop your industries. It is definitely, definitely a pro-business, pro-entrepreneurial direction that we are leading and will continue to lead.
I want to stress one last thing. I said that we're in a world of great technological change. This is true. It presents possibilities that could not be contemplated in history. And that is also true. It gives billions of people the opportunity to have at their fingertips the knowledge of centuries, and the accumulation of knowledge is proceeding at a stupendous pace. All of that is true. So we have the possibility of what appears to be almost a limitless future. Yet at the same time, we are facing another force that challenges modernity, and that force is a savage early and primitive medievalism that seeks to take our world back to a dark age of humanity, over a thousand years ago. There's a great clash in the world today between the forces of medievalism and the forces of modernity. The forces of medievalism are led by the two forces of militant Islam, those led by Iran on the extremist Shiite side, and those led by Daesh on the extremist Sunni side.
Many, many in the Muslim world are the first victims of this militancy, and of course everyone else is. The problem that we face is that the militants are using the technologies I just described. This is one of those few times in history in which the forces that seek to take humanity back are using some of the forces that take humanity forward. And this presents a greater challenge to us.
Israel is firmly on the side of modernity. We're very proud of our ancient heritage. We're proud of the nearly 4,000 years that we are attached to this land and the great values that we've given to humanity from the People of the Book. But we are absolutely committed to the future and it's based on our heritage. It's based on the biblical values that we developed in this country and on the Talmudic tradition of constantly expanding knowledge and querying, asking questions and reiterating solutions and finding new solutions. It's very much in our history, so we are proud of our past, but we seize the future.
But our future and your future, the future of all mankind, the future of all humanity, depends on this battle. We have to make sure that the forces of the future defeat the forces that seek to take the world back to a dark age. I think this is also part of our challenge. I think that we have to pool resources to make sure that tomorrow wins over yesterday. And that too is part of our task in cybersecurity, in the assurance of cybersecurity.
I would welcome all of you to come and invest in Israel. It's just good business. Thank you, thank you very much.”
PM Netanyahu meets with global cyber industry leaders in Davos
Israel has set for itself being a cyber power as a top priority. In the new age, it is cyber defense that makes the future possible and constitutes a precondition for growth and security.
Prime Minister Benjamin Netanyahu, today (Thursday, 21 January 2016), at the World Economic Forum in Davos, held a unique meeting on advancing cyber defense with managing directors and senior figures in the global cyber industry, including from Sony, Hitachi, Lenovo, Intel, IBM and Hewlett Packard. Participants discussed cyber threats and their implications on the development and assimilation of innovative technologies, the economic, social and strategic risks posed by these threats and the unique cooperation required between governments and the business sector in order to be prepared to ensure the ability to use the cyber revolution for the benefit of global social welfare and economic growth.
Prime Minister Netanyahu emphasized that the rapid development of cyber is creating unprecedented opportunities for human society and the global economy and said that cyber has substantially changed basic elements of our lives both as individuals and nations. In the new age, it is cyber defense that makes the future possible and constitutes a precondition for growth and security. In light of this understanding, Israel has set for itself being a cyber power as a top priority, this by becoming a global cyber greenhouse - in which the spirit of innovation and technological assets create pioneering strategies and solutions for Israel and the world. The Prime Minister noted that Israel is carrying out various improvements in order to reduce the organizations' vulnerability to cyber threats and referred to the establishment of a national cyber defense authority that is working with the private sector on an ongoing basis even as it leverages the capabilities and know-how of the defense establishment.
The company leaders expressed appreciation for Israel's cyber activity; Prime Minister Netanyahu invited them to invest in Israel and join the cyber companies that are already in Israel.
Prime Minister's Office Director General Eli Groner, Israel National Cyber Bureau (INCB) Head Dr. Eviatar Matania and National Economic Council Chairman Prof. Avi Simhon also participated in the meeting.
INCB cyber industry data for 2015:
Exports – approximately $3.5 billion, or around 5% of $75 billion global market. Regarding products only, Israel's share is approximately 7%.
Photo : GPO/Haim Zach
State Leaders and International Cyber Experts Convene for CyberTech in Israel, Tel Aviv 26-27 January
The event will allow B2B, startups, investors, government officials, military personnel, ambassadors and exhibition visitors to focus on networking, strengthening existing alliances, and forming new ones.
Photo & Video provided by The CyberTech 2016 Conference PR
State Leaders and International Cyber Experts Convene for CyberTech in Israel, Tel Aviv 26-27 January
The event will allow B2B, startups, investors, government officials, military personnel, ambassadors and exhibition visitors to focus on networking, strengthening existing alliances, and forming new ones.
Photos provided by The CyberTech 2016 Conference PR
Innovative drug for treating prostate cancer approved in Mexico
A successful Phase III clinical trial in Latin America, involving 80 patients, confirmed the high rate of local cures and minimal side effects, as evidenced by negative biopsies and maintenance of patients’ potency, continence and quality of life
A therapy invented at the Weizmann Institute of Science and clinically developed in collaboration with Steba Biotech (Luxembourg) has been approved by Cofepris, Mexico’s health authority, for the focal treatment of early-stage prostate cancer.
The therapy involves a laser and a novel drug, TOOKAD® Soluble. A successful Phase III clinical trial in Latin America (Mexico, Peru and Panama), involving 80 patients, confirmed the high rate of local cures and minimal side effects already reported in Phase II clinical trials, as evidenced by negative biopsies and maintenance of patients’ potency, continence and overall quality of life.
The marketing approval in Mexico comes in the wake of the recent completion of a second Phase III clinical trial in Europe. This randomized pivot study compared disease progression, cancer-free rate and urinary and erectile functions in patients treated with TOOKAD® Soluble and those undergoing active surveillance with a follow-up of two years. It involved more than 400 patients at 43 hospitals in 11 European countries and is currently under evaluation by the European Medicines Agency (EMA).
The approved therapy follows a new paradigm developed by Prof. Yoram Salomon of the Biological Regulation Department and Prof. Avigdor Scherz of the Plant and Environmental Sciences Department in the framework of photodynamic therapy. It comprises an intravenous infusion of TOOKAD® Soluble, immediately followed by near-infrared laser illumination through thin optic fibers that are inserted into the cancer prostatic tissue, under ultrasound control. Tookad® Soluble was first synthesized in Scherz’s lab from bacteriochlorophyll, the photosynthetic pigment of certain aquatic bacteria that draw their energy supply from sunlight. The drug stays in the patient’s blood circulation until it totally clears 3-4 hours later, and it shows no toxicity. Confined illumination of the diseased tissue activates the circulating drug locally, resulting in the extensive generation of short-lived toxic molecules: oxygen and nitric oxide radicals. These highly reactive molecules initiate rapid occlusion and destruction of the tumor
In the currently approved focal therapy setting, TOOKAD® Soluble VTP (TS-VTP) is a day-case procedure lasting approximately 90 minutes. Patients are released a few hours later and can return to normal activities within a few days, with none of the side effects frequently associated with prostate removal by surgery or radiotherapy. This new minimally invasive technology offers a good alternative to patients diagnosed with early-stage prostate cancer. The number of these patients has dramatically increased in the last two decades due to widespread screening relying on levels of prostate specific antigen (PSA). This population faces the dilemma of undergoing the radical treatment of prostate removal with the risk of high morbidity, or remaining under active surveillance with increased risk of further cancer progression.
Tookad® Soluble answers an unmet need in providing this category of patients with an appropriate treatment, which combines good efficacy with a preservation of the quality of life.
Weizmann institute and Steba Biotech are currently pursuing an extensive oncological research program in collaboration with several clinical groups at Memorial Sloan Kettering Cancer Center in New York City. Four clinical studies for more advanced prostate cancer and other oncological indications stemming from this research are scheduled to start in 2016.
Yeda Research and Development Company, the Weizmann Institute’s technology transfer arm, has licensed the drug to Steba Biotech, which manufactures Tookad Soluble. Amir Naiberg, CEO of Yeda: “Our cooperation with Steba covers 20 years of fruitful collaboration. The commitment made by the shareholders of Steba and their personal relationship and effective collaboration with Weizmann Institute scientists and Yeda, have enabled this tremendous accomplishment.”
In recent weeks, two extraordinary stroke cases were successfully treated at Haifa’s Rambam Health Care Campus, thanks to a unique, time-saving “Red Carpet Treatment.”
The first patient, a 93-year-old woman, made history as the oldest stroke victim in Israel to successfully undergo mechanical thrombectomy to remove the blockage in her brain. Admitted to Rambam, she received the fast-track Red Carpet Treatment for suspected stroke patients under the supervision of Professor Gregory Talman of the Department of Neurology and Dr. Yaakov Amsalem, Director of the Interventional Neuroradiology Unit. One day after surgery the patient was fully functioning and laughing with her family.
In the second case, a 67-year-old Gazan woman was at Rambam visiting her grandson when she suffered a stroke. Seeing that something was terribly wrong, the boy called for help. Upon transferring her to the emergency department it was learned she had suffered an ischemic stroke with a total blockage of the artery that supplies blood and oxygen to the left side of her brain. For her too, a mechanical thrombectomy was considered the best approach.
“The patient was lucky to be here when she had the stroke,” said Dr. Amsalem. “Time is a critical factor, and the needed treatment she needed just happened to be available. From the moment she reached our emergency department to the time the blockage was cleared, an hour and 15 minutes passed—record time for patients like this.”
Mechanical thrombectomy is a complex and delicate procedure. A catheter is guided to the blockage site, and the thrombus is “captured” and removed by means of a specially fitted stent. This treatment is available in only six hospitals in Israel—Rambam is one of them. This procedure is yet another example of how state-of-the-art interventional approaches are transforming the standard of health care and saving precious lives.
Photo : Inessa Azarov and Prof. Gregory Teleman by Pioter Fliter
Israeli Startup Emaze Challenges PowerPoint and Releases the Next Generation of Presentations
Advanced Tool for Automatically Transforming PowerPoint Slides into Beautifully Designed Presentations in Just Minutes
Tel-Aviv, October 15, 2015 - Everyone who presents before an audience knows the difficulties involved in creating a presentation that will impress your audience and convey your message in a compelling manner. Certainly, the templates offered by PowerPoint fall short with their limited and uninspiring designs.
Israeli startup emaze aims to solve this problem with it’s new feature, Automaze, which enables users to transform PowerPoint slides into well crafted and beautifully designed presentations – in just a few minutes. The Automaze feature, based on advanced algorithms involving Big Data and Machine Learning, scans the text and photos in the PowerPoint slides and offers a visually stunning version that is best suited to the content of the slides. With this new technology, everyone can present like a pro with an elegant, impressive presentation- created in just minutes with no additional design required.
In addition to Automaze, emaze offers innovative presentation making capabilities such as the ability to add in gifs, media, live data, hyperlinking, and more. Video, pan and zoom and 3D transitions, guide your audience through a fascinating visual journey that captures the essence of your narrative.
In addition, these presentations can be shared easily via social media, thereby transforming into valuable marketing tools. Each presentation can also be tracked based on how many views it received, where those views occurred, and further segmentation options to meet the needs of each user.
How does it work?
The user enters emaze through the website and uploads their existing PowerPoint presentation and chooses from any of their designer templates. Automaze technology scans the contents of the Powerpoint presentation and then utilizes its extensive database of 10M presentations to beautifully redesign the original presentation. Within minutes, the user receives their new and improved version.
Motti Nisani, the founder and CEO of emaze, notes that “we all have occasion to present before some kind of audience – students, investors, potential clients, etc., and we spend hours, even days, designing a presentation that will convey our message and make the desired impact. But, at present, there is a gap between the boring templates offering by PowerPoint and the compelling content that we create. emaze bridges that gap by enabling us within seconds to transform our PowerPoint slides into fantastically designed emaze presentations that captivate audiences by bringing them into our story through dynamic, state-of-the-art features. All of this is possible without any design skills and within literally a few blinks of an eye. In a world in which more than 30 million slide presentations are created every single day, we’re striving to be the Wix of the presentation universe and to set the industry standard for years to come".
Is there a cost?
emaze is available for free, or with premium upgrades, available to individuals at a cost of $9 a month, or $14 a month for businesses.
emaze currently operates out of The Time accelerator, is led by advertising executive Ilan Shiloah, and has 11 employees.
Photo Silvia Golan
WATEC 2015: 13-15 OCT- Water Technology and Environmental Control
Water Technology and Environmental Control Exhibition and Conference at the TLV Convention Center
WATEC- taking place at the Israel TLV Convention Center on October 13-15, 2015 will be bringing together Israeli & international business executives, water utility engineers, political decisions makers and leading researchers to foster substantive debate and insights, on the key issues facing the world's water and ecological systems. WATEC 2015 promises to be a premier showcase for the most advanced technologies and solutions from Israel and around the world.
The unique exhibition will present state of the art Israeli technological innovations in the fields of water and environmental control. Among the companies presenting are companies that have been appropriated by large international consortiums, others that have shown impressive success in penetrating and developing worldwide markets, as well as young startup companies. Having coped with decades of water shortages has afforded the State of Israel tremendous accumulated experience for developing unique solutions for issues such as Water management, Wastewater and water treatment, Desalination, Water security, and Drip irrigation.
The Israeli water market is internationally recognized as highly developed, having benefited from many years of experience in managing scarce water resources. Moreover, the national industry is widely regarded as a nexus of world-class expertise in the water field.
WATEC presents the perfect opportunity to hear from and meet a range of growing water, energy & environment companies seeking a combination of partners, investment and professional services to develop their companies.
Website : http://watec-israel.com/
Photo : Watec PR
Tel Aviv Selected to Host First Meeting Leading Up to UN Habitat III Conference
Last week, Tel Aviv hosted the first of 7 thematic meetings leading up to the UN Conference on Housing and Sustainable Development (UN Habitat III). Held every 20 years, this is the third conference of its kind, aimed at reinvigorating global commitment to sustainable urbanization. Chosen as the Smartest City in the World in 2014, Tel Aviv was selected as the host for a thematic meeting on smart civic engagement as a beacon of civic participation and technological innovation.
Dr. Joan Clos, Executive Director of UN-Habitat and Secretary-General of Habitat III, hosted and participated on several panels, and held meetings with Tel Aviv Mayor Ron Huldai, along with Deputy Mayors and civic officials from around the world brought together at Tel Aviv’s Cities Summit conference. Among the key questions he asked centred on the role national governments, municipal departments and technology have in promoting civic engagement.
“Civic engagement must be a key topic of the New Urban Agenda, as in order to achieve equality and accountability in cities we need civic engagement to become real. I thank the city of Tel Aviv for hosting the first Thematic Meeting towards Habitat III and for inspiring the global discussion through its innovative urban solutions”, stated Dr Clos.
The Tel Aviv Municipality has spearheaded several initiatives built around the principle of engaging with its residents and leveraging their input to improve urban life in the city. Various projects have been implemented such as the shared workspaces for example the Library and Atidim 7 where entrepreneurs can work in an interactive environment. Other initiatives include the The App2u competition which opens city databases to the public for crowdsourced solutions, as well as providing free Wi-Fi across the city. These initiatives have all fostered a climate where partnerships between citizens, businesses, third sector organisations and the municipality grow and evolve at an impressive rate.
“At the heart of our understanding of the concept of ‘smart cities’ is not necessarily the newest or most expensive technology, but rather, stripping away the barriers between the municipality and the residents to create an era where information is free-flowing, and the city is responsive to the needs of its residents,” said Hila Oren, Founder & CEO of Tel Aviv Global.
The Cities Summit Tel Aviv is a conference run by the Tel Aviv-Yafo Municipality, which aims to address all the crucial factors that are facing urban administrators in today’s complex digital world. With the goal of contributing to the city and optimizing its potential to the fullest extent, the Tel Aviv-Yafo Municipality invites entrepreneurs, politicians, city counsellors, and other senior urban administrators to join forces and come together for an opportunity to share their experiences on how to promote innovation in their cities, while engaging a broader audience in both the public and private sectors.
The Habitat III Advisory Board will discuss the inputs and recommendations gathered during the event in Tel Aviv, and issue a final declaration. This will constitute an official document to be used to feed discussions and member states negotiations leading to the formulation and agreement on the global new urban agenda. The Tel Aviv Declaration on Smart Civic Engagement will be published on 20th September, after considering contributions by partner’s constituent groups from the Thematic Meeting.
Photo by Ori Taub.
Picture of Dr. Joan Clos – the Executive Director of UN-Habitat,
A joint team from NRGene and Tel Aviv University has completed the mapping of the wild Emmer wheat genome in just one month, giving a significant boost to global research into crop improvement, improving global wheat yields and helping combat the world food crisis.
Wild Emmer, the progenitor of today's durum and bread wheat varieties, was one of the first crops to be domesticated about 10,000 years ago in the Middle East. According to Dr. Gil Ronen, CEO of NRGene, "Mapping the Emmer genome in Israel brings everything full circle. Aaron Aaronson identified the variety in Rosh Pina in 1906 and proved that Emmer wheat was the basis for the development of cultivated wheat."
Dr. Assaf Distelfeld and other scientists at Tel Avi University have been working on wheat improvement for more than 10 years. "Mapping Emmer wheat is critical to global wheat research as it is the direct ancestor of cultivated wheat," said Dr. Distelfeld, head of the Emmer wheat consortium. "With a genome map of Emmer wheat, scientists at universities, global seed research centers, and the major seed companies will be able to breed seeds with higher yields, better disease resistance, and more adaptability to extreme growing environments, such as drought or extreme heat conditions."
For example, wild Emmer wheat is rich in nutrients such as iron and zinc, and can be naturally crossed with cultivated wheat. Transferring this trait to bread could reduce malnutrition among those whose diet is based on this staple crop.
"The repercussions of the mapping will be felt around the world," continued Dr. Distelfeld. "Scientists will now be able to identify key genes in the Emmer wheat and introduce them into commercial wheat via classical breeding, creating hardier varieties across environmental conditions, ultimately increasing the global food supply."
Researchers participating in the program represent leading universities in Israel and across the globe, including Tel Aviv University, Hebrew University, Weizmann Institute of Science, University of Haifa, Ben Gurion University, and the Volcani Institute for Agricultural Research in Israel; United States Department of Agriculture; University of California, Davis; University of Illinois; University of Minnesota; University of New Hampshire; Sabanci University in Turkey; and IPK and MIPS research institutes in Germany.
NRGene, located in Ness Ziona, Israel, is a genomic big data company developing cutting-edge software and algorithms to reveal the complexity and diversity of plants and animals for the most advanced computational breeding. NRGene tools are already been employed by some of the leading seed companies as well the most influential teams in academics and NGOs.
Emmer wheat (Triticum dicoccon)
Copyright: U. S. Department of Agriculture
2015 Shanghai Rankings - Technion consolidates its standing among the world’s elite universities
2015 Shanghai Rankings: Technion consolidates its standing among the world’s elite universities
Technion-Israel Institute of Technology has consolidated its standing as one of the top 100 universities in the world, according to the annual Academic Ranking of World Universities (ARWU) released by Shanghai Jiao Tong University, considered the most reliable global university ranking. The 2015 results, which were published yesterday (Saturday, Aug. 15), highlight Technion’s position among the world’s elite universities, especially in the Technion's core areas of research and education:
· In the field of computer science the Technion ranks 18th for the third consecutive year. The Technion is one of only four non-U.S. universities among the world's top 20 in computer science. This is the highest ranking of any Israeli university in a specific subject area.
“The Shanghai ranking is recognized as the leading academic ranking of world universities and it continues to acknowledge Israeli scientific achievements, and Technion in particular,” stated Technion President, Prof. Peretz Lavie, following the publication of this year’s rankings. “I am very pleased at Technion’s standing among the world’s elite universities in engineering and especially in the field of computer science. These achievements are a clear manifestation of Technion’s excellence. Our outstanding faculty members, researchers and staff will continue to nurture and train Technion students, who represent the future of Israeli science and technology.”
The Shanghai Ranking was established in 2003 with the aim to identity the global standing of top Chinese universities while comparing them to 500 of the world’s leading institutes. Since then it has evolved into the most influential ranking of universities worldwide. Many objective indicators are examined, including the number of faculty and alumni who have won Nobel Prizes and other prestigious awards; the number of articles published in leading scientific journals; and other per capita performance indices of the universities. More than 1000 universities are ranked by ARWU every year and the top 500 are including in the published rankings.
Heading the list of the world's top universities are leading American institutions such as Harvard, Stanford, Massachusetts Institute of Technology (MIT) and the University of California, Berkeley.
The World Economic Forum has published the annual list of Technology Pioneers. Two of the 14 companies chosen in the category of Life Sciences & Health are Israeli: Consumer Physics and ElMindA.
The World Economic Forum's Technology Pioneers programme recognizes early-stage companies from around the world that are involved in the design, development and deployment of new technologies, and are poised to have a significant impact on business and society. Technology Pioneers come from a wide range of sectors such as life sciences and health, energy and environment, and information technologies and new media.
The World Economic Forum has published the annual list of Technology Pioneers, which this year consists of 49 companies from 10 countries, recognizing the world's 49 most promising Technology Pioneers for 2015. Two of the 14 companies chosen in the category of Life Sciences & Health are Israeli: Consumer Physics and ElMindA.
Consumer Physics, founded in 2011 and based in Herzliya, has produced the SCiO - a tiny spectrometer that allows you to get instant relevant information about the chemical make-up of just about anything around you, sent directly to your smartphone. The world's first molecular sensor that fits in the palm of your hand, it allows users to explore objects by scanning materials.
For example, you can:
Get nutritional facts about different kinds of food: Dairy products, Fruits and vegetables. Other apps for drinks, meats, ripeness, salad dressing and more will be released on a regular basis as our database expands.
ElMindA, also based in Herzliya, was founded in 2006, with the vision of revolutionizing the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice.
ElMindA Ltd. has developed Brain Network Activation (BNA), a non-invasive technology that allows physicians to accurately differentiate between the function of a healthy brain and the dysfunction of an injured brain. With BNA physicians can monitor change in brain networks and address brain health by identifying disease onset and assessing treatment efficacy. ElMindA is revolutionizing our ability to assess and treat the brain across a broad range of previously elusive conditions such as depression, pain, or memory loss.
ElMindA’s innovative approach and supporting data have led to partnerships with top pharmaceutical companies and leading neurological and psychiatric institutes around the world. The company has already completed several clinical trials establishing the utility of the BNA™ technology, and its technology is already being utilized by leading pharmaceutical companies as an integral part of their clinical development programs for monitoring drug effect on the brain.
BNA™ as a measure of brain state and brain changes, can potentially be applied to a wide spectrum of indications and their therapeutic interventions including Alzheimer’s disease, Parkinson’s disease, Concussion, ADHD, pain, stroke, depression, and other Central Nervous System related conditions. In addition, the technology serves as a valuable tool in the development of CNS related treatments.
Photo: Israel's Technological Pioneers: Consumer Physics and ElMindA
Copyright: World Economic Forum Technology Pioneers
In light of the limitations of existing drugs for AIDS:
Researchers at the Technion Faculty of Biology offer a new strategy to combat the HIV-1 virus
However, the new strategy also has its weaknesses. Assistant Prof. Akram Alian of the Technion Faculty of Biology explains that when the virus encounters a barrier on its way into a cell, it looks for ‘detours’ that will enable it to take advantage of the cell nevertheless. Since there is redundancy in the host cell - various mechanisms leading to the same operation - the virus may exploit a self-mutation that could enable it to make use of that detour. “Our hypothesis is that the redundancy in the cellular pathways may represent a survival mechanism that allows the virus to take advantage of a wide variety of similar processes,” says Assistant Prof. Alian. “The virus can use these detours when the favored route is blocked by natural cellular mechanisms or artificial drugs and under other circumstances in which it is better for the virus to circumvent the obstacles of the cellular environment and the various stages of replication.”
An earlier article, published in the journal Cell Structure in October 2014, reviewed a new approach to AIDS research developed by scientists at Assistant Prof. Alian’s laboratory. The researchers conducted a comparison of an important viral protein (integrase) that exists in both HIV-1 and FIV, the AIDS pathogen in cats, and discovered new differences that could aid in the understanding and prediction of the development of resistance. With both viruses, the integrase inserts the viral DNA into the DNA of the infected cell, and then replicates itself in a manner that enables it to spread throughout the body. “The virus is a kind of Trojan horse, which uses the host’s genome in order to replicate,” explains Assistant Prof. Alian. “Now we are studying this issue in depth and trying to develop this idea of ‘multiple route reproduction of the HIV virus,’ as a new strategy in the treatment of AIDS.”
Ants in the Lead A physics-based model can explain how ants cooperate in steering food to their nest
Anyone who has ever watched a group of ants scurrying to carry a large crumb back to their nest has probably wondered how these tiny creatures manage the task. New research at the Weizmann Institute of Science, which appeared today in Nature Communications, explains how a balance of individual direction and conformist behavior enables ants to work together to move their food to in the desired direction.
Dr. Ofer Feinerman’s research is supported by the Yeda-Sela Center for Basic Research; the Clore Foundation; and the Tom Beck Research Fellow Chair in the Physics of Complex Systems. Dr. Feinerman is the incumbent of the Shlomo and Michla Tomarin Career Development Chair.
Prof. Nir Gov's research is supported by the Yeda-Sela Center for Basic Research. Prof. Gov is the incumbent of the Lee and William Abramowitz Professorial Chair of Biophysics.
Videos taken during the research:
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.
Weizmann Institute news releases are posted on the World Wide Web at
Photo provided by Weizmann Institute
NIS 5 Million to Be Granted for Innovative Ideas Helping Resolve Global Health Issues and Ensuring Food Safety. Ten Initiatives Will Receive Grants from the Office of the Chief Scientist and the Ministry of Foreign Affairs of Up to Half a Million Shekels Each
JERUSALEM. JULY 22nd 2015– The Grand Challenges program is an international initiative taking place in countries like the US, Canada, India, Brazil, China and others, aimed at encouraging novel solutions for global food safety and health challenges, with an emphasis on developing countries. The Chief Scientist at the Israeli Ministry of Economy in cooperation with the Ministry of Foreign Affairs' Agency for International Development Cooperation (MASHAV) and the Prime Minister's Office are launching the second round of Grand Challenges Israel, a competition aimed at encouraging innovative technological or social solutions in food safety and global health, with an emphasis on developing countries. The program promotes Israeli technological innovation in new markets as an expression of Israel's commitment to offering aid to these countries.
Israeli Minister of Economy and Minister for the Development of the Negev and Galilee Aryeh Machluf Deri: "This exceptional program helps the weakest sectors. Most of the world's population suffers from lack of food and access to fresh water and increased exposure to disease. We invite Israeli entrepreneurs to develop technologies that will improve the quality of life of billions of people around the world."
Developing countries face complex challenges related to under-development, lack of resources, technology, skilled personnel and advanced infrastructure. They require innovative solutions adapted to their complex environment. Israel enjoys a large community of developers and entrepreneurs, focusing mainly on the markets of Western Europe and North America - with extensive knowledge and industrial R&D capabilities in the life sciences in general and public health in particular.
The Israeli Ministry of Economy, through the Office of the Chief Scientist, helps strengthen and broaden the technological base of Israeli industry with a variety of support programs. As part of this support and in light of Israel's international cooperation and assistance programs, the Ministry of Foreign Affairs’ MASHAV agency, the Prime Minister's Office and the Israeli Ministry of Economy have initiated a unique program operated by the Office of the Chief Scientist intended to promote research and development to find technological solutions for health challenges in developing countries - Grand Challenges Israel.
As part of the program, up to NIS 500,000 will be granted to prove the viability of innovative solutions for problems in global health or food safety. The program aims at directing Israeli entrepreneurs to seek solutions for developing markets - markets where urgent solutions are needed on the one hand and which offer large, unrealized business potential for Israeli industrialists and entrepreneurs on the other.
Among the ten initiatives given grants last year: a novel device to diagnose cervical cancer, a tool for diagnosing malaria, innovative water purifiers and affordable wheelchairs for children to enable maximum mobility and access to education.
Israel’s Chief Scientist at the Ministry of Economy Avi Hasson said: “The Israeli segment of the International Grand Challenges competition is an expression of Israel's capabilities in the field of technological innovation, together with the Israel’s world-renowned entrepreneurial spirit. A combination of doing good by helping resolve global challenges and establishing a foothold in new markets with unique consumer demands for the Israeli industry can bring Israeli entrepreneurs vast new business opportunities."
Head of MASHAV at the Ministry of Foreign Affairs, Ambassador Gil Haskel, said: "This unique program reflects Israel's wish to continue helping developing countries in relevant fields and constitutes the meeting point between Israel's diplomacy and technological innovation."
In light of the complex business environment in developing countries, the Office of the Chief Scientist and MASHAV will help entrepreneurs who show interest in finding compatible partners for the development and implementation of initiatives in developing countries. The criteria for submissions include: Potential effect on the health situation in developing countries - the contribution R&D products can have on health challenges in developing countries; the possibility of implementing developed products in developing countries in order to improve public health, save lives or minimize disability. The product and the technology - a different and original approach, technological viability, advantages over existing solutions, the ability to reach significant milestones within the implementation period and the ability to undertake a realistic R&D program during the implementation period. Quality of personnel - knowledge and experience of applicants in the relevant field, personnel available for attaining the program's goals. Scalability - the existence of a clear plan to implement R&D products to solve health challenges in developing countries on a commercial scale within a reasonable amount of time, including the possibility of fundraising and/or finding compatible partners for continued development and commercialization; and Integrated innovation - combining technological innovation with social and business innovation in a way which can maximize the effect of R&D on health challenges, including cooperation with relevant social initiatives in developing countries.
Applications are welcome from researchers, entrepreneurs, small and medium sized businesses (up to 100 employees), research institutions and NGOs. Submissions found compatible will receive funding at up to 90% of the initiative's approved budget, to a maximum of NIS 500,000 - for proof of concept.
Additional data is available at http://www.grandchallenges.org.il
Technion ranked 31st in the world in the U.S. Academy of Inventors index
The rankings list of the National Academy of Inventors, founded in the U.S. in 2010, ranks the Technion in 31st place in the list of universities around the world, based on the number of patents approved in the U.S. in 2014. The Technion, with 65 approved patents last year, ranks above well-known universities such as Yale, Duke, Rutgers, USC (University of Southern California) and Tokyo University, as well as all the other Israeli institutions that placed in the rankings: Tel Aviv University (43rd place), the Weizmann Institute (52nd place) and Hebrew University (73rd place). The top-ranked university is MIT, which advanced from second place in 2013, with 453 approved patents in 2014.
A few of the patents registered by the Technion and approved in 2014 are: medical scaffolding; a system for monitoring air passage in the lungs; a system for the rapid imaging of the macula; non-friction molecular engines; an innovative device for separating oxygen from air; silicon-air batteries; and assessment for the early diagnosis of growths in the large intestine.
Prof. Wayne D. Kaplan, Technion’s Executive Vice President for Research, congratulated the researchers, senior staff and students on this impressive achievement.
Benjamin Soffer, director of T3―Technion Technology Transfer Office, which houses the patent registration department, said that this impressive accomplishment is “an expression of the Technion’s tremendous openness to innovation and to the balance between the entrepreneurial spirit and excellence in academia and research. In the past few decades the Technion has been constantly increasing the entrepreneurial component in training students, with the intention that at the end of their studies the students will be equipped not only with scientific and engineering tools, but also with the managerial and entrepreneurial skills that will enable them to ‘invent their own workplace’ and not only to find jobs as salaried employees in existing companies.”
“It’s important to take into account that the Technion’s research budget, $135 million a year, is very low compared to the other universities and is only 8% of the MIT’s research budget. If the universities were ranked based on their revenues from commercialization relative to their research expenditures, the Technion would be in third place, behind Princeton and New York University,” said Soffer.
The Technion Technology Transfer (T³) office operated in the framework of the Technion Research & Development Foundation, and is responsible for the commercialization and protection of intellectual property developed by the Technion. One of the outstanding successes in this field is the commercialization of Azilect, a drug developed in cooperation with Teva Pharmaceuticals, based on research by professors Moussa Youdim and John Finberg. Sales of this drug top $400 million annually.
T3 manages holdings in some 50 active companies and over the past three years, the Technion’s portfolio companies have raised over $250 million in investment capital. These companies include Argo Medical Technologies (which develops exoskeletons to help the disabled to walk); Applied Immune Technologies (a drug development company specializing in T-Cell Receptor-Like, TCRL, antibodies); Accellta (media and cell cultures for the stem cell industry), Sealantis (tissue adhesive); Avraham Pharmaceuticals (drugs to slow the progression of Alzheimer’s and mild cognitive disorders), Corindus (robotics technology that enables cardiologists to perform remote catheterization), VibeSec (information security on web-based telephony), NanoSpun Technologies (smart fibers), ElMindA (imaging system for neuron network activity in the brain and treatment based on network stimulation) DigiFlex (products for the printing industry and industrial processes) and Regentis (gel for regenerating tissue).
For the full list of the rankings: http://www.academyofinventors.com/pdf/NAI-IPO-Top-100-Universities-2014.pdf
Israel's Defense Minister Ya'alon at 5th Annual International Cybersecurity Conference: "Cyberspace enables attacking other nation states without (leaving) a footprint"
5th Annual International Cybersecurity Conference concludes today at Tel Aviv University
Photo provided by Cybersecurity Conference
PM Netanyahu's Address at the 5th Annual International Cybersecurity Conference
"The whole point of your being here today, here in Tel Aviv University under the invitation of Professor Joseph Klafter and Major General Yitzhak Ben-Israel, my friend, and Ambassador Dan Shapiro and Ambassador Gould from Great Britain, I think you're all here because you know that we do question things. The whole point about cyber is you've got to question and challenge all the time. This is a rapidly-evolving discipline or lack of discipline. It's the fastest growing, fastest changing domain in the international economy and international security in our world.
The greatest force of change and growth is the internet-driven economy, with all its derivatives. It is changing by the hour, and we have to be constantly ahead of the curve. I've set a goal a few years ago to ensure that Israel is one of the leaders of cybersecurity. My job as Prime Minister is to make sure that it stays that way. We are living in a new normal of data generation. Each year, more data is accumulated and created than in the world's entire history. We're in the throes of a great change. We're moving from atoms to bits, from place to space. I don’t want to say that we're walking in the clouds, but we sort of are. And it requires that we be at the cusp, at the edge of innovation all the time.
The cyber needs and the cyber market is not a staid, low growth market where you can establish a position of dominance as we have and rest on your laurels. This is the classic high-growth, super high-growth markets in which you have to constantly innovate to maintain your position. We've done that now. We said we'd be among the top three. We are. But we have to make sure that we're there ten years from now, twenty years from now, fifty years from now, because it's not going away. And therefore we have established two major arms to deal with this, two government resolutions that we accepted, that we passed a few weeks ago. One is to create the National Cybersecurity Authority, in order to build market resilience, in order to define how we approach the question of defense. I'll say more about that in a minute. And the second is the decision to create the IDF cyber forces. And we are eager to build capacities that endure and develop in order to have the cutting-edge needs that we need for national defense.
Let me say something about defense and cyber. The most difficult question is where you draw the fence. Do you draw it around a company? Do you draw it around an airbase or a power plant? And the answer is yes and no. Yes because you need it in every one of these installations, facilities or services. No because it's not enough. But how far do you go? Where do you draw the fence? And if somebody punctures that fence, what do you do about it? Who do you tell? How do you prepare in advance? Who do you share this information with? What do you do about it?
These are exceedingly complex questions and there are no obvious answers. And so in the face of this uncertainty, you can basically do two things. You can do something and just say: It's too complicated, I don’t know what the solution is. It's fast-evolving, or you can say: We'll organize ourselves by making decisions and moving forward. We have a saying in the military: We organize ourselves in movement. God, that's a terrible translation. I'll say it in Hebrew - מסתדרים תוך כדי תנועה. That means you move, you decide where you're going and you sort of get the forces, the vehicles, moving alongside as you decide a direction. We've decided on these two directions, I think they're monumental decisions. We may be ahead of most countries, we may be ahead of all countries, but we're moving, and we can see the change that is developing once we've decided what we're doing.
We learn as we go along. We can share with governments, with companies, with entrepreneurs what we're doing, well, some of what we're doing. I think that's important. And Israel is a unique place. It's unique because it has first of all a relatively large number of people who excel in this area, but I think it's not merely a question of numbers although I'll have something to say about that in a minute. It is a unique place because of the culture that we have that is absolutely necessary here and that is to challenge assumptions, challenge assumptions. This is something that is deeply embedded in the DNA of our people. The father of our nation, Abraham, challenged God. That's as big a challenge as you can have. And we have had that embedded in our culture throughout and it's very much something that we see in the development of businesses.
I think that we have another advantage, which is perpetual investment in this field. And our task is to take this perpetual investment and make it into not only a vehicle for national defense but also a vehicle for business. Now, I think there are many factors that have contributed to our concept of how to advance it, how to advance business here, but one of them was borne of an experience that I had studying in Cambridge Massachusetts a hundred years ago. I lived on the campus in a place called Kendall Square and I used to go down to the Sloan School where I went to school and right across the street was this warehouse, ugly, very different from the other buildings that you had there, I.M. Pei towers and modern facilities, and here there's this, right across the street where I live, this warehouse, opaque windows, bars, and I said: What is this? And I was told: Well, this is some kind of government labs, CIA, no, NSA – first time I heard those words, those letters – and of course what that was the implantation of government investments in the middle of a campus that eventually produced Route 128 and Route 495, a Silicon Valley, replicated pretty much the same way in Stanford, in the San Francisco area with that other Silicon Valley.
And I thought: That's a pretty good combination. You have government investment of military and security intelligence and academia that produces spawns, business start-ups, and that's essentially what we decided to do in Be'er Sheva. We've decided to take our NSA and our other associated units, put them in the Negev and smack, in Be'er Sheva, right next to the university, to have our National Cyber Headquarters, Ben-Gurion University, and a cyber-park, which is rapidly expanding with some of the world's leading firms.
This is a prescription of getting the forces that can build the future in one place, in a small place where that culture that I spoke about can grow and thrive. And we encourage our young people who come out of the military to enter into these fields. It's not merely that they encourage themselves. We encourage it, and we'll be giving tax breaks in a few months to companies that go to Be'er Sheva in order to further enhance this ongoing investment because every year we take our brightest young men and women and we put them through our military and security system and encourage them to become entrepreneurs.
And so Israeli start-ups have been bought at the rate of about a billion dollars in the last eighteen months. We've had hundreds of millions of dollars of investment in the last year alone in Israeli start-ups, and more is coming. And our job is to make sure that this machine, this perpetual motion machine continues to move and at a rapid pace, and we're committed to it, and everything that we do. We view this as the future, we view this not just as an auxiliary part of our economic effort. We view it as a major, major thrust of our economic effort, a growth engine for the next fifty years.
A few days ago I had a visit in my office by Eric Schmidt, you’ve heard of him? Small company. He said to me: Israel is the digital powerhouse of the world. I said: Eric, you don’t think you're exaggerating? He said: Well, let me be precise. In absolute size, you're number two, after the Western Silicon Valley, but you're ahead of New York, you're ahead of Cambridge MAS, you're ahead of Cambridge England, he said. I don’t want to offend anyone. Dan Shapiro, the Ambassador of the US, this is an American citizen saying, and Matthew, that's what he said.
I'm just saying that there is tremendous growth. He said that he's investing in Israel, that he's done wonderfully well with a lot of these start-ups, he said: This is where the future is built because, he said, of this particular culture. Culture is very difficult to replicate. It's not clear how you repeat something like this, but it's happened here and our job is to make sure that it keeps on growing, so we're going to invest a lot in making sure that we have an abundant supply of young people, I mean kids who study math at the highest level. We have special programs for cyber education, both in our schools and in the military. We're absolutely, absolutely committed to this domain because we want to make sure that we're dominant.
I said that it's not going to go away because the problem of protecting the internet-driven products, services, is so vast, it's so challenging that it's just going to get more and more complicated. We have certainly hackers that attack, we have non-governmental organizations that attack. But the greatest threat comes from governments, and like-minded governments that want to protect the privacy of their citizens, their bank accounts, their infrastructure, their economies, have to work as far as they can together to cooperate against this new threat.
Specifically, Iran has been launching attacks against us, against Saudi Arabia, against the United States, against many others, and we're determined to enable ourselves to protect ourselves from these attacks and others. And the way we're doing it is this combination of government, military, academia and business. We think this is a potent opportunity.
My point to you is that we are moving ahead and we're committed to stay ahead. And I think each of you can have your own opportunity here. I think Israel is exciting, it's open, it's open for your business. I'm glad you're here in the 5th International Cyber Conference. The numbers grow each year, the investments grow each year, the opportunities grow each year, and I'm here to basically tell you if you're not in Israel, you should be; if you are, do more.
And one more word. If you haven’t met Eviatar Matanya, who is our National Cyber Director, you should know this guy. He's been doing a fabulous job and he'll keep on doing it in the years to come.
Thank you very much, thank you all."
Photo Credit: Jenna Shapiro
The Illuminated Heart : A recent Technion study describes a novel optogenetic approach for pacing and resynchronizing the heart in case of heart rhythm disorder
Technion researchers have developed a new approach for the treatment of abnormal heart rhythms by using a light based therapy. This technology has been reported in the journal Nature Biotechnology. The study was conducted at the laboratory of Professor Lior Gepstein from the Rappaport Faculty of Medicine and Research Institute at the Technion. Professor Gepstein is the director of the Department of Cardiology at Rambam Health Care Campus.
Abnormalities in the function of the heart’s pacemaker cells or electrical conduction system can lead to an abnormally slow heart rate, or lead to a decrease in the hearts’ pumping efficiency by delaying the transmission of electrical signals. In either case, the underlying electrical disease can result in negative and serious consequences for patients including weakness, dizziness, fainting, worsening heart failure symptoms and even the risk of death. The conventional medical treatment used today relies on the implantation of an electronic pacemaker, which corrects the dysfunction of the natural pacemaker mechanism using electrodes inserted into various areas of the heart. Electronic pacemakers however have many limitations including the risk of infection and the need for repeated invasive surgical procedures for implantation, manipulation, and battery replacements. Furthermore, clinicians are limited by the number and locations of the pacing wires used, and patients are at risk for a decline in heart function since pacemakers cannot re-create the normal electrical activation pattern of the heart. Perhaps most importantly, children who require pacemakers quickly outgrow their pacemaker wires and thus require repeated and invasive interventions over time.
In light of these disadvantages, many researchers are working on developing biological alternatives to the electronic pacemaker. This article describes a study that examines the use of the optogenetic approach for the treatment of abnormal heart rhythms. The study was conducted by Dr. Udi Nussinovitch as part of his PhD work in Professor Gepstein’s laboratory at the Technion. Dr. Nussinovitch is currently an intern at the Department of Internal Medicine at Rambam.
The optogenetic technology employed allowed researchers to selectively activate light-sensitive proteins (such as the ion-channel ChR2, first identified in algae), which were overexpressed in excitable cells (such as nerve or muscle cells), in an attempt to modulate (either augment or suppress) their electrical activity. Optogenetics has become an important tool in brain research and the current study is the first to translate this important innovation to pace and resynchronize the heartbeat.
In the study, conducted in rats, the researchers first directed a beam of blue light at an area in the heart where the light-sensitive genes were delivered. This resulted in effective pacing of the heart at different rates as dictated by the frequency of the blue light flashes applied. Subsequently, a more advanced experiment was conducted, in which various locations in the rat hearts expressing ChR2 were activated simultaneously by light, resulting in improved synchronization of the contractions of the ventricles.
Professor Gepstein stresses that this is a preliminary study, and that “in order to translate the aforementioned approach to the clinical arena, we must overcome some significant hurdles. We must improve the penetration of light through the tissues, ensure continuous expression of the protein in the heart for many years, and develop a unique pacing device that will provide the necessary illumination. But despite all of this, the results of the study demonstrate the unique potential of optogenetics for both cardiac pacing (as an alternative to electronic pacemakers) and resynchronization (for the treatment of heart failure with ventricular dys-synchrony) therapies."
Professor Lior Gepstein
Dr. Udi Nussinovitch
Cardiac resynchronization by illumination of the heart
Credit: Technion-Israel Institute of Technology
Clean Water for Advanced Agriculture in Kibbutz Bror Hayil
A pipeline for wastewater and an upgraded pumping system are about to solve the sewage problem in Kibbutz Bror Hayil, which is located near the Gaza perimeter. The project, which was undertaken with the support of Ma'alot 360, Friends of JNF in Victoria, Australia, is expected to be completed within a few weeks. The upgraded system will enable an influx of new residents, agricultural expansion, environmental protection and a higher standard of living for the people of the entire region.
“The new system is very important to us and to other rural communities in the vicinity as far as ecology and agriculture are concerned,” said Simon Guthrie, the Economic Coordinator of Kibbutz Bror Hayil, regarding the upgraded sewage system. “The water is used for irrigating the fields, and without proper treatment of effluents, it would be impossible to absorb new residents and expand the kibbutz.”
The old oxidation pools provided low quality water and did not meet the standards of the Ministry of Health. The new facility includes an upgraded pumping station and the installation of sewage pipelines, 1.2 kilometers long, that reach the regional wastewater treatment plant in Sderot. The water will be treated in the Sderot Wastewater Treatment Plant and conducted back to irrigate the fields of Sderot and the local rural communities. Upgrading the sewage system keeps the environment clean, ensures a high standard of living for the people and prevents sanitation problems that could inhibit expansion of the kibbutz.
Read more at :
Photo Simon Guthrie in front of Jojoba groves
Credit.: Yoav Devir
20 COMPANIES TO PRESENT MOBILE TECHNOLOGIES IN ISRAEL'S NATIONAL EXPO BOOTH AT COMMUNICASIA - EAST ASIA’S LARGEST COMMUNICATIONS EXPO IN SINGAPORE
Israeli Exports to Asia Grow Threefold, From $5.8 Billion in 2004 to $16.7 Billion in 2014
[JERUSALEM. May 31st, 2015] – The Foreign Trade Administration at the Israeli Ministry of Economy, through its Singapore Trade Mission and in cooperation with the Israel Export Institute, are facilitating the Israeli national booth at the CommunicAsia communications expo, one of the flagship mobile communications exhibitions in Asia. Representatives from 20 Israeli companies will be presenting their technologies at the booth, representing the wide range of technological solutions Israel offers in leading mobile fields such as optimization for networks, digital TV solutions and IOT.
Some 40,000 participants from all over Southeast Asia are expected to attend the expo, which takes place in the first week of June. Trade missions of the Israeli Ministry of Economy across Asia have coordinated hundreds of meetings for representatives of the Israeli companies with decision makers from different countries, primarily Vietnam, the Philippines, Taiwan, Thailand, Indonesia and Singapore. The expo is unique in the opportunities it offers for companies to create ties in new and remote markets like Indonesia, from where 30% of the visitors to the expo arrive.
Ron Snir, Head of Trade Mission for the Israeli Ministry of Economy in Singapore said: "For many years, the Israeli trade mission in Singapore has been active in the largest telecommunications event of its kind in Asia, and like in past years, is facilitating a booth at the exhibition. We see great interest in Israeli technologies and companies from firms and other bodies throughout Asia in recent years, especially in light of significant exits. A basket of products has been developed for the different and changing needs of the markets in the region with attractive prices compared with similar companies from other Western nations."
Ilan Rosenberg, of the Hi-Tech Division at the Israel Export Institute, said: "The expo provides a unique platform for Israeli companies and serves as an excellent meeting grounds for partners and clients from all over Southeast Asia. This year, in addition to the traditional visitors coming to the expo like cellular operators, device manufacturers and integration companies, we also expect to see senior representatives from financial companies (banks), smart infrastructure, cyber-security and more. The Israeli companies will present a range of technologies at the expo, including: a solution for compressing and sending 4K video clips, long-distance optimization and updating, a platform for smart TV and solutions for cloud services (NFV/SDN), MEDIA & OTT and IOT: smart transportation, payment solutions and more."
Among the companies represented at the booth: RAD, MER Telecom,One Smart Star,Fibrolan, Alvarion, Vidmind, MRV, IPGallery, Friendly Technologies, cVidya, Latto, Office Core, Cellmining, mce Systems, Kaltura, Foxcom, SURF Solutions, Appnext, Viaccess-Orca and Allot.
Ahead of the expo, the Israeli companies will visit Vietnam and meet with representatives of the three largest cellular operators in the country, senior officials in the Vietnamese Communications Ministry as well as with local distributors.
Head of Trade Mission to Vietnam from the Israeli Ministry of Economy, Tzafrir Asaf, said: "90 million Vietnamese own more than 130 million mobile devices, and content and Value Added Services on mobile devices is consistently on the rise. It is therefore understandable that there is a growing market here that has become more and more significant for Israeli companies active in this field."
According to the Foreign Trade Administration at the Israeli Ministry of Economy, over the last decade, Israeli exports to Asia trebled, from $5.8 billion in 2004, to $16.7 billion in 2014. Trade with ASEAN countries (the trade union of Southeast Asian countries, not including India and China) also trebled over the past decade - from $1 billion in 2004 to $3 billion in 2014.
Singapore is Israel's largest trade partner in Southeast Asia, with trade between the countries standing in recent years at $1.6 billion, divided roughly evenly between Israeli and Singaporean exports, with communications equipment making up 10% of trade between the two countries.
The economy of Singapore is based significantly on exporting goods and services, mainly electronic consumer products, IT systems, pharma products and significant sectors of exported services. Singapore enjoys a modern infrastructure which is a permanent catalyst of growth, including an efficient sea port (almost all global shipping and trade from the East to the West stops at the Singapore port). In the middle of 2010, the Singaporean Ministry of Industry published impressive data showing 14.5% growth (an additional 5% was noted in 2011), data which puts Singapore in the top tier of developed countries worldwide. Since then Singapore is growing at an average rate of 4.5% annually, and reached a GDP of $67,000 per capita.
Singapore succeeds in drawing many foreign investments in different sectors and excels in encouraging foreign companies and multinationals which choose to locate their regional management HQs there and thus contribute to local development and knowhow. The Singaporean economy is dynamic, competitive and efficient and is based on excellent physical infrastructure and a leading academic infrastructure which develops technological and professional human resources. Most banks, insurance companies and global investment houses have centers in Singapore and give the country an excellent business and financial base for the operation of multinationals, manufacturing industries, businesses and corporations which are active there or in other southeastern Asian countries with Singapore as a base. The mobile market in Singapore is an active market with much interest in innovation and in groundbreaking products and can be viewed as the entry gate to the rest of Asia. The prices of mobile devices and services in Singapore are the lowest in the world compared to average income, with mobile market penetration rate estimated at 165%.
Texas and Israel’s Technion team up to build water system
California could learn a thing or two about innovative water technologies from university researchers in Israel and Texas, whose joint desalination project won the Honorable Mention award in a USAID competition. A prize of $125,000 grant will be used in the near future to build a groundwater treatment plant in Jordan.
Driven perhaps by a common pioneering spirit or the aridness of their land, researchers at the Technion-Israel Institute of Technology in Haifa, Israel and the University of North Texas teamed up to enter the competition held by USAID— the United States Agency for International Development. The competition’s goal was to develop innovative technology for producing food and potable water in the Third World, using sustainable alternative energy. "By 2050, global water demand is expected to increase by 55%, and 70% of global water use occurs in food production,” said Christian Holmes, USAID Global Water Coordinator.
Researchers at the Technion’s Stephen and Nancy Grand Water Research Institute joined the competition at the request of researchers from the electrical engineering department at the University of North Texas. The American researchers, who focused on developing a solution to the alternative energy aspect of the competition, asked Prof. Carlos Dosoretz and Prof. Ori Lahav, researchers from the Technion Faculty of Civil and Environmental Engineering, to design a solution for the desalination aspect, and to submit a joint proposal. Other researchers from universities in Jordan, Nepal and Brazil also participated in this project.
“Hundreds of proposals from around the world were submitted in this competition,” explains Prof. Ori Lahav, who heads the Stephen and Nancy Grand Water Research Institute, where the desalination system was designed. “At the end of 2014 our proposal advanced to the semi-final stage, along with the proposals of seven other groups.” Six groups participated in the final round, which was held last month in the deserts of New Mexico. The participating teams were given two days to set up a complete, fully operational pilot system, and operate it autonomously for 48 hours to demonstrate its effectiveness in the field.
“The water treatment process was based on an innovative combination of three technologies – reverse osmosis, ion exchange and nano- filtration,” explains Prof. Lahav. “The challenge was to find a solution for problematic water characterized by particularly high concentrations of dissolved calcium and sulfate.” University of North Texas researchers used a combination of wind and solar energy to power the system.
The group in which the Technion participated included the engineer Ran Nahir and Dr. Liat Birnhack, of the Faculty of Civil and Environmental Engineering. The group was placed among the top three winners, making it eligible for $125,000 in financing for the implementation of innovative technologies in the Third World. Massachusetts Institute of Technology (MIT), jointly with Jain Irrigation Systems, won first place.
USAID is a division of the U.S. State Department with financial aid from Sida, the Swedish International Development Cooperation Agency and The Ministry of Foreign Affairs of the Kingdom of the Netherlands.
Photo caption: The desalination system built for the competition, which includes a wind turbine and solar panel. Copyright Technion
The Ruth Rappaport Children’s Hospital at Rambam has joined forces with the Cincinnati Children’s Hospital (CCHMC) in Ohio on a collaborative agreement related to prenatal testing for oral and maxillofacial deformities. The agreement follows a similar one made between Rambam and the University of North Carolina two years ago.
The prestigious US hospital, ranked third in its field in the USA, maintains widespread professional ties with different Israeli bodies, but this is the first time the Cincinnati facility has collaborated with a medical/academic institution in Northern Israel. The agreement further cements Rambam’s formal collaborations in academia, clinical work, and research with prestigious institutions in the US.
The signing ceremony was held last week. Attending were Rambam representatives Prof. Karl Skorecki, Director of Medical and Research Development; Prof. Adi Rachmiel, Head of the Department of Oral and Maxillofacial Surgery; Dr. Omri Emudi, Senior Department Physician; as well as Dr. John van Aalst, Director of the Division of Plastic Surgery at CCHMC.
Rambam has extensive experience in the surgical treatment of oral and maxillofacial deformities, which has a particularly high incidence in Northern Israel. Hence, the percentage of children with facial defects here is higher than in central Israel. An interdisciplinary surgical team at Rambam specializes in treating maxillofacial and oral deformities, bringing together experts the Departments of Oral and Maxillofacial Surgery and Plastic Surgery.
The new collaboration between Rambam’s children’s hospital and CCHMC will benefit the people of Northern Israel through the exchange of research and advanced medical training.
Photo description: : (R-L) Dr. Omri Emudi, Prof. Karl Skorecki, Dr. John van Aalst, and Prof. Adi Rachmiel at the signing ceremony
Photo credit: Pioter Fliter
A Cocktail Reception was hosted by His Excellency, the Ambassador Mr. Lars Faaborg-Andersen, Head of the Delegation of the European Union (EU) to the State of Israel, and Mrs. Jean Murphy in the new EU Residence in Herzliya Pituach on 11 May 2015. This reception took place on the occasion of Israel National Science Day in 2015, and in order to stress the scientific cooperation between EU and Israel.
Mr. Lars Faaborg-Andersen opened his speech by expressing his great pleasure to welcome the distinguished guests to the EU reception in honour of Israel's National Science Day in which we celebrate one of the strongest bonds between the EU and Israel – cooperation in the field of scientific and technological research
He continued with the following remarks:
· Our cooperation in science and technology is a model for the type of close relations we hope will continue and which we would like to see in more fields in the future
· It is also proof that it is ludicrous to talk about an EU boycott of Israel
· Israel has been associated to the EU's Framework Programmes for R&D since 1996 and is the only non-European country to be associated
· As you are probably, with a budget of close to 80 million EURO, the current Framework Programme Horizon 2020 is the biggest research programme in the world. We hope that Israel will be as successful in this programme as it was in the previous one -FP7 - which saw Israel researchers participating in over 1,600 projects.
· The EU's cooperation with Israel in the field of science and technology is a thus win-win situation for both of us. We both have a great deal to learn and benefit from each other. It is beyond an issue of numbers – the exposure for both our academia and industry to cutting edge research, the links to leading institutions and to key actors in the private sector are invaluable contributions to both our research worlds and economies
· We will be hearing later on from Professor Hossem Haick of the Technion whose work on the "electronic nose" has been supported by the gamut of Framework Programme actions from the Marie Curie fellowship through the prestigious European Research Council grant to the collaborative research grant
· But our cooperation starts at an even earlier stage than that of post-doc. We will be hearing from high school student Avner Okun who will be speaking on behalf of the six winners of the Israeli Competition for Young Scientists and Developers who will be going on to participate in the EU Competition for Young Scientists that will take place this September in Milan. I would like to take this opportunity to wish them all the best of luck
· Both in Israel and in the European Union, we share a common problem: how to ensure that future generations of young people take an interest in science and decide to take up a career in research
· For the fifth year, the EU Delegation is organising the annual EU-Israel Innovation Seminar which brings together innovation experts to exchange ideas and forge the basis for future collaboration. Last year, the seminar was attended by close to 130 participants including 50 from 13 EU countries
Mr. Lars Faaborg-Andersen ended his speech by wishing all the guests an enjoyable evening and continued excellent cooperation.
The reception continued with a recorded video with greetings from the European Commissioner Carlos Moedas in charge of Research, Science and Innovation.
Then, Mr Ido Sharir, Director General, Ministry of Science, Technology and Space, greeted His Excellency Mr. Lars Faaborg-Andersen, Head of the EU Delegation to the State of Israel, and the distinguished guests. He thanked the Delegation of the EU for organizing this event on the occasion of Israel's National Science Day and pointed out the following remarks:
· Science and Technology are an imperative part of our lives; from the moment we open our eyes in the morning and throughout every second of our day.
· All our experiences, starting with what we see and do in our daily behavior, continuing to the instruments and devices we use on a daily basis and ending in the explanation of physiological and sociological phenomena – all are connected to Science and Technology.
· Israel's National Science Day enables us to present and promote the contribution of science to our life and society.
· The National Science Day will be celebrated tomorrow (May 12th) in over a 100 events all over Israel. (We usually mark the Science Day around March 14th - Albert Einstein's birthday, but this year we postponed it due to the general elections held at mid-March.)
· These events include interactive activities for the entire family and are open to the public.
· They will be held at the universities, at science museums, at community centers, at Regional Research and development Center, etc.
· The Ministry of Science, Technology and Space has put on its agenda to reach out to the general public.
· We are conducting training activities for youth, women, orthodox communities and ethnic minorities to bring them closer to science and scientific activities.
· We believe that science is a bridge to minimize gaps in the society.
· Practicing science can allow every man and woman to fulfill their goals and to contribute to society regardless of gender, economic background, or religion.
· The scientific cooperation with the EU, particularly with the R&D Framework Programs, has proven to be one of the most important tools to promote academic - scientific research in Israel in the past decade.
· We are glad to be part of Horizon 2020 and encourage Israeli scientists to take part in this important European Program.
· I hope and know that through the scientific cooperation, all side will benefit and our bilateral ties will bloom.
Mr Ido Sharir ended his speech by thanking Mr. Lars Faaborg-Andersen for his hospitality and wishing all the guests a good evening.
The reception continued with presentations of the following distinguished scientists:
· Professor Hossem Haick, Department of Chemical Engineering and Russell Berrie Nanotechnology Institute, Technion Israel Institute of Technology.
· Mrs Maya Halevy – Director, Bloomfield Science Museum.
· Mr Avner Okun, Young Scientist, Himmelfarb Yeshiva High School, Jerusalem
The important EU Reception on 11 May 2015 is part of a series of events that took place in different sites in Israel along a week in order to commemorate Israel's National Science Day.
Photo Silvia Golan
Breakthrough in Cancer Research
A new study by researchers at the Technion-Israel Institute of Technology could hold one key to control cancer cell growth and development. In a paper published in the April 9, 2015 edition of CELL. The team reports on the discovery of two cancer-suppressing proteins.
The research was conducted in the laboratory of Distinguished Professor Aaron Ciechanover, of the Technion Rappaport Faculty of Medicine. The team was led by research associate Dr. Yelena Kravtsova-Ivantsiv and , included additional research students and colleagues, as well as physicians from the Rambam, Carmel and Hadassah Medical Centers, who are studying tumors and their treatment.
The heretofore-undiscovered proteins were found during ongoing research on the ubiquitin system, an important and vital pathway in the life of the cell, which is responsible for the degradation of defective proteins that could damage the cell if not removed. The ubiquitin system tags these proteins and sends them for destruction in the cellular complex known as the proteasome. The system also removes functional and healthy proteins that are not needed anymore, thereby regulating the processes that these proteins control.
Usually, the proteins that reach the proteasome are completely broken down, but there are some exceptions, and the current line of research examined p105, a long precursor of a key regulator in the cell called NF-κB. It turns out that p105 can be broken down completely in certain cases following its tagging by ubiquitin, but in other cases it is only cut and shortened and becomes a protein called p50.
NF-κB has been identified as a link between inflammation and cancer. The hypothesis of the connection between inflammatory processes and cancer was first suggested in 1863 by German pathologist Rudolph Virchow, and has been confirmed over the years in a long series of studies. Ever since the discovery (nearly 30 years ago) of NF-κB, numerous articles have been published linking it to malignant transformation. It is involved in tumors of various organs (prostate, breast, lung, head and neck, large intestine, brain, etc.) in several parallel ways, including: inhibition of apoptosis (programmed cell death) normally eliminates transformed cells; acceleration of uncontrolled division of cancer cells; formation of new blood vessels (angiogenesis), which are vital to tumor growth; and increased resistance of cancerous cells to irradiation and chemotherapy.
As noted, the precursor p105 is “handled” by the ubiquitin system in one of two parallel and equally prevalent ways. It is either destroyed completely, or shortened and transformed to p50. The current research deciphers the decision-making mechanism that determines which process will be applied to the protein: when a ubiquitin system component called KPC1 is involved in the process and attaches ubiquitin to p105, the protein is shortened to become p50. When ubiquitination is mediated by another component of the system (and without KPC1), p105 is degraded.
The decision between these two options has significant implications on the cell, as the presence of high levels of KPC1 (which generates p50) and p50 (the product of the process) – with the accompanying disruption of the normal ratios between the processes – suppresses the malignant growth and apparently protects the healthy tissue. The current research was conducted on models of human tumors grown in mice, as well as on samples of human tumors, and a strong connection was discovered between the suppression of malignancy and the level of the two proteins, clearly indicating that the increased presence of KPC1 and/or p50 in the tissue can protect it from cancerous tumors.
Professor Ciechanover, who is also the president of the Israel Cancer Society, notes that many more years are required “to establish the research and gain a solid understanding of the mechanisms behind the suppression of the tumors. The development of a drug based on this discovery is a possibility, although not a certainty, and the road to such a drug is long and far from simple.”
Professor Ciechanover won the Nobel Prize in chemistry in 2004 (jointly with Professors Avram Hershko – also from the Technion – and Irwin Rose, of the Fox Chase Cancer Center) for the discovery of the ubiquitin system. The current line of research is a continuation of that discovery.
Distinguished Professor Aaron Ciechanover. Photographer: Dan Porges.
“When rainwater flows through the city streets it picks up a variety of toxic substances. This water goes to waste and actually causes damage...This innovative initiative allows us to transform a nuisance into a valuable resource.”
Two hundred million cubic meters of rainwater go to waste in Israel every year. They are washed down to the coast, where they pollute the beaches, the sea and marine life. The innovative bio-filter project is designed to allow this rainwater to be utilized in order to avoid pollution and prevent groundwater levels from dropping further.
The technology was developed in Australia, and KKL-JNF promotes its use in Israel with the support of Friends of JNF Australia. The new facilities in Ramla and Bat Yam were installed with the help of Blue Box donors and members of the JNF Australia Gold Club.
Photo Biofilter along a street promenade in Bat Yam under construction. Water is harvested and purified in the vegetation pit (in the far background). Photo: Yoav Devir
INTV 2015 Innovative TV Conference
The global TV industry is undergoing a constant dramatic sea-change; viewers are taking center stage, new online outlets are emerging, integrated social media and interactive services and of course new business models. These rapid changes leave us - executives and creators - sometimes staggering, sometimes challenged, but always yearning to keep up with the latest innovations.
Photo : Copyright: Keshet Media Group
President Reuven Rivlin this afternoon, Wednesday, hosted a delegation from Apple, led by CEO Tim Cook, currently on a visit to Israel. The President warmly welcomed Mr. Cook and his team. He said, "It is a great privilege to host you and your team here in Israel."
He continued, "Your contribution to humanity is unprecedented. Even for me as one who prefers to write with a pen and paper, it is clear to me, when I see through my staff, and my grandchildren, what a great miracle you have created."
Mr. Cook thanked the President for his warm welcome and said, "We have an enormous admiration for Israel, not just as an important ally for the US, but as a place to do business."
The President congratulated Mr. Cook on the opening of the new Apple center in Herzliya, and expressed his hope it would be a source of employment for the full spectrum of Israel's population. He said, "True innovation can only result from full access to education for all, regardless of race, religion, or sex. We would like to learn from your experience in the US, in bringing education and technology to periphery groups and communities."
The President also noted his pride at the inclusion in the delegation of Johny Srouji, Vice President for Hardware Technology at Apple, a member of the Israeli Arab community, born in Haifa. The President said, "Imagine what the world would be like with another five 'Johny Srouji's, we are proud of him, and all he has achieved."
Mr Cook told the President, "Diversity for us is part of how Apple achieves what it achieves. Employing people for who they are and not because of their ethnicity or background. When we work like this, we celebrate diversity, and benefit on all sides." Mr. Cook said to the President, "I personally admire your work in human rights, You are an inspiration for us to work even better."
The President and Mr. Cook spoke at length about the role of education in the advancement of different populations, and about the wide range of Apple's educational activities in underprivileged areas, and about possible future cooperation to promote equal access to education in areas where it was needed in Israel. "We must learn from you how to help our students also in difficult places, as you have done in many schools in the US."
Mr. Cook told the President about their educational activities in different areas to aid access in education to technology. "We are huge believers in education, and always felt that education is the great equalizer. We are working hard to bring schools that have under-served children, to a much higher level. We chose 120 schools from across the US, and we are working hard in the classroom, to help the children and their access to education."
Mr. Cook concluded by saying, "The will to leave a better world for our children and grandchildren is perhaps the greatest motivator, and listening to you, Mr. President, speak about your beliefs, is incredibly inspiring, and it has to be making a difference across the region."
President Rivlin with Apple CEO Tim Cook at the President's Residence in Jerusalem
Copyright: GPO/Amos Ben Gershom
NYU Langone Medical Center and the Technion-Israel Institute of Technology to Forge Groundbreaking Partnership in Cancer Research
Funded by Major Gift from Philanthropists Laura and Isaac Perlmutter
The first $3 million of the grant will finance six cancer-focused research projects that will be conducted by teams spearheaded by co-investigators from both NYU Langone and the Technion. The remaining $6 million will be used to establish a state-of-the-art research facility on Technion's campus in Israel that will support these and other research projects-- and which will have a principal focus on the emerging field of cancer metabolomics.
NYU Langone is a world-renowned leader in the investigation and treatment of cancer. The Technion is one of Israel's leading academic and research centers and a top-ranked science and technology global research university.
"NYU Langone and the Technion have a shared, longstanding commitment to advancing cancer research," said Dafna Bar-Sagi, PhD, senior vice president and vice dean for science at NYU Langone, chief science officer at NYU School of Medicine, and a principal architect of the NYU Langone-Technion partnership. "We are now at a great moment in our institutions' illustrious histories, a point from which we can jointly leverage the talent and creativity of our researchers toward accelerating breakthroughs. The foresight and the generosity of the Perlmutters, particularly at this time of financial challenge in funding for basic research, will have tremendous impact."
"Bringing together the unique expertise of researchers from both NYU and the Technion will hopefully enable us to overcome some of the most difficult challenges in treating cancer patients," said Technion Distinguished Professor Aaron Ciechanover, MD, D.Sc., the 2004 Nobel Prize Laureate in Chemistry, and Distinguished Research Professor and head of the David and Janet Polak Cancer and Vascular Biology Research Center at the Technion Faculty of Medicine.
Internationally Renowned Researchers to Lead the Charge
The latest gift from the Perlmutters coincides with two new appointments at NYU Langone and the Technion that will be integral to the partnership. Renowned cancer biologist Benjamin G. Neel, MD, PhD, an expert in the field of cell signal transduction, recently joined the NYU Langone faculty as director of the Perlmutter Cancer Center, and Eyal Gottlieb, PhD, a world leader in cancer metabolism, has been recruited to lead the new research facility at the Technion funded by the Perlmutter gift – and spearhead joint efforts in cancer metabolomics.
Dr. Neel will work closely with Prof. Ciechanover to lead the collaborative cancer research effort between the two institutions.
In addition, Dr. Neel will oversee at NYU Langone the building of world-class translational programs in immunotherapy, cancer genetics/targeted therapies and epigenetics, imaging, as well as expanded programs in clinical care, community outreach and supportive oncology. Prior to joining NYU Langone, Dr. Neel served as Director of the Ontario Cancer Institute at Princess Margaret Cancer Center, a position he held since 2007.
Dr. Gottlieb currently serves as Director of the Cancer Metabolism Research Unit at the Cancer Research UK, Beatson Institute in Glasgow, Scotland. His work principally focuses on cancer metabolism and metabolomics, combining analytical chemistry with basic cancer research to explore metabolic adaptations and vulnerabilities of cancer and with it, new potential clinical approaches for cancer treatment.
Champions in the Fight Against Cancer
The gift to foster the NYU Langone-Technion partnership continues the efforts of the Perlmutters to champion projects in the fight against cancer. In January 2014, they made an extraordinary gift in excess of $50 million to advance cancer research and treatment at NYU Langone. As part of that gift, NYU Langone renamed the NYU Cancer Institute – a National Cancer Institute-designated cancer center – the Laura and Isaac Perlmutter Cancer Center at NYU Langone. The Perlmutters both serve as members of the Board of Trustees at NYU Langone.
The latest gift also recognizes the Perlmutters' commitment to wed Israel's strengths as a global leader in research and technological innovation with other institutions and endeavors. They note that Israeli institutions like the Technion spearhead many of the world's top advances in medicine, science and technology with a proven record in the development of effective cancer treatments – and that it was important to them to further these efforts through partnerships like the newly established one with NYU Langone.
Novel imaging approaches, early detection blood tests and new targeted drugs to fight cancer would all be facilitated with a deep and comprehensive understanding of cancer metabolomics. These types of studies integrate biology, chemistry, mathematics and computer science, making it an ideal focal point for collaboration between a science and medical institution like NYU Langone and a technological and academic powerhouse like the Technion.
First Phase of Project Launched
Collaborative efforts between NYU Langone and the Technion are already underway. Under the auspices of the initial $3 million grant, a request for proposals (RFP) for cancer-focused projects was recently disseminated among key researchers at both NYU Langone and Technion. A major stipulation in the RFP is that all submitted projects have co-principal investigators representing both institutions. The RFP request follows a highly successful two-day joint workshop, held in New York City in fall 2014, at which many researchers from both NYU Langone and Technion presented updates on their work and learned of ways in which they could collaborate.
Approximately six research projects will be selected with each receiving a two-year, $500,000 grant --$250,000 to fund research at each site. Funding for selected projects will commence in late spring 2015.
About The Technion-Israel Institute for Technology
The Technion-Israel Institute of Technology is a major source of the innovation and brainpower that drives the Israeli economy, and a key to Israel's renowned as the world's "Start-Up Nation." Its three Nobel Prize winners exemplify academic excellence. Technion people, ideas and inventions make immeasurable contributions to the world including life-saving medicine, sustainable energy, computer science, water conservation and nanotechnology. The Joan and Irwin Jacobs Technion-Cornell Institute is a vital component of Cornell Tech, and a model for graduate applied science education that is expected to transform New York City's economy.
About NYU Langone Medical Center
NYU Langone Medical Center, a world-class, patient-centered, integrated academic medical center, is one of the nation's premier centers for excellence in clinical care, biomedical research, and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals—Tisch Hospital, its flagship acute care facility; Rusk Rehabilitation; the Hospital for Joint Diseases, the Medical Center's dedicated inpatient orthopaedic hospital; and Hassenfeld Children's Hospital, a comprehensive pediatric hospital supporting a full array of children's health services across the Medical Center—plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The Medical Center's tri-fold mission to serve, teach, and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education, and research. For more information, go to www.NYULMC.org, and interact with us on Facebook, Twitter, and YouTube.
1. The principal collaborative groundwork for the new research partnership between NYU Langone Medical Center and The Technion-Israel Institute for Technology began at a two-day joint workshop, held in New York City in fall 2014, at which researchers from both institutions presented updates on their work and learned of ways in which they could work together. Pictured at the conference are (l. to r.): Dafna Bar-Sagi, PhD, senior vice president and vice dean for science at NYU Langone and chief science officer at NYU School of Medicine; Aaron Ciechanover, MD, D.Sc., the 2004 Nobel Prize Laureate in Chemistry and Distinguished Research Professor and head of the David and Janet Polak Cancer and Vascular Biology Research Center at the Technion Faculty of Medicine; and Eliezer Shalev, MD, Dean of the Technion Faculty of Medicine.
Photo Credit: Technion's Spokesperson's Office
£3.2 million of funding has been awarded to eight new joint medical research projects by British and Israeli scientists, the British Council announced today.
UK and Israeli research institutions will work together on eight new three-year bilateral projects in to the use of stem cells to tackle degenerative diseases.
The projects, that will develop stem cell therapies to treat diabetes, heart disease, Parkinson's disease, liver disease, and Multiple Sclerosis, are the latest additions to the British Council's Britain Israel Research and Academic Exchange programme (BIRAX), a £10 million initiative of the British Council investing in world-leading research jointly undertaken by scientists in Britain and Israel.
Alan Gemmell, Director of the British Council in Israel said: "BIRAX combines the best of what Britain and Israel can offer the world; world-class scientists working together to improve the lives of millions of people. When the UK's education and research sectors engage with Israel, the benefits go beyond our two countries and can be truly universal"
Professor Raymond Dwek, CBE, FRS, Director, Glycobiology Institute, Oxford University and Chair of the UK-Israel Science Council said "Every now and then a technology breakthrough in science holds promise for dramatic progress in disease therapy and cures. The BIRAX initiative which is supported by leading scientists in the UK has focussed on stem cell therapies with this goal and acknowledges that the UK science base is complemented by the outstanding work in this area in Israel. This combination offers real hope of substantial progress in may disease areas.
"The quality of the scientists involved and the different areas of medicine which could benefit as a result of their research will be for the benefit everyone – something that a global university like Oxford supports strongly" Prof Dwek added.
Matthew Gould CMG, British Ambassador to Israel said: "Science is right at the heart of UK-Israel relationship. Top British and Israeli scientists are already collaborating to develop cures to some of the most awful diseases. I am delighted that so many medical research powerhouses have now given their support to this collaboration. The new projects we are announcing today have the potential make a real difference to the lives of people who suffer from diabetes, heart disease, liver disease, multiple sclerosis and Parkinson's disease."
Funding will be awarded to eleven leading universities in Britain and Israel: Cambridge, Cardiff, Edinburgh, Manchester, Nottingham and Oxford, and Hadassah – Hebrew University, Hebrew University of Jerusalem, MIGAL – Galilee Research Institute, Technion-Israel Institute of Technology and the Weizmann Institute.
The British Council has raised £3.2 million for this round of research funding from leading UK Medical Research Foundations including the British Heart Foundation, JDRF, the Multiple Sclerosis Society UK and Parkinson's UK [and the UK Stem Cell Foundation]. Additional funders include the Parasol Foundation Trust, Pears Foundation, United Jewish Israel Appeal and the Maurice and Vivienne Wohl Charitable Foundation.
UK Prime Minister David Cameron launched the BIRAX research call during his visit to Israel in March 2014.
BIRAX awarded its first research grants to seven projects in 2013.
Britain and Israel are world leaders in science. Both countries continue to win disproportionate numbers of Nobel Prizes.
Photo Provided by The British Council
Technion scientists solve structural challenge that has intrigued chemists for decades
In a recent report, in the prestigious journal Nature Communications (published the 6th of February), researchers working under the guidance of Assistant Professor Alex M. Szpilman of the Schulich Faculty of Chemistry, Technion - Israel Institute of Technology in collaboration with Dr. Mark Iron of the Weizmann Institute of Science, report a solution to a decade long conundrum: The preparation of stable α-hydrogen nitroxide radicals. These radicals have the potential to be used as both catalysts for chemical reactions and detectors for potentially harmful radicals in biological systems.
The new nitroxide radicals have already been shown to be efficient catalysts for the aerobic oxidation of alcohols. These applications are illustrated both in the Nature paper and in another paper from the Szpilman group in the journal ChemCatChem.
Szpilman and his colleagues demonstrated the generality of their ideas by preparing two different families of stable radicals. In both cases the synthesis of the radicals is easy, short, flexible, and starts from inexpensive readily available chemicals. The new radicals are more efficient catalysts for alcohol oxidation than the venerable TEMPO. The radical catalyst can be recycled and used over and over again which as a big advantage from the environmental point of view. Additionally, the only byproduct of the reaction is water.
"Because the synthesis is so flexible we are now able to prepare tailor made radicals for different applications. For example, water soluble radicals for biological studies or more efficient catalysts for oxidation or polymerization (in plastic production) and other industrially important uses. The possibilities are endless. From the scientific point of view we have the possibility of studying radical processes in biological systems. The understanding of these potentially harmful processes may eventually lead to the development of ways to treat or prevent disease."
Alex M. Szpilman is a native of Denmark. He first came to Israel as a volunteer at Kibbutz Hamadia when he was 18. Upon completing his M.Sc. degree at the Technical University of Denmark (DTU) he returned to Israel for doctoral studies at the Weizmann Institute of Science. After postdoctoral studies at the ETH Zurich he started his independent career at the Schulich Faculty of Chemistry at the Tehcnion in 2009.
During his studies Szpilman worked on the total synthesis of natural products and the understanding of their biological activity, a very applied branch of organic chemistry. Upon joining the Technion he decided to return to the study of fundamental chemistry. He explains that "It is my strategic approach to science to first research chemical discoveries of fundamental importance and then develop them further for use in synthesis and other applications. Chemistry is a wonderful and exciting field. A lot of creativity is needed in order to come up with new ways of making chemical bonds or new molecules. There is something incredibly awarding in writing down an idea on a piece of paper and make it come alive in the laboratory."
Attached: A photo of Asst. Prof. Alex Szpilman. Credit: Technion's Spokesperson's Office
HAIFA, ISRAEL (February 2, 2015) - A research consortium headed by Professor Hossam Haick of the Technion-Israel Institute of Technology is developing a product that, when coupled with a smartphone, will be able to screen the user's breath for early detection of life-threatening diseases .Funded by a grant from the European Commission, the SNIFFPHONE project will link Prof. Haick's acclaimed breathalyzer screening technology to the smartphone to provide non-invasive, fast and cheap disease detection. It will work by using micro- and nano-sensors that read exhaled breath and then transfer the information through the attached mobile phone to an information-processing system for interpretation. The data is then assessed and disease diagnosis and other details are ascertained.
The technology is supported by a recent €6 million (US$6.8 million) grant to the consortium to expand the "electronic nose" breathalyzer technology that Prof. Haick has been developing since he joined the Technion in 2006. That technology can identify individuals from the general population who have a higher likelihood for contracting a specific disease, and treat them in advance or at an early stage.
"The SNIFFPHONE is a winning solution. It will be made tinier and cheaper than disease detection solutions currently, consume little power, and most importantly, it will enable immediate and early diagnosis that is both accurate and non-invasive," says Prof. Haick. "Early diagnosis can save lives, particularly in life-threatening diseases such as cancer."
In the photo: Professor Hossam Haick
In mid-January, Technion President, Prof. Peretz Lavie, and Prof. Dan Shechtman travelled to China, along with Dr. Moshe Marom, the site Director of the Technion- Guangdong Institute of Technology in China. On this visit Profs. Peretz and Shechtman met with senior leaders of Peking University (ranked among the top universities in mainland China) to discuss future cooperation in areas including innovation, environmental engineering, chemistry and others. They also visited the High School Affiliated to Renmin University of China - one of the most prestigious high schools in Beijing. Prof. Shechtman lectured in front of 600 students here.
The visit to China aimed to deepen and strengthen Technion's ties in China. In the near future, the Technion intends to invest great efforts in initiating similar visits, as well as in building a presence on 'weibo' (China's Twittter-like microblogging service), promoting the Technion through media exposure in the forms of interviews, articles and marketing materials, and in advancing collaborative initiatives with universities and other Chinese educational institutes.
The Technion-Guangdong Institute of Technology (Technion-Guangdong) – a scientific-research institute of technology founded on the 'Technion model' – will be established in the Guangdong Province in southern China. Technion-Guangdong will be launched according to the 2013 agreement signed between the Technion, Shantou University (STU) and the Li Ka Shing Foundation. At the signing ceremony, STU Provost, Prof. Gu Peihua stated that Shantou University chose Technion as its partner from 74 potential partners that were carefully selected – "because the Technion had shown the world what the future university should do in order to deliver values of regional, national and international significance. What Technion has done to advance the Israeli economy through student and staff research and innovation is an example for Chinese universities to follow. If many universities in Guangdong and China do the same as Technion has been doing in Israel, an innovation-based economy will emerge."
Strengthening relationships in China in general and the partnership with STU in particular, reflects the globalization strategy adopted by the Technion, a move which also led to the launching of the Jacobs Technion-Cornell Institute in New York City. At the Technion-Guangdong signing ceremony, Prof. Peretz Lavie said, "When you combine the innovation and entrepreneurial spirit of Israel with the unbelievable scale of China, you have a great partnership. We believe in globalization and cross-cultural dialogue, and hope that by combining our research methodologies with the scale and resources of China, we will create a major research institute that will help not only China and Israel, but also mankind in general."
Norway's largest charitable foundation bestows cash prize for TAU cancer geneticist's research on cell survival and DNA stability
Norway's largest charitable organization, the Olav Thon Foundation, which invests heavily in medical research, awarded its first international research award in the medical and natural sciences to Tel Aviv University's Prof. Yosef Shiloh and Prof. Judith Campisi of the Buck Institute for Research on Aging, California. The prize money, NOK 5,000,000 (approximately $660,000), was split between the two winners.
Prof. Shiloh, the Myers Professor of Cancer Genetics and Research Professor of the Israel Cancer Research Fund at TAU's Sackler School of Medicine, was recognized for his pioneering research on the mechanisms that maintain the survival of human cells and the stability of human genetic material.
A member of the Israel National Academy of Sciences and Humanities, Prof. Shiloh was a recipient of the prestigious Israel Prize (considered "Israel's Nobel") in Life Sciences in 2011, the 2011 American Association of Cancer Research G.H.A. Clowes Award, and the 2005 EMET Prize in Life Sciences.
"A prize means scientific recognition," said Prof. Shiloh. "Scientists do not work in order to get prizes or any other monetary benefits, but the award of a prize means that our work is recognized by our colleagues, and this is probably the true reward of a scientist."
Unraveling the genome
Prof. Shiloh has spent much of his career investigating the processes that maintain genome stability and the defense mechanisms against substances that damage our DNA. He has investigated how the harmful effects of such substances can be countered and offered insights into how mammalian cells react to DNA damage produced by environmental factors, such as radiation and carcinogenic chemicals.
According to the Foundation, "The laureates have provided us with new insights into the molecular basis of aging, aging-related diseases, and cellular degenerative processes."
Prof. Shiloh has dedicated most of his scientific career to understanding the genomic instability syndrome, ataxia-telangiectasia (A-T). (Watch a video on Prof. Shiloh's research.) He began his work on A-T while working on his PhD thesis, and this quest culminated in 1995 with the identification of the responsible gene, ATM, in his lab. He and his team have since been engaged in exploring its function, its mode of action, and its many roles in cellular metabolism.
Prof. Shiloh obtained his BSc degree at the Technion Institute of Technology and his PhD in Human Genetics at The Hebrew University of Jerusalem. A Fogarty Fellow at the National Institutes of Health, Prof. Shiloh also studied at Harvard Medical School, the University of Michigan, and New York University Medical Center.
In addition to his research, Prof. Shiloh devotes considerable time to giving popular scientific lectures to the general public and high school students on the medical, social, and ethical implications of the genome revolution and its effect on cancer research and therapy.
Technion and Microsoft launch Internet of Things joint venture, which simulates a startup work environment
The first course held at the lab was on programming systems in an Arduino environment, under the guidance of Prof. Yossi Gil with support from Microsoft experts. As part of the course, which was designed to challenge the students with independent product building projects, the students designed smart systems combining hardware and software based on Arduino controls, connected to Azure – Microsoft's cloud. The projects exhibited at the launching of the lab included: a musical glove that responds to color and plays sounds that correspond to various colors; a sensor for using hand gestures to control a telephone during driving; a smartphone application for guiding the visually impaired, and more.
The university is developing the most important resource for Israeli industry," says Yoram Yaacovi, General Manager of Microsoft R&D Center,
"The course is an incubator for initiative and originality," says Prof. Yossi Gil, who heads the course. "We give the students the equipment, guidance and tools, in order for them to take the next step. We tell them, 'You're talented – surprise us.'"
This endeavor at the computer science faculty is part of the ongoing collaboration between Microsoft's R&D center and the Technion. In the framework of this collaboration, Microsoft and the Technion have opened an academic research center for ecommerce studies. The lab and the research center are part of U.next – a comprehensive program run by Microsoft's R&D center, focusing on Israeli academic institutions, students, and researchers. The program includes support for the students, educational programs, research grants, access to Microsoft tools and resources and the hosting of workshops and conferences. The program's goal is to encourage academic excellence in research and study by leveraging the company's abilities and resources.
Photo Students present their Projects
Photo credit :Technion Spokesperson's Office
Agency directors, astronauts, officials from Israeli and international space industries and scientists from the academia will participate in the 10th Ilan Ramon International Space Conference on January 28-29. The conference is being organized by the Israel Space Agency at the Ministry of Science and the Fisher Institute for Air & Space Strategic Studies. Among the distinguished guests will be the Director of the Italian Space Agency - Prof. Roberto Battistone, the director of the United Nations Office for Outer Space Affairs, NASA Astronaut Nicole Stott, NASA Astronaut Rex Walhaim, Japanese Space Agency Astronaut Soichi Noguchi, Vice Commander - USAF Space Command, Business Development Director at Space X and Space Florida President Frank DiBello.
The conference will open with taped greetings from The President of the State of Israel - Mr. Reuven Rivlin; CEO of the Fisher Institute for Air & Space Strategic Studies - Brig. Gen. (Res.) Asaf Agmon and the Director of the United Nations Office for Outer Space Affairs - Prof. Simonetta Di Pippo. In an official ceremony, the Science Ministry's Ilan Ramon Scholarships will be awarded to outstanding researchers and the first session will conclude with a lecture given by NASA Astronaut Nicole Stott as well as a review of the past year's space achievements and trends given by Dr. Margaret Weitekamp, Curator at the National Air and Space Museum in the Space History Department Division.
The conference's first session will focus on space and science: Prof. Ehud Bechar of the Technion's Asher Space Research Institute will review the past year's events in the field of space sciences. The Italian Space Agency Director Robert Battistone will also speak during this session, followed by the Israel Astronomy Association Chairman, Dr. Igal Pat-El, who will present impressive findings from the Rosetta Mission for the study of the Churyumov-Gerasimenko comet. The session will conclude with a presentation byProf. Yoav Yair, Dean at the IDC Herzliya, who will present research on the upper atmosphere using balloons.
The afternoon session that will focus on space navigation systems will be opened by Sharafat Gadimova, Global Navigation Satellite System Program Officer at the United Nations Office for Outer Space Affairs (UNOOSA). She will be followed by a senior representative of the European Commission, who will speak about the European navigation satellite systems and Joao Romana, Head of the Space and Aeronautics Programs at the European R&D Program Administration, will review the satellite navigation systems for national applications. The session will conclude with a presentation by Israeli entrepreneurs who won first places at the Galileo Masters Competition.
The first day's closing session will focus on security aspects in the space industry, led by Brig. Gen. (res) Amnon Harari, Director of Israel's MOD Space Directorate. The first speaker in this session will be Maj. Gen. David J. Buck, Vice Commander, USAF Space Command. He will be followed by an annual address given by the Commander of the Israel Air and Space Branch, Maj. Gen. Amir Eshel. The first day of the conference will be closed by Israel's Minister of Defense, Moshe Ya'alon.
The second day of the conference will open with a presentation of products from the small satellite workshop and a lecture given by Tal Inbar, Director of the Space Research Center at the Fisher Institute for Air & Space Strategic Studies. The opening session will focus on Space in the Service of Man and Country: challenges for the Mediterranean Sea - which will begin with a comprehensive review of the events of the past year in the field of Space and Security Policy, given by Dr. Deganit Paikowsky, senior researcher and consultant at the National Council for R&D at the Ministry of Science. Following the review, there will be a comprehensive discussion with the participation of senior officials from space agencies and institutions from around the world: the director of the United Nations Office for Outer Space Affairs (UNOOSA); Prof. George Zalidis, Director of the Remote-Sensing Lab at the Aristotelian University in Greece; and Menachem Kidron, Director General, Israel Space Agency at the Ministry of Space.
The next session will focus on Space and the Security Industries with the participation of Opher Doron - Director General, MBT-Space, Israel Aerospace Industries; Zvi Zukerman of Rafael, Ilan Porat - Head of Space Directorate, Elbit Systems Intelligence and Electro Optics at Elop and Maria Ruess - VP International Business Development at Lockheed Martin Space Systems Company.
The conference's closing session will deal with Innovation, Entrepreneurship and Non-traditional Uses of Space with the participation of leading global space industry companies. The first part of the session will present a review given by the leading global companies of the activities of the past year and the plans for the coming year, including: Stella Guillen - Director of Business Development at Space X, Frank DiBello - President of Space Florida and Craig Campbell - President of Alaska Aerospace Corporation. The second session will focus on the newest applications and technologies in the field of Space Access, with the participation of Arie Halsband - founder and CEO of Effective Space Solutions who will present the De-Orbiter: a service satellite for station keeping and removal of geo-stationary satellite; Gershon Melnik of Elbit, who will review the Gideon–Nano Satellite Constellation for special missions and Mike Safyan - the Director of Launch and Regulatory Affairs at Planet Labs will close the session with a presentation of a paradigmatic change in the field of remote sensing.
NASA Astronaut Rex Walheim and Japanese Space Agency Astronaut Soichi Noguchi will speak about the future of manned space exploration. The conference will end with concluding remarks given by Maj. Gen. (Ret.) Herzl Bodinger, Chairman of the Board at the Fisher Institute for Air and Space Strategic Studies.
The conference will be held at the IAF Center in Herzliya. During the conference, there will be a comprehensive professional exhibition featuring presentations by leaders from Israel's military and civil industries, featuring the latest innovations in their fields.
For a complete and up-to-date conference program: http://www.fisherinstitute.org.il/?CategoryID=139&ArticleID=82
Science Tips – January 2015
Israel-Japan Conference to Foster Cooperation in Brain Research
Autistic Brains Go Their Own Way
Autism spectrum disorder (ASD) has been studied for many years, but there are still more questions than answers. For example, some research into the brain functions of individuals on the autism spectrum have found a lack of synchronization between different parts of the brain that normally work in tandem. But other studies have found the exact opposite – over-synchronization in the brains of those with ASD. A new study by Avital Hahamy and Prof. Rafi Malach of the Weizmann Institute's Neurobiology Department, and Prof. Marlene Behrmann of Carnegie Mellon University, Pittsburgh, which was recently published in Nature Neuroscience, suggests that the various reports – of both over- and under-connectivity – may, in fact, reflect a deeper principle.
Prof. Rafael Malach's research is supported by the Murray H. and Meyer Grodetsky Center for Research of Higher Brain Functions, which he heads; and the Friends of Dr. Lou Siminovitch. Prof. Malach is the recipient of the Helen and Martin Kimmel Award for Innovative Investigation; and he is the incumbent of the Barbara and Morris L. Levinson Professorial Chair in Brain Research.
Innovators from Israel receive seed grants for bold ideas, tackling issues in global public health and food security in developing countries.
The announcement of the grant recipients was jointly made in the presence of Israeli Foreign Minister Avigdor Liberman and his Canadian counterpart, Minister of Foreign Affairs John Baird at a festive ceremony held at Israel's Foreign Ministry, with the participation of the Chief Scientist Avi Hasson; the Head of MASHAV Ambassador Gil Haskel; and the Head of Grand Challenges Canada, Mr. Peter Singer (January 18).
The goal of this program is to steer Israeli entrepreneurs towards finding solutions for developing nations - those markets in which there's a real need for urgent solutions - as well as opening up a huge, untapped business potential for Israeli entrepreneurs and industrialists. Nothing speaks louder than success, and today the success that these entrepreneurs and innovators have achieved will pave the way for our future scientists and entrepreneurs, working together to 'do good and do well.'"
Within this framework, Grand Challenges Israel offers yearly grants of up to 500,000 NIS to Israeli researchers, innovators and entrepreneurs for the proof of concept and development of their product/innovation in areas of global public health and food security, while providing a suitable framework for channeling and introducing Israeli innovative technology and services to this challenging and growing market.
After a call for proposals by Grand Challenges Israel in early 2014 ten Israeli companies out of more than 100 applicants with promising innovations, were awarded a seed grant to develop their bold idea.
Water, Food Security & Agriculture:
Photo Awarding of the Grand Challenges Israel grants (left to right): Canadian FM John Baird, Israel FM Avigdor Liberman, Head of Grand Challenges Canada Peter Singer, and Head of MASHAV Ambassador Gil Haskel
Israeli researchers find exposure to nanoparticles may threaten heart health
Technion-Israel Institute of Technology research shows for first time inhaled nanoparticles of silicon dioxide increase risk of atherosclerosis; laboratory, manufacturing workers may be at greatest risk
Nanoparticles, extremely tiny particles measured in billionths of a meter, are increasingly everywhere, and especially in biomedical products. Their toxicity has been researched in general terms, but now a team of Israeli scientists has for the first time found that exposure nanoparticles (NPs) of silicon dioxide (SiO2) can play a major role in the development of cardiovascular diseases when the NP cross tissue and cellular barriers and also find their way into the circulatory system. Their study, published in the December issue of Environmental Toxicology, can be found on-line at http://onlinelibrary.wiley.com/doi/10.1002/tox.22084/abstract.
The research team was comprised of scientists from the Technion Rappaport Faculty of Medicine, Rambam Medical Center, and the Center of Excellence in Exposure Science and Environmental Health (TCEEH).
"Environmental exposure to nanoparticles is becoming unavoidable due to the rapid expansion of nanotechnology," says the study's lead author, Prof. Michael Aviram, of the Technion Faculty of Medicine, "This exposure may be especially chronic for those employed in research laboratories and in high tech industry where workers handle, manufacture, use and dispose of nanoparticles. Products that use silica-based nanoparticles for biomedical uses, such as various chips, drug or gene delivery and tracking, imaging, ultrasound therapy, and diagnostics, may also pose an increased cardiovascular risk for consumers as well."
In this study, researchers exposed cultured laboratory mouse cells resembling the arterial wall cells to NPs of silicon dioxide and investigated the effects. SiO2 NPs are toxic to and have significant adverse effects on macrophages. a type of white blood cell that take up lipids, leading to atherosclerotic lesion development and its consequent cardiovascular events, such as heart attack or stroke. Macrophages accumulation in the arterial wall under atherogenic conditions such as high cholesterol, triglycerides, oxidative stress - are converted into lipids, or laden "foam cells" which, in turn, accelerate atherosclerosis development.
"Macrophage foam cells accumulation in the arterial wall are a key cell type in the development of atherosclerosis, which is an inflammatory disease" says co-author Dr. Lauren Petrick. "The aims of our study were to gain additional insight into the cardiovascular risk associated with silicon dioxide nanoparticle exposure and discover the mechanisms behind Si02's induced atherogenic effects on macrophages. We also wanted to use nanoparticles as a model for ultrafine particle (UFP) exposure as cardiovascular disease risk factors."
Both NPs and UFPs can be inhaled and induce negative biological effects. However, until this study, their effect on the development of atherosclerosis has been largely unknown. Here, researchers have discovered for the first time that the toxicity of silicon dioxide nanoparticles has a "significant and substantial effect on the accumulation of triglycerides in the macrophages," at all exposure concentrations analyzed, and that they also "increase oxidative stress and toxicity."
A recent update from the American Heart Association also suggested that "fine particles" in air pollution leads to elevated risk for cardiovascular diseases. However, more research was needed to examine the role of "ultrafine particles" (which are much smaller than "fine particles") on atherosclerosis development and cardiovascular risk.
"The number of nano-based consumer products has risen a thousand fold in recent years, with an estimated world market of $3 trillion by the year 2020," conclude the researchers. "This reality leads to increased human exposure and interaction of silica-based nanoparticles with biological systems. Because our research demonstrates a clear cardiovascular health risk associated with this trend, steps need to be taken to help ensure that potential health and environmental hazards are being addressed at the same time as the nanotechnology is being developed.
A cell programming technique developed at the Weizmann Institute turns them into the earliest precursors of sperm and ova
Groups at the Weizmann Institute of Science and Cambridge University have jointly managed the feat of turning back the clock on human cells to create primordial germ cells – the embryonic cells that give rise to sperm and ova – in the lab. This is the first time that human cells have been programmed into this early developmental stage. The results of their study, which were published today in Cell, could help provide answers as to the causes of fertility problems, yield insight into the earliest stages of embryonic development and potentially, in the future, enable the development of new kinds of reproductive technology.
Dr. Jacob Hanna's research is supported by Pascal and Ilana Mantoux, France/Israel; the New York Stem Cell Foundation, the Flight Attendant Medical Research Institute (FAMRI), the Israel Cancer Research Fund (ICRF), the Helen and Martin Kimmel Award for Innovative Investigation, the Benoziyo Endowment Fund for the Advancement of Science; the Leona M. and Harry B. Helmsley Charitable Trust; the Sir Charles Clore Research Prize; Erica A. Drake and Robert Drake; the Abisch Frenkel Foundation for the Promotion of Life Sciences; the European Research Council; the Israel Science Foundation, and the Fritz Thyssen Stiftung. Dr. Hanna is a New York Stem Cell Foundation-Robertson Investigator.
This work was made possible by a grant from BIRAX Britain Israel Research and Academic Exchange Partnership – Regenerative Medicine Initiative.
The Weizmann Institute of Science in Rehovot, Israel, is one of the world's top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.
Weizmann Institute news releases are posted on the World Wide Web at
Photo provided by The Weizmann Institute
Tel Aviv has previously received official recognition from UNESCO as a world heritage site for its extraordinary and beautiful collection of more than 4000 original white Bauhaus buildings scattered throughout the city. Today, the White City is to enjoy an additional title of Creative City as Tel Aviv is now the newest member of UNESCO's Creative Cities Network in the category of Media Arts.
UNESCO - United Nations Educational, Scientific and Cultural Organization established the Creative Cities Network in order to encourage cooperation between international cities as a means to promote local creative industries, harnessing entrepreneurship and creativity to strengthen the local economy and social development. This evening, Tel Aviv will join 41 other cities each recognized in one of seven categories: Literature, Film, Music, Craft and Folk Art, Design, Media Arts and Gastronomy. Other notable members include Dublin (Literature), Liverpool (Music), Sydney (Film) and Berlin (Design).
Link to UNESCO's website: http://www.unesco.org/new/en/culture/themes/creativity/creative-cities-network/
Tel Aviv will become a member of the Creative Cities Network recognized in the field of Media Arts. Cities in this area are characterized by the existence of creative industries and cultural activity driven by the use of digital technology and the successful implementation of media arts for the benefit of improving urban life. This is measured by the accessibility of cultural events and products through digital technology and the existence of electronic art forms and their integration into the life of civil society and their ability to strengthening local working studios and media arts projects.
The city's flourishing high-tech scene and enterprises, especially in the media arts field - both earned Tel Aviv its place in the Creative Cities Network. Currently there are more than 700 early stage startups in Tel Aviv, a city with just over 400,000 residents. Tel Aviv has the second highest number of startups of any city in the world, and has the highest number of startups per capita.
The acceptance of Tel Aviv into the Creative Cities Network is a great honor for the city and will only strengthen the development of activities, projects and initiatives in the field of Media Arts and culture, and continue the Municipalities activities with the wide range of communities living in the city, academia, the business sector, industry, cultural institutions and more. Alongside local activities, an important aspect of the Network is creating international partnerships between the cities. Partnerships based on cooperative learning and the exchange of knowledge, enabling each partner to harness the creativity in their local economy and use it for social development. In order to retain the title, Tel Aviv will present annually to the organization and demonstrate the past-years cooperative initiatives with officials in the city and internationally.
Commenting on the achievement, the Mayor of Tel Aviv-Yafo, Ron Huldai said:
https://www.youtube.com/watch?v=jxvevYZ2suw Urban Symphony featuring the Mayor of Tel Aviv-Yafo
Comical clip about Tel Aviv with quotes from Barack Obama
photo by Kfir Bolotin
A professional course to demonstrate best practices, knowhow and new agricultural technologies in the citrus production field was recently conducted in Israel within the framework of the Israel-India Agricultural Cooperation Program.
The course (Nov. 3-18) took place at CINADCO's Shefayim Training Center, MASHAV's main professional and operational affiliate for international agricultural rural development cooperation; and counted with the participation of 19 professionals involved in the ongoing Israeli-Indian agricultural cooperation program.
The professional program of the course included lectures and workshops covering different aspects of citrus production such as: Grafting; citrus propagation; economy of agricultural production in citrus groves; irrigation; and more. Professional visits covered, among others, citrus nurseries; storage and post-harvest facilities and packing houses.
Under the existing Indo-Israel cooperation in agriculture work plan, 30 Centers of Excellence are in various stages of development in 10 states across India. Implementation and adaptation of Israeli technologies has succeeded in increasing production and to significantly raising produce quality.
Photo Professionals from India during the Citrus Production course
The Office of the Chief Scientist at the Israeli Ministry of Economy Selected Israeli Companies with Innovations in Cleantech, ICT, Biotech and Medical Devices to be Represented at CII Knowledgexpo
Jerusalem, November 19, 2014 –A top, multi-sector business delegation from Israel will be attending the Global Innovation and Technology Alliance Platform, an international conference being held as part of the 1st CII Knowledgexpo mega-event for technology and innovation in Delhi, India on November 20-21.
The delegation includes twelve leading Israeli tech companies focusing on cleantech, ICT, biotech and medical devices. It is an initiative of MATIMOP, Israel's Industry Center for R&D, and the Office of the Chief Scientist at the Israeli Ministry of Economy, in cooperation with Israel's Foreign Trade Administration.
The companies and innovations will be highlighted in a large purpose-built pavilion in the International Exhibition Hall of the conference. It will be the second year in a row Israel is sending such a group.
The Knowledgexpo will give delegates the opportunity to showcase their technologies and engage in B2B meetings. Several of the Israeli company delegates will be speaking in sector-specific sessions at the conference about their technologies and opportunities for business collaboration.
"The Israeli delegation represents some of the finest technology companies in their fields, with cutting-edge products and services that are a great fit to the Indian market," said Avi Luvton, Executive Director of the Asia Pacific Department at MATIMOP. "Delegations like this are a powerful tool to strengthen collaboration between India and Israel, providing a boost to the strategic ties between the two countries with mutual benefits. This kind of event compliments our core industrial R&D cooperation programs, which provide access to funding and support for partner matching. All these activities support industrial R&D cooperation and contribute to the development of strong ties between India and Israel."
Since the establishment of diplomatic relations between India and Israel in 1992, bilateral trade and economic ties between the two countries has grown rapidly. Bilateral trade increased from US$200 million in 1992 to more than US$5 billion in 2013. India continues to be a 'focus' country for the Israeli Government's increased trade efforts, and Israel's economic relationship with India is expected to strengthen under the new Modi Administration.
At the conference, a spotlight will be given to Israeli medical devices innovator ReWalk, whose representative, Mr. Yishai Potack (Director of Sales and Business Development), will deliver a keynote presentation during the Awards Evening for the India Innovation Initiative (i3) on November 20 at 6pm local time, as well as a demonstration of ReWalk's groundbreaking gait-mimicking system that allows people affected by spinal cord injuries to walk independently.
About CII Knowledgexpo
The CII Knowledgexpo will showcase the world's top technologies in life sciences and biotechnology, renewable energy, sustainable urbanization, IT, robotics and animation and security technology and many more innovative products and services. The Indian government is reaching out to experts, pioneers and visionaries in technology. Through the CII Knowledgexpo, India is seeking the knowledge and expertise it needs in order to reach its economic goal for 2020: becoming a US $5 trillion economy.
About the Israeli Office of the Chief Scientist & MATIMOP
The Office of the Chief Scientist (OCS) in the Israeli Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth and encouraging R&D collaboration both nationally and internationally. MATIMOP, the executive agency of the OCS, promotes international cooperation in industrial R&D, providing access to funding for cooperative international R&D projects and assistance in identifying partners.
The Foreign Trade Admin & Economic Department at the Embassy of Israel
The Foreign Trade Administration at the Ministry of Economy is responsible for managing and directing the international trade policy of the State of Israel. The Administration's main fields of activity include promotion of trade and exports, initiating and maintaining trade agreements, attracting and facilitating foreign investments and creating strategic cooperation with foreign companies.
The Economic Department at the Embassy of Israel, New Delhi has been promoting cooperation in technologies between the business communities from both countries. This promotion has been by visiting delegations from Israel to India, Indian delegations visiting Israel, signing MOUs for cooperation with states and organizations active in various sectors, etc.
Photo of Avi Luvton
On Wednesday, November 12, 2014 at 17:30 Israel time, the Philae lander will land on comet Churyumov-Gerasimenko as planned by a group of comet researchers 25 years ago - a group that includes Prof. Akiva Bar-Nun of Tel Aviv University.
On Wednesday November 12 at 17:30 Israel time, the Philae lander will land on comet Churyumov-Gerasimenko - the first ever landing on a comet. The lander will be anchored to the surface by harpoons and screws that will penetrate the comet's icy surface. This anchor is necessary to hold the lander on the brittle ice surface of the comet's exterior.
Twenty-five years ago a group of comet researchers which included Prof. Akiva Bar-Nun of the Department of Geosciences at Tel Aviv University developed the idea of flying the Rosetta spacecraft for a year alongside the comet's nucleus, and to land the Philae lander on its surface, in order to examine the strength and composition of the ice.
Photo : Comet 67P on October 30, 2014
Photo Mr Avi Hasson
Samsung Introduces the Latest in its Iconic Note Series - The Galaxy Note 4
Offering a new dimension to Samsung's unique Note culture, the Galaxy Note 4 strengthens Samsung's category leadership with the most progressive mobile device on the market
Tel Aviv, Israel – October 27, 2014 – Samsung Electronics Co., Ltd. today announced the expansion of its flagship Galaxy Note series with the new Galaxy Note 4. Blending an evolved S Pen with a superior viewing experience, the Galaxy Note 4 provides users with the most unique and powerful mobile experience on the market.
"The Galaxy Note series signaled extraordinary innovation within the technology industry. Its larger screen size and iconic S Pen technology launched a new standard in smartphone culture," said Kobi Kalif, head of mobile devision at Samsung Israel. "With the introduction of the Galaxy Note series, we brought the age-old culture of the pen and notepad into the digital world. The new Galaxy Note 4 introduces the most refined Note experience to-date by combining all the latest technology that users expect from the Galaxy series."
Powerful Performance that Matters the Most to You
Due to its large screen, the refined Multi Window feature is able to maximize the user's experience providing them with the key to easier multi-tasking. Users can choose how they access their applications with full, split or pop-up screens, and easily change the size and positioning of apps on the screen with one intuitive swipe.
The Galaxy Note 4 also sports an advanced camera system that is able to reproduce brighter and clearer images. The device is equipped with a 16 megapixel rear-facing camera featuring a Smart Optical Image Stabilizer that counter-balances camera shake and automatically extends exposure time in dark settings. In addition, a 3.7 megapixel front-facing camera with f1.9 offers a default 90 degree shooting angle and up to 120 degree wide angle so users can take the best group shots with friends.
The Galaxy Note 4's wide selection of enhanced essential features enable users to get even more from their mobile device. With the Fast Charging feature and Ultra Power Saving Mode, the Galaxy Note 4 charges faster and ensures that users don't run out of power when they need it most. The Galaxy Note 4 comes equipped with multiple microphones and an improved speaker phone for better noise cancellation when speaking in loud environments. A built-in Voice Recorder offers eight different directional voice tagging and a selective playback capability that allows users to isolate and listen to specific voices in a group conversation.
The Galaxy Note 4 also offers an improved Fingerprint Scanner, to secure personal data and the world's first UV sensor in a mobile device.
S Pen and S Note for Everyday Tasks
The Galaxy Note 4 also provides users with a choice of multiple, seamless note-taking methods integrated with Samsung's S Note application that allows everyday tasks to get done faster and more easily. In addition to typing and writing, the innovative Snap Note feature allows users to take a picture of their notes on a paper or a classroom board, and then quickly and easily convert to an S Note. They can also further unleash their creativity by jotting down their thoughts quickly with Voice Memo.
Premium Yet Functional Design
Samsung Galaxy Note 4 Product Specifications:
Rear Facing Camera : HDR (Rich tone), Selective Focus, Rear-cam Selfie, Beauty face, Virtual Tour Shot, Shot & More, Dual Camera
Ultra Power Saving Mode
Voice Recorder (Normal Mode, Interview Mode, Meeting Mode, Voice Memo)
S Health 3.5
Dynamic Lock Screen
Ending a three day visit with senior researchers and physicians at Rambam Health Care Campus Professor Richard Horton, Editor-in-Chief of The Lancet, stated that his visit to Israel was "a turning point for me and my relationship with this region." His visit holds promise for new academic and medical collaborations that Horton has pledged to support.
Professor Richard Horton, Editor-in-Chief of The Lancet, spent three days meeting with senior researchers and physicians at Rambam and the Technion's Ruth and Bruce Rappaport Faculty of Medicine, talking with Jewish and Arab physicians, touring Rambam's medical units, attending a series of medical lectures, including presenters from many of Israel's medical institutions and universities, ethical discussions, and debates, and visiting Nahariya's Western Galilee Hospital, Isifiya, and Acco. The visit was initiated by Professor Karl Skorecki, Director of Medical and Research Development at Rambam, and Professor Rafi Beyar, Director of Rambam, followed by the endorsement of the Israeli Ministry of Health, following The Lancet's publication of a controversial open letter that accused Israel of war crimes. The letter itself was discussed on a number of occasions, including during a lecture by renowned ethical philosopher Professor Asa Kasher.
Concluding his visit, Professor Horton gave a lecture entitled Geopolitical Issues and Responsibilities of Medical and Scientific Journals. Beginning on a personal note, he stated "...I deeply regret the completely unnecessary polarization that publication of the letter by Paola Manduca caused... I was personally horrified at the offensive video that was forwarded by two of the authors of that letter. The world view expressed in that video is abhorrent and must be condemned, and I condemn it." After a round of applause, Horton continued, "I will be publishing what I have just said in The Lancet next week." The visit of Professor Richard Horton, in his own words, represents "a fresh start for a new and different future."
Photo caption: Professor Richard Horton with his Rambam Hosts
Top political, technological and financial leaders gathered to share insights and make key announcements
Leading telecommunications vendors and universities backed by the Office of the Chief Scientist (OCS), in the Israeli Ministry of Economy, collaborate to lay foundation for Network Programming
ISRAEL —July 31, 2014 – Today, ten leading Israeli companies along with ten Israeli universities and research institutions announced the formation of the Neptune (Network Programming) consortium. Its goal is to develop efficient methods to automate and programmatically manage service provider networks, irrespective of their underlying network technologies. The ability to program and automate networks will increase the efficiency and flexibility of service provider networks, thereby simplifying deployment and operation and reducing dramatically associated costs.
With financial support from the "Magnet Program" of the Office of the Chief Scientist in the Israel Ministry of Economy, the founding members include ECI Telecom, RAD Data Comunications, Gilat Satellite Networks, Elbit Systems, Ceragon Networks, BATM Telecom, ADVA Optical Networking Israel, Mellanox Technologies, Mobilicom, Bezeq International, the Technion Israel Institute of Technology, Ben-Gurion University, the Hebrew University in Jerusalem, Bar-Ilan University, Tel-Aviv University, University of Haifa, Tel-Aviv Jaffa Academic College, Holon Technological Institute, the Lev Academic Center in Jerusalem, and IDC Herzliya.
Tighter financial restrictions along with ever-growing demand for bandwidth as well as the dynamic introduction of various new services and applications are forcing service providers to adopt ever more efficient, automated, and service-aware networks. This necessitates a totally new network architecture, enabling simplified network provisioning, fast creation of new services, real time network optimization, as well as CAPEX and OPEX reduction.
Future heterogeneous networks will additiobnally benefit from optimized combined terrestrial and satellite technologies.Service providers are looking for ways to integrate wired and wireless networks into a single orchestrated network. "By applying sophisticated multilayer optimization algorithms combined with new virtualized network functions, we will enable what we call the AutoMagically configured Network - a new level of network programability solutions, allowing the operator to shift from 'network planning' to 'network programming', says Gali Malkiel ,Chairman of the Neptune Consortium and Head of ECI Telecom's SW & SDN Solutions Line-of-Business. "By exploiting the expertise in and synergies between Israeli industry and academia, the Neptune consortium will employ a unique blend of skills, guaranteeing the success of the project and a better future for open service provider networks."
Research and development efforts are already in progress worldwide towards two complementary technologies: Software Defined Networking (SDN) and Network Functions Virtualization (NFV). The goal of the Neptune consortium is to exploit SDN and NFV technologies in order to enable Carrier-grade automated network solutions.
Topics currently being reasearched under the aegis of Neptune include:
· Automatic and dynamic network resource allocation
The Emergency Department of the Ministry of Health recently adopted one of the most advanced computerized information and control systems in the world—developed at Rambam Health Care Campus. With the beginning of "Protective Edge" it is now being used for the first time.
During emergency situations hospitals must quickly adapt to the circumstances. To that end, this award winning innovation, called emergency System, facilitates multi-tasking and rapid transfer to emergency operations throughout a hospital. It also enables informed decisions by hospital management under emergency situations, based on integrated real-time data received from all other hospital systems together with essential and scenario-based information.
Following the Second Lebanon War, the system was conceptualized under the visionary guidance of Professor Shimon Reisner, the Deputy Director and Director of Rambam under Emergency Situations, assisted by Leora Otitz, the hospital's emergency situations coordinator. The system was developed by Rambam's IT Department, headed by Sara Tzafrir. Prior to its first use by the Ministry of Health, the system was tested during various emergency drills in which Rambam participated.
Rambam's Computing Division customized the system for the Emergency Department of Israel's Ministry of Health. The ministry has expressed interest in integrating the system with Israeli hospitals to facilitate communication between emergency operations rooms nationwide.
The Ministry of Health is also utilizing another system developed by Rambam—"Adam." The Adam System automatically provides a full picture of patients received by hospitals during security incidents and helps decision-makers follow their care based on up-to-date information. This system is being used during operation "Protective Edge," enabling the ministry to receive updates on all casualties evacuated to hospitals over the past few weeks.
Photo : Rambam's Emergency Staff working with the emergency system during a drill
Photo credit: Ben Yuster
This week, Rambam Health Care Campus hosted the fifth annual Rambam Summit, a meeting place for medicine, technology, and humanity. Since 2010, the Rambam Summit, which includes a scientific conference, has hosted friends from around the world, updating them on Rambam's contributions to medicine and clinical research.
The summit began with attendees meeting a patient before and after treatment for essential tremor (as in Parkinson's disease)—a treatment available in Israel only at Rambam. Attendees also visited the Sammy Ofer Fortified Underground Emergency Hospital in its peacetime configuration as an underground parking lot, the newly opened Ruth Rappaport Children's Hospital, and the soon to open Joseph Fishman Oncology Center. The first day ended with a gala evening and presentation of the prestigious 2014 Rambam Award, which recognizes outstanding individuals for their contributions to Rambam, Israel, and humankind.
This year's recipients of the 2014 Rambam Award were Haifa's Mayor, Yona Yahav, Professor Howard (Chaim) Cedar, Ms. Herta and Mr. Paul (Shmuel) Amir, and Ms. Relly and Mr. Brent Dibner.
The scientific conference focused on Promises and Horizons in Next Generation Medicine. Attendees included renowned experts in health care and genetic medicine, with Professor Elizabeth Nabel, President of Brigham Hospital in Boston, Massachusetts giving the Key Note lecture. Professor Karl Skorecki, a world-renowned genetic researcher and Director of Medical and Research Development at Rambam, was the conference moderator.
By the end of the summit, it was clear: by placing people at the heart of every medical endeavor, Rambam's vision is becoming reality.
Share the Rambam Summit 2014 Experience
In the space of a few days, an international delegation that included two Rambam physicians changed the lives of dozens of children and adults in northern Ethiopia. How? With all their hearts they used their hands…
A surgical marathon was conducted in northern Ethiopia as part of Operation Smile, a program focusing on third world countries to treat cleft lip and palate. After landing in the nation’s capital, the delegation travelled an hour to the city of Mekele to set up base.
The 40-member delegation flew in from South Africa, Peru, United States, Sweden, India, Ghana, Ethiopia, and of particular note—the Middle East—represented by two Israeli physicians from Rambam, Dr. Omri Emodi, a senior physician in the Department of Oral and Maxillofacial Surgery, and Dr. Zach Sharony, a senior plastic surgeon, and an Egyptian orthodontic specialist.
The residents of Mekele are mostly from the area’s ruling Tigri tribe, most of whom are Catholics. The city itself has about 200,000 inhabitants and is surrounded by villages. News of the delegation’s arrival spread throughout the region; when they arrived at the main city hospital there were already long lines of patients seeking medical help and a solution to their problems. During the first few days in Ethiopia, the delegation performed examinations to determine which patients could be best treated in the short time available—11 days in total.
After seeing dozens of patients, 91 patients were chosen. Over the remaining five days the delegation set out to do the impossible: from dawn to dusk, four surgical tables were under constant use for patients ranging in age from six months to 50 years and more. Each one had suffered from life-long facial defects, and medical and speech problems due to cleft lip and/or palate. Full treatment involved multi-disciplinary teams that included surgeons, anesthesiologists, nurses, operating room technicians, pediatricians, speech therapists, dentists, orthodontists, operating room technicians, and more, all of whom were assisted by translators, and logistics and hospital professional staff.
In addition to treating the local patients, the international delegation utilized the operating room time to train local doctors, hospital staff, and specialists who came from throughout Ethiopia with the particular goal of advancing their knowledge to help their patients.
"This is the second time I’ve come to Ethiopia under this framework," says Dr. Emodi, "I was amazed by my first experience; this time I've been excited by the immense satisfaction gained from this moving situation. I have met people who needed help and couldn’t get it, and I’ve had the power and tools to meet their need and to improve their quality of life—there is no better way."
Watch it on YouTube:https://www.youtube.com/watch?v=8qhTrcQ0dtg
Videography: Nathaniel Ayzik, RHCC
As part of the revamped Technological Incubators Program of the Office of the Chief Scientist (OCS) in the Israeli Ministry of Economy - where licensees are chosen via open competition - two new incubators have been awarded:
1. Inspire Healthcare Innovations Ltd. – a joint venture between Holland's Philips Healthcare and Israel's Teva Pharmaceuticals to advance medical innovations and technologies. The choice was based on the high level of risk in med-tech as well as the significant added value that Philips and Teva will bring to the incubated startups. Teva and Philips are expected to avail their worldwide network of resources, technological and business knowhow and experience - including clinical and regulatory resources - to the startups, which is expected to contribute significantly to their efforts to bring products to market. The joint effort of multinational corporations like Philips and Teva - which come from different disciplines within the medical field - also brings significant added value.
2. Food-Tech Hub LP – an initiative of The Strauss Group to develop Israel's innovative ecosystem in the field of food and beverages. The incubator will focus on technologies pertaining to the entire "food chain," including: basic foodstuffs, agricultural techniques, production processes, packaging and more. The choice was based on the high level of risk in developing these types of technologies, and startups' need for support from a large, experienced corporation. It was also based on the need to develop innovation in a traditional industry such as food and beverages which has previously not received appropriate support from the incubator program.
"The OCS's Technological Incubators Program has become one of the leading tools for nurturing and growing startups in Israel," said Israel's Minister of Economy Naftali Bennett. "I expect to see many successful companies growing out of these new incubators."
"The cooperation between Philips Healthcare (Philip's Israel division) and Teva Pharmaceuticals signifies a deep understanding of the direction the market is heading and of the future of medical devices," said Israel's Chief Scientist Avi Hasson. "This field demands significant, long-term investment –a serious challenge for the private sector without government incentives."
"Strauss' food-tech incubator will focus for the first time on a traditional industry which nevertheless demands significant innovation," added Hasson. "Much like in biotech, there is a clear advantage to the type of broad infrastructure which a global company can provide. Injecting innovation into this field will allow Israel to remain competitive in an area in which it already has a relative advantage. This could very well have a broad impact on the Israeli economy."
"In light of the large number of quality proposals, the final decision was extremely difficult," said the Technological Incubators Program Director Yossi Smoler. "We hope that the applicants that weren't granted a license this time will participate in the next round of the competitive process that is expected to be announced later this year."
About the Technological Incubators Program
The Technological Incubators Program was established in 1991 and is administrated by the Office of the Chief Scientist in Israel's Ministry of Economy. The primary goal of the program is to transform innovative technological ideas that are too risky for private investments into viable startup companies that after the incubator term should be able to raise money from the private sector and operate on their own. Secondary goals of the program are as follows: 1. Promote R&D activity in peripheral and minority areas. 2. Create investment opportunities for the private sector, including venture capitalists. 3. Transfer technologies from research institutes to industry. 4. Create an entrepreneurial culture in Israel. See more at:
The Solution to Solving Security Vulnerabilities in all Devices and Protocols – Educating Developers Not to Release a Product until Thoroughly Tested
The solution to solving security vulnerabilities in all devices and protocols lies in the proper education of developers, who should be taught not to release a product until it has been thoroughly tested.
This is what was said by Professor Eli Biham at the Seminar Day on Cyber & Information Security, held this week at the Technion. The seminar was organized by Professor Biham, Dr. Sara Bitan and the Technion Computer Engineering Center (TCE), which was founded jointly by the Faculty of Computer Science and the Faculty of Electrical Engineering.
As for the timing of the conference, at a date when massive attacks are plotted and carried out on servers all around Israel, Professor Biham stated that these types of security attacks are ongoing occurrences, usually not planned for any particular date. "Today we are getting ready for DOS attacks (Denial of Service)," he explained. "This kind of attack only succeeds if numerous requests are sent to a server simultaneously, and therefore, they are usually more coordinated than other kinds of attacks. Many have suggested that we shutdown servers on this day, and my answer to this is that this is precisely the hackers' intensions – that we shutdown our servers, why should we help them accomplish their goals?"
Tel Aviv, X April, 2014, Ramot at Tel Aviv University Ltd. (Ramot), the University's technology transfer company, today announced it has completed the selection process for the first round of project funding by the Technology Innovation Momentum Fund ("Momentum Fund"). Of the more than 60 applications submitted, six projects were selected with an approved budget of approximately five million NIS. Pending successful completion of milestones, funding of the selected projects can potentially increase to more than 20 million NIS. The next call for proposals is scheduled for Q3-2014 for a selection process to take place in Q4-2014.
The Momentum Fund, with $18 million already secured out of targeted $20 million, will invest in promising breakthrough technologies in a wide range of fields, including pharmaceuticals, healthcare, high-tech and the physical sciences.
Professor Klafter, Tel Aviv University (TAU) President commented: "Bridging the gap between basic science and commercializable technologies has been a major challenge to most academic institutions around the world. The Momentum Fund is uniquely positioned to bridge this gap with suitable levels of funding combined with professional management, structured to generate financial returns to investors as well as TAU and the scientists. Tata's involvement as a lead investor, paved the way to successfully secure this fund."
Mr. Shlomo Nimrodi, Ramot CEO and the Fund manager said: "Our goal is to take our most promising TAU innovations from basic science and bring them to the point where they have a solid, proven concept, according to industry standards. At that stage, they are sufficiently attractive to multi-national companies or venture capital funds prepared to commit substantial resources for funding the technologies all the way to commercialization. At the same time, the potential licensing terms are maximized. This perfectly aligns with our vision of translating TAU's theoretical discoveries into useful products and applications in the real world."
The Momentum Fund's lead investor is Tata Industries, part of the Indian Tata Group conglomerate. Tata has committed to an investment of up to $5M. The fund's other main investor is SanDisk, along with other angel investors from South Africa, USA, India and the UK.
Four experts committees, comprised of three Scientific Committees and an Investment Committee, thoroughly reviewed selected technologies from Tel Aviv University for funding and selected the following six leading technologies:
· Novel Bio-Adhesives for Large Incisions and as an Internal Surgery Sealant - Prof. Meital Zilberman - Dept. of Biomedical Engineering - delivering a novel Gelatin-Alginate polymer-based tissue adhesive, providing high bonding strength, biocompatibility, easy application, and wound healing acceleration using controlled drug release.
· Hyaluronic - Nanotube Hydrogel for Aesthetic Tissue Augmentation - Prof. Zvi Nevo, Prof. Ehud Gazit - Dept. of Human Molecular Genetics and Biochemistry - delivering a new hydrogel filler, combining the favorable biological properties of the natural polymer Hyaluronic Acid, and the mechanical strength of self-assembling Peptide Nanostructures
· Small Molecule - Trp-Naphthoquinone Derivatives for Amyloidosis - Prof. Dan Segal - Dept. of Molecular Microbiology and Biotechnology - generating pre-clinical data, supporting the therapeutic effect of NQTrp in AA amyloidosis and in Dialysis-related amyloidosis (DRA)
· Smart Image Sensor - Prof. David Mendlovic, Mr. Ariel Raz – Department of Electrical Engineering - the program will revolutionize the mobile phone and automotive cameras market by replacing the old Bayer color sensing mechanism with a mechanism that will deliver 4X higher resolution, stabilized image, enhanced colors and improved low-light performance
· Peptide Nucleic Acid (PNA) Luminescent Materials for OLEDs - Prof. Ehud Gazit - Molecular Microbiology & Biotechnology Department, Faculty of Life Sciences - fundamentally change the OLED TV and mobile phone display arena by introducing a unique bio-inspired "green" technology for flexible displays, delivering low cost, long life, and impressive luminescent spectrum
· Superconducting Fault Current Limiter (FCL) on Sapphire Tapes - Prof. Guy Deutscher, Dr. Boaz Almog, Mr. Mishael Azoulay - School of Physics and Astronomy - delivering superconducting tapes, utilizing sapphire substrate, which will serve as the heart of future FCL products that will provide superior Grid Electric Power protection against burnouts and blackouts
The Momentum Fund is managed by Ramot at Tel Aviv University, its Scientific Committees and Investment Committee. Mr. Shlomo Nimrodi, Ramot CEO, is the General Partner of the Momentum Fund and heads the Investment Committee.
On April 7, 35 new technologies in innovative fields were exposed. Among these technologies: 3D, multi-layered reality, user interfaces for technical applications, entertainment, robotics, machine learning, etc.
Developers: Israeli start ups, academic institutions and Microsoft laboratories
Microsoft's R&D Center in Israel opened its yearly Think Next innovation event at Hangar 11 in the Tel Aviv port, on April 7. This event is taking place this year for the 6th time. About 1,800 participants are invited from the hi-tech industry, including: developers, development managers, chief technologists, entrepreneurs and start up companies, venture capital funds, students and researchers from academic institutions, and more.
The event, which takes place in cooperation with Microsoft Ventures, deals with 'unlimited innovation in technology' and shows the special capabilities of the Israeli industry to continue breaking limits by means of creativity. Although Microsoft promotes the Think Next events, it provides a central stage for young Israeli entrepreneurs to expose their innovative ideas and products to Microsoft's international senior staff, and to the leaders of Israeli hi tech. The Israeli entrepreneurs and their developments are also exposed to delegations from abroad, among them, a delegation of 50 managers of accelerator start ups from the whole world, who have arrived to the event and examine the Israeli innovations.
In the event, 35 new technologies are exposed: about half of them belong to Israeli start up companies and academic institutions, selected as part of Microsoft Ventures' activities within these companies and institutions. The second part presents technologies developed by Microsoft's R&D centers in Israel and throughout the world.
Yoram Yaacobi, Chairman of Microsoft's R&D centers in Israel, said: "The Israeli industry shows in this event innovations in a number of hottest technological fields in the world; among them: 3D, multi-layered reality, user interfaces for technical applications, entertainment, robotics, machine learning, etc. These developments strengthen the user capabilities and enrich our lives by means of friendly devices that will soon be available to all. For example, new devices will enable everyone to develop an application without any knowledge in programming. Everyone will be able to easily design a 3D object and print it. I hope that the exposure of start ups to delegations from abroad and to Israeli industry leaders will pave their way to success in the world market".
The guest of honor this year is Harry Shum, senior vice-president, manager of Microsoft's R&D and technology in the world, who came in his first visit to Israel. Harry Shum appeared in the conference in a free talk with Dr. Kira Radinsky, former researcher in Microsoft's research laboratory, researcher in the Technion, founder of Sales Predict, and one of the leading entrepreneurs in Israel.
Harry Shum is responsible of Microsoft's technological strategy and on Microsoft's research group, which specializes in basic research, and research applied to computer science and software engineering. This research group, one of the largest in the world in this field, includes 850 researchers in 10 laboratories throughout the world, including Israel. Harry Shum is the last in a long chain of Microsoft's senior officials that have arrived to Think Next events. Among these: Steve Ballmer, Ray Ozzie, Craig Monday, Chi Lo and Rick Rashid.
Besides Harry Shum, also appeared on the event stage a series of lecturers that break-thru in technological fields; among them: Doron Meirsdorf, Oshri Even Zohar and Eyal Shahar. James Whitaker, one of Microsoft's leaders in the technology field, also presented his views on this issue.
Photos Silvia Golan
InSightec's Vision: Dr. Kobi Vortman, CEO and President, Explains InSightec's Vision: Building the Next Generation Operating Room
"The way I see the future is the building of the next generation operating room, replacing traditional surgery by non-invasive outpatient procedure.
InSightec was established in January 1999. The company developed a breakthrough technology that in essence allows treating human beings without cutting the body. We developed technological systems that allows the destruction of targets deep inside the body completely non-invasive. The unique part of InSightec is that all these procedures are being done under real time monitoring and control of treatment outcome. So the user is capable of changing treatment parameters on-the-fly, not in retrospect and achieves the desired outcome.
The main part of the system is the transducer that transmits the ultrasound waves from this area here. This has thousands of elements in it each one is electronically controlled by a complicated electronic system together with mechanics and software that supports it. Each one of those elements is transmitting the ultrasound waves focusing at the treatment point.
The technology allows us to treat almost any tumor inside the body. We started with uterine fibroids. It's a huge problem about 25% of women will suffer from significant symptomatic effects. Today the gold standard is hysterectomy. The patient goes through a hysterectomy then she will be hospitalized for a couple of days (3-5), sent home to recover. It will take weeks to recover. In our treatment the next day the patient is back to her life, work and family. It's a dramatic change for women.
Step two was turning to oncology. We selected a specific application which is metastatic bone tumor. It's a palliative treatment. The next one which is in many ways the holy grail of this technology is brain treatments. We are treating central nervous system diseases like Parkinson's, like essential tremor. We've seen patients that for tens of years suffered from these diseases leaving the table immediately post treatment with no tremors.
We'll definitely look as the next step at brain tumors, prostate cancer, liver tumors, breast cancer and so on. Eventually we see it as a next generation operating room centralized service in the hospital.
I did my first degree in physics and mathematics in Jerusalem and then I moved to the Technion and did my first engineering degree in electrical engineering and then continued directly to a PhD in electro-optics. In parallel I started working at Rafael. During my days at Rafael we had a very tight collaboration with a couple of laboratories and researchers at the Technion and as a combined team we worked on a couple of breakthrough programs in essence until now are playing a major role in the defense of Israel.
When we started InSightec the whole R&D team came from the Technion. I would say I had a hard time persuading the leaders to interview anyone from any other institute in Israel. To an extreme it was a Technion based company so these are ongoing relations. I would guess at least 80% of our R&D team is coming from the Technion.
This is the new brain system that we develop and manufacture here at InSightec. The main challenge in developing this system was to be able to penetrate the skull the non-uniform skull and still get the focal point of the waves in the required spot in the brain. These was never done before by any company and add to it the idea of having everything MRI guided makes it very complicated involving so many disciplines and excellence in science and technology.
In many ways the system is a "Star Trek" because the notion that you could place someone on a table look at him using MRI and then three hours later this guy rides his bike back home is something that at least in my generation is perceived as "guys send me a postcard when this will be ready, o.k.?"
Think about a stroke. Think about the possibility that this technology will be able to liquefy a clot in the brain really fast in the first three to four hours and get reflow back again to the brain and save the brain.
101 world-class scientists immigrated to Israel and were accepted as faculty members at the universities in the six years since declaring nanotechnology as national priority in Israel.
According to INNI (Israel National Nanotechnology Initiative) statistics, gathered towards NanoIsrael 2014, the 4th international conference & exhibition, the number of junior scientists in the field (including post-doctorates) is 220, the number of doctoral students is about 750 and the number of masters students is more than 850. In the past three years over 7,500 scientific papers have been published where 1500 of which resulted from collaboration between the universities.
"In the six years since declaring nanotechnology as national priority, the field marked significant achievements", says Rafi Koriat of INNI (Israel National Nanotechnology Initiative) and a conference co–chair.
According to INNI, in these years there were 830 collaborations between Israeli academia and industry (domestic and foreign), and 206 "success stories" in the form of startup companies and approved patents, with another 860 patent filings.
Commercializing technologies will stand out again in this year’s NanoIsrael conference, says Koriat. "The conference will be attended by large delegations and experts from around the world, who will come to Israel to experience its vibrant nanotechnology scene. Both industry and academia, with its six nanotechnology centers at the leading research universities, will feature strongly in the conference."
NanoIsrael 2014 will be held on March 24th-25th , at the Tel–Aviv David Intercontinental Hotel, Israel. Prof Uri Sivan of the Technion, renowned scientist and the first head of the Russell Berry Nanotechnology Centre at the Technion, is chairing the scientific committee this year, and Nava Swersky Sofer, is a conference co–chair.
NanoIsrael 2014 is held in cooperation with the Israel National Nanotechnology Initiative (INNI) and the nanotechnology centers at Israeli universities, and is supported by the Ministry of Trade & Industry, the Foreign Ministry, key companies, universities and organizations from Israel and abroad.
The conference site: WWW.KENES.COM/NANO
During the night between Tuesday March 4 and Wednesday, the Wise Observatory of Tel Aviv University that operates near Mizpe Ramon in the Negev observed a rare astronomical event: the occultation of a star some 50 light-years away by a Solar System object that belongs to the Pluto family. This kind of events is similar to a solar eclipse when the Sun is blocked by the Moon and a narrow shadow falls on a small part of the Earth. The difference is that in this case the "Sun" was a distant star and the "Moon" was a tiny dwarf planet, an asteroid. The occultation was predicted by the French astronomer Jean Lecacheux within the international collaboration PLANOCCULT, but the low accuracy in the knowledge of the asteroid trajectory and in the location of the star caused the predicted area from which the event could have been seen to range from the western end of Europe to the border of Iran.
The asteroid that caused the brief eclipse circles the Sun every 246 years and is known only by its catalog number: 2003 VS2. When it gets closest to the Sun it is about 36 times more distant than the Earth from the Sun. 2003 VS2 belongs to the family of small bodies called "Plutinos", since their orbit around the Sun is similar to that of the dwarf planet Pluto. Measurements by the HERSCHEL satellite indicate that the asteroid has an average diameter of some 520-km. It spins around itself every 7.5 hours, but its exact shape (round, flattened, or elongated) is not known.
At the Wise Observatory of Tel Aviv University the scientists prepared to operate for the first time two telescopes to observe the occultation. One is the large telescope of the observatory that operates since 1971 and has a primary mirror one meter in diameter. The other is a new telescope that is still being commissioned for regular and routine operations. This telescope, called "The Jay Baum Rich telescope" is equipped with a primary mirror of 0.7-meter diameter. Both telescopes image the sky with modern, large-format CCD cameras that are orders of magnitude more sensitive than the human eye.
In the night of the event the occultation was predicted to take place at about 22:00 and the observations were started some ten minutes before. While the large telescope imaged the sky every four seconds, the new telescope took images every five seconds; this tactic increases the accuracy of determining the start and the end of the occultation. The two astronomers, Dr. Shai Kaspi and Dr. Noah Brosch, observed the computer screens on which the sky images were shown. At one instant one of the stars in the field disappeared; it was clear that the occultation had begun. In the same moment the star disappeared also in the images from the other telescope. Some 40 seconds after the disappearance, the star reappeared on the screen.
The data from the Wise Observatory are now being analyzed together with the
Three .jpg images created by combining images before the occultation, during the occultation, and after the occultation.
International Space University 2016
Space Studies Program Session hosted by Technion
São Salvador da Bahia, Brazil, 4 March, 2014 - Elbit Systems demonstrated for the first time, during the traditional Carnival in São Salvador da Bahia, a new breakthrough wide-area, persistent surveillance ground system, which generates real-time intelligence imagery in high resolution enabling the security forces to enhance the safety and security of the thousands participating in the Carnival celebrations.
GroundEye was developed by Elbit Systems as a solution to the growing demand of security forces and decision makers to achieve continuous intelligence imagery covering a wide area-of-interest in high resolution and in real-time for situational awareness purposes, especially during large scale events.
GroundEye is a highly sophisticated wide-area, persistent surveillance ground system that covers extremely wide areas providing comprehensive situational awareness for multiple users. With GroundEye, security forces can monitor and deal with multiple events simultaneously in the area-of-interest under their responsibility. In addition, the system detects and issues alerts upon the occurrence of pre-programmed events, thereby complementing and enhancing human detection capacity.
The system used during the Salvador Carnival is designed for both civilian and military applications, including border protection, perimeter control of infrastructure and critical sites, military operations, Safe City programs and large scale events.
Bezhalel (Butzi) Machlis, President and CEO of Elbit Systems said: We are grateful for the opportunity provided to us by the Governor of São Salvador da Bahia to demonstrate the capabilities of this new innovative system which is intended to provide enhanced safety and protection to participants in the Carnival in Brazil. The successful demonstration of GroundEye attests to our ability to develop solutions for civilian applications, based on Elbit Systems' existing knowledge and experience, positioning us as leaders in the growing field of homeland security".
GroundEye is an innovative, high resolution, wide-area, persistent surveillance ground system, which provides real-time, comprehensive situational awareness for multiple users. With GroundEye, security commanders can now truly dominate the area under their responsibility. Multiple events can now be simultaneously dealt with in real time, or, if missed in real time, as soon as an operator is available. In addition, the system detects and issues alerts upon the occurrence of pre-programmed events , thereby complementing and enhancing human detection capacity. GroundEye retains in its memory both the Area and Time dimensions in their entirety, allowing precise comprehension of activities in the area and generation of high-quality and comprehensive intelligence data.
In contrast to current surveillance systems, which typically provide a single user with a single video stream covering a small area, GroundEye allows several simultaneous users to independently probe any region of interest anywhere in the entire sector. It also facilitates immediate and convenient access to pre-recorded imagery, providing forensic capability in real time.
GroundEye's main components are a mast-top, non-rotating panoramic sensor head, a processing and storage unit and several operator stations. GroundEye enables the following:
GroundEye implements "monitoring and recording of everything" and does not let any event go unnoticed. Every event can be investigated, in real time or after the fact. This concept of monitoring and recording everything facilitates situational awareness control over the entire area.
GroundEye can be operated either in a Stand-Alone mode or in a Command & Control (C&C) Network Integrated mode, meshing with the customer's existing command and control networks. GroundEye features Wide Area Persistent Surveillance, an advanced way of looking at the world. It employs the technology and building blocks of the SkEye system, Elbit Systems' Airborne Wide Area Persistent Surveillance system. GroundEye employs several high resolution sensors which operate in parallel, coupled with fast and parallel specialized electronics/software, for processing and controlling the imagery. Located at the foot of the mast is a large storage device used to store the vast volume of imagery flowing from the mast-top sensors, at the same time it is being viewed. This multiple random-read access, allows several users to examine, in parallel, several events which occurred at different times and in different locations. Built into the system are powerful image processing capabilities, aimed at providing users with rigorous investigation and alert tools.
With GroundEye technology, the whole sector covered by the sensors is being recorded continuously, regardless of the specific areas being examined by the operators in real time. This enables off-line examination of areas not previously monitored by a human observer. In other words, if an event is missed in real time by an operator, it is not lost forever – the operator can find the event in the recorded imagery at the proper place and time, re-play it and examine it.
On-going high resolution video capture and recording of large areas;
About Elbit Systems
Photo Elbit Systems
Samsung Israel, the main sponsor of the Tel Aviv Samsung Marathon, is proud to present: SAMSUNG CITY
1200 m2 of electronic innovation in a Kikar Rabin offering a great experience for the whole family.
The Tel Aviv Samsung Marathon 2014 opens with a symbol of contribution to the community and an experience for the whole family. Samsung Israel, the main sponsor of the Marathon, invites the runners and their families to SAMSUNG CITY, first site of its type in Israel, which offers an experience of electronic innovation. This exhibition will be open in Kikar Rabin from Thursday, February 20, until February 27.
Ana Lipnik Levy, the Marketing Manager of Samsung Israel, says: "We, in Samsung, look at technology as a way to live new experiences, and create contents in unique fashions. As an international leader in the technological area, Samsung is proud and excited to lead the Tel Aviv Samsung Marathon to the worlds of most advanced technological contents. We decided to organize the present marathon in the symbol of innovation, quality of life, and an experience for Samsung's clients and their families, and a contribution to the community".
For additional information, see our website link: www.samsung.com.
Photo Silvia Golan
Prof. Reisner was awarded a $60,000 prize for his groundbreaking contribution in the study of bone marrow transplant therapy and Dr. Nahmias was awarded a $40,000 prize for identifying a small molecule, naringenin, derived from grapefruit, capable of blocking viral production. The prizes will be given in Tel Aviv on March 17
Rappaport Prizes for Excellence in Biomedical Research in 2014 will be granted by the Rappaport Family Foundation to Prof. Yair Reisner of the Weizmann Institute of Science and to Dr. Yaakov Nahmias of the Hebrew University. The prizes will be granted in a ceremony to take place at the Tel Aviv Museum of Art on March 17, 2014. The prize for excellence was established in order to promote visionary, groundbreaking and innovative research with therapeutic repercussions that are unique and significant to promoting human health.
photo Prof Reisner ( PR)
Innovative approach to bone marrow transplant
Worldwide, more than 30,000 patients benefit from bone marrow transplant therapy every year. The success of these procedures largely relies on genetic compatibility between the donor and recipient. Unfortunately, only a minority of eligible patients find a compatible match. Prof. Reisner’s research paved the way for implementing bone marrow transplantation in patients without a matched donor.
Insights from Prof. Reisner’s basic research initially led to a successful treatment for ‘bubble’ children who are born with a severely defective immune system and his approach was adopted by many centers throughout the world, resulting in impressive cures. Subsequently, Prof. Reisner’s continued discoveries paved the way for the successful transplantation of mismatched bone marrow in leukemia patients. More recently, he has described a novel approach for bone marrow transplantation in leukemia patients who cannot tolerate strong irradiation.
Prof. Yair Reisner is an outstanding example of an independent thinker and a highly creative researcher. He has painstakingly, over the past 30+ years, contributed fundamental insights to the field of transplant biology and developed methods, translating them from the bench to the clinic, which have greatly improved standards of patient care. For these important scientific breakthroughs, which have given many patients a new lease on life, the Rappaport Prize Committee unanimously agreed that Prof. Reisner is worthy of the Rappaport Prize for Excellence in Biomedical Research in the category of “Established Investigators.”
Grapefruit against viral and nanotechnology for diabetes
Complex problems in biology and medicine can only be addressed using an integrated multidisciplinary approach. By combining an in-depth understanding of physics, engineering and biology, Dr. Yaakov Nahmias exemplifies this paradigm, achieving many accomplishments in his nascent career. His work on liver tissue engineering and the Hepatitis C Virus (HCV) lifecycle has been recognized by the leading journals of the field. Dr Nahmias identified a small molecule, naringenin, derived from grapefruit, capable of blocking viral production. He then created a nanotechnology-based complex that dramatically increases the bioavailability of naringenin, leading to a clinical trial at Massachusetts General Hospital that was completed with excellent results. Dr. Nahmias was able to take his discovery from the lab to a successful clinical trial in an astonishing short period of time of less than three years and without industrial support.
Photo Dr Nahmias ( PR)
Utilizing his knowledge in nanotechnology, Dr. Nahmias also developed advanced treatments for diabetes, ranging from nano-encapsulated insulin that can replace current injections, to robotic nanoparticles for the treatment of diabetic foot ulcers. The technologies hold significant promise in blocking the progression of diabetes and its many complications.
An additional major accomplishment of Dr. Nahmias is the establishment of BioDesign – Israel, a joint effort of the Hadassah Medical Center, the School of Business Administration, and the Alexander Grass Center for Bioengineering at the Hebrew University of Jerusalem. The program aims to synergize multiple disciplines such as medicine, engineering, and finance, offering an integrated approach to medical innovation. Already, the first class (2012-3) generated four successful projects in various stages of commercialization, drawing a sponsorship agreement from Boston Scientific.
For these innovations, breakthroughs and leadership initiatives, the Rappaport Prize Committee unanimously agreed that Dr. Yaakov Nahmias is worthy of the Rappaport Prize for Excellence in Biomedical Research in the category of “Young Investigators”
The Rappaport Prize for Excellence in Biomedical Research is given at the same time as the Rappaport Prize for Art, which is granted by the Rappaport Family Foundation in cooperation with the Tel Aviv Museum of Art and the Rappaport Prize for the Change Generating Woman in cooperation with La'Isha Magazine.
Winners of Technion's prestigious 2014 Harvey Prize are Professor Paul B. Corkum from the University of Ottawa, Canada, and Professor Jon M. Kleinberg from Cornell University, New York, USA.
In the photo: Professor Paul B. Corkum and Professor Jon M. Kleinberg.
President Peres met his Avatar on the Xbox One and visited the Ilumiroom which was presented for the first time in Israel
During the visit President Peres experimented with an application to explore space on an interactive table, met with young people who presented newly developed applications and met with employees of the company
The President of the State of Israel, Shimon Peres, visited Microsoft Israel earlier today () and during the visit he was presented with new technologies developed in Israel. President Peres was shown the new Microsoft entertainment console – Xbox One, which has been a great success across the world. While being shown the console, President Peres came face to face with his avatar, a surprise created for him by the employees of the company. Among the initiatives presented to President Peres was a kinetics camera which recognizes voice and movement and the new Microsoft development, Ilumiroom. The Ilumiroom projects expands and enriches the surroundings of the television set and changes the gaming and television watching experience. The Ilumiroom uses the kinetics camera to learn the lay out of the room and enhance the experience, the technology was shown in Israel for the first time.
During the rest of the visit President Peres experimented with the PixelSense table with touch technology which includes an interactive application to navigate through galaxies and stars. The application allows for study and research into space. Alongside the table President Peres was presented with technological applications developed by youngsters taking part in the Innovate for Good project.
President Peres congratulated the employees of Microsoft Israel during a meeting with them and said, "I am extremely proud of you and the work that you do. Greatness is to contribute to society and think in terms of generosity. I see you not only as an advanced technological company but a community organization based on technology. Israel's technological potential is vast. Within Israel we have talented people and we must find the ways to continue developments here."
President Peres was accompanied throughout the visit by the CEO of Microsoft Israel, Mr. Danny Yamin.
Photos Silvia G Golan
Yair Shamir (Minister of Agriculture) and Todd Dollinger (Chairman and CEO of The Trendlines Group
On December 4, more than 250 professionals gathered at Eretz Yisrael Museum in Tel Aviv on Tuesday for an international conference exploring the state of agriculture technology and investment, specifically focusing on how Israel’s R&D advantage, the country’s unique multidisciplinary approach, and more than 100 years of experience tackling “food security” may indeed solve current global challenges. Distinguished panelists included members of the Israeli government, executives from leading international agrochemical and food companies, as well as venture capitalists from international agritech-focused firms.
Avi Hasson (Chief Scientist of the Israeli Ministry of Economy) and Steve Rhodes (Chairman and CEO of The Trendlines Group)
Margaret Dohnalek, global head of technology scouting in corporate R&D for PepsiCo, remarked that she understands “we don’t know what we need to know about Israel,” underscoring a sentiment across the panel of corporate executives, that technology currently being developed in Israel may be the next game-changer. The conference was part a 4-day Agrivest Tour of Israel organized by The Trendlines Group (www.trendlines.com), which included visits to Israel’s top agricultural research organizations, as well as agritech start-up success stories, such as Evogene and Bio-Bee.
At the conference, Dohnalek, along with corporate leads from Syngenta, Bayer, and Monsanto spoke on a panel (“Profiling Tomorrow’s Ag Solutions”) offering insights into why companies are looking to Israel for the next addition to their pipelines, and discussed their “dream technologies.” Precision agriculture, with a focus on gaging weather patterns, was the most popular response. Virginia Ursin, Technology Prospecting Lead at Monsanto added that this sector -- “smart farming” -- is growing rapidly.
Ofra Strauss (Chairperson of the Board, Strauss Group) and Dr. Nitza Kardish (CEO of Trendlines Agtech)
Prof. Avi Perl, chief scientist, Israeli Ministry of Agriculture agreed and emphasized the formal funding structure the government gives to agritech start-ups as a sign of the government’s commitment to the sector’s growth and success. Dohnalek of PepsiCo said the formal support makes it more feasible for Israel entrepreneurs to successfully come up with ideas that address multiple challenges. She acknowledged this as a reason why large corporations seek collaborations and acquisitions in Israel. Ron Meeusen, managing partner of Cultivian Sandbox Ventures, said that what sets the Israeli start-up ecosystem apart is a culture of serial entrepreneurs who are willing to start over again and again.
Photos : Moshe Amar Liran Shemesh
Israeli pride. An innovative development with regards to babies' twisted feet. Children orthopedics is evolving with no need for casts or surgery.
UNFO MED Company was introduced this week during the thirty-third Orthopedics Conference held in Tel-Aviv. The company was previously titled one of Israel's promising companies in the Med in Israel Conference.
What are the various ways of treating Metatarsus Adductus? Introducing a unique, easy-to- use solution, developed and manufactured in Israel, which solves the problem perfectly.
Metatarsus Adductus is common amongst babies and is usually caused by the position of the baby in the womb. The baby's feet look like two halves moon bending towards one another. Up until today there has been no effective solution to this problem. The common treatment is the use of a special splint or casting of the foot till the baby turns 9 months old.
The cast is changed once a fortnight. The casts are outdated and were originally designated for a graver problem called Clubfoot. Usually the cast or splint is used till the baby starts walking. This obsolete and awkward treatment leads many families and doctors to avoid treatment due to the cumbersome process of changing the casts once a fortnight which is performed by a specialist doctor at a hospital or qualified stuff at a special ward. This tiresome process also requires preparation prior to the hospital visit. The process lasts for weeks and weeks and also involves dealing with hygienic issues related to the baby's stool and urine. When plastic casts are used the changing of casts is done by sawing which might cause injuries to the baby's feet.
In other cases, doctors recommend physiotherapy sessions at home, hoping to achieve some improvement. In such cases the responsibility falls on the parents rather than on the doctor. In the worst case scenarios, parents are sent home, being told that "there is no need for treatment, it will improve by itself". Indeed, sometimes the problem is solved without treatment, but in most cases it doesn't. One can never know in which case the problem will resolve itself and in which case the baby will continue to suffer from the problem and its side-effects in the future.
We are proud to introduce: a new, easy-to-use and effective solution to Metatarsus Adductus, made in Israel.
A one-of-a-kind biomechanical shoe which completely solves the problem. It is light, simple and elegant and has a unique feature – the shoe is worn below the ankle.
UNFO MED Ltd. which developed the footwear is an ISO 13485-certified orthopedic company.
The company was founded by Dr. Izak Daizade, a specialist in the field of orthopedic surgery with over 35 years of experience in the field. UNFO MED is the manufacturer of the revolutionary orthopedic system for newborn feet. The system is based on the expertise of Dr. Daizada in pediatric surgery. Dr. Daizade developed a treatment for Metatarsus Adductus and Clubfoot in newborns and is nowadays promoting this revolutionary treatment.
According to the company's owners there is no longer a reason to make do with answers such as "it will be fine" or "perhaps the problem will go away with time". You no longer have to go through the exhausting archaic treatments or complicated surgeries. The most important thing is to identify the problem at an early stage and start treating it with UNFO Foot Brace, preferably before the child is 6 months old. At a later stage it is much more difficult and complicated to treat the problem and it might even be impossible to do so.
What could happen if the child is not treated at all?
According to Dr. Daizade it might cause future side effects which are usually reflected in footwear fitting, frequent wear and tear of shoes, calluses, pains, toes deformation and other orthopedic and aesthetic problems. It is easier to deal with the problem when the babies are younger and their skeleton is softer. You don't need to take the risk and see what the future holds.
Dr. Daizade adds that he is very proud that Israeli children are the first to enjoy this innovative treatment.
For further information :
Address: 52 Weizmann Street, Holon
Photos provided by UNFO MED